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Abstract 
In the mammalian heart, the action potential spontaneously generated in the sinoatrial 
(SA) node propagates through the atria to reach the atrioventricular (AV) node. As the only 
conduction pathway between the atria and ventricles, the AV node functions to delay and 
regulate action potential conduction between the atria and ventricles. Since Tawara described 
the anatomical and morphological characteristics of the AV node in 1906, it has been difficult to 
correlate electrophysiological recordings with distinct cell types and the three dimensional 
structure of the AV node due to the exceptional functional and architectural complexity of this 
region. The cardiac voltage-gated Na+ channel isoform (Na1.5) is known to play a major role in 
the generation and conduction of the action potential in the heart. Recently, various mutations of 
Na, 1.5 responsible for AV conduction block and Na,, 1.5+"- mice with impaired AV conduction 
have been reported. Various neuronal Na' channel isoforms have also been shown to be 
expressed in the heart (mouse ventricular myocytes and rat and mouse SA node) and to be 
functionally important. The distribution of neuronal Na' channel isoforms in the AV node is 
unknown. The aim of this study was to investigate the distribution of cardiac and neuronal Na' 
channel isoforms in and around the AV node. 
The nodal cell region was identified by Masson's trichrome staining and confocal 
microscopy with immunohistochemical markers, such as connexin43 (Cx43), desmoplakin 
(DP), atrial natriuretic peptide (ANP) and the type 4 hyperpolarization-activated cyclic 
nucleotide-gated cation (HCN) channel. The unique pattern of expression in the nodal cell 
region (DP-positive/Cx43-negative/ANP-negative/HCN4-positive) allowed it to be 
distinguished from the surrounding working myocardium (DP-positive/Cx43-positive/HCN4- 
negative). 
I have investigated the expression of Na,, 1.5 and other Na' channel isoforms in rat AV 
node. Na1.1 was distributed in a similar manner to Na, 1.5. Na, 1.2 was not detected. Na,, 1.3 
labelling was restricted to nerve fibres and nerve cell bodies and was not detected in myocytes. 
Na,, 1.3 labelling was abundant in the enclosed node and the common bundle, but much less 
abundant in other regions. Na, 1.4, the skeletal isoform, was not studied. Na, 1.5 labelling was 
present in atrial and ventricular myocardium and the left bundle branch (right not studied). 
However, Na, 1.5 labelling was absent in the open node, the enclosed node and the common 
bundle, but present at a reduced level in the posterior nodal extension, transitional cells and AV 
ring bundle. Na,, 1.6 was not detected. 
The study has revealed a complex organisation of three different myocyte types at the 
AV junction (including the tricuspid annulus). Impaired AV conduction as a result of mutations 
in or loss of Na,, 1.5 must be the result of impaired conduction in the AV node inputs (posterior 
nodal extension and transitional cells) or output (bundle branch) rather than the AV node itself 
(open and enclosed nodes). 
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Chapter 1 
General Introduction 
1.1. AV node: structure and function 
The cardiac impulse is generated in the SA node from where it traverses and activates 
the atria before arriving at the AV node. From the AV node, the impulse is distributed to the 
ventricular myocardium via a specialised conduction system consisting of the His bundle, the 
bundle branches to each ventricle and the ramifying Purkinje fibre network (Fig. 1.1A) 
(Anderson & Ho, 2000; Schram et al., 2002). 
Tawara (2000) was the first to describe the morphology of the AV node in the hearts of 
several species. His major achievement was to show that the AV conduction axis is a 
continuous system of histologically distinctive cells from the atrial septum to the ventricular 
Purkinje cells. 
The AV nodal area is within the boundaries of the so-called triangle of Koch (Koch, 
1909). This is the region demarcated by the attachment of the septal leaflet of the tricuspid 
valve, the ostium of the coronary sinus and the tendon of Todaro. Precise borders for the AV 
2 
B 
TV 
Figure 1.1 Sub-divisions in the AV conduction axis 
Common to all studies 
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A, 'l'awara's initial description of AV conduction axis. This figure originally drawn by Tawara 
(2000) shows the various sub-divisions of the AV conduction axis. A, anterior; L, left; P. 
posterior; R, right. From Mazgalev et al. (2001). B, AV node landmarks and sub-divisions. CB, 
common bundle; CN, compact node; CS, coronary sinus; EN, enclosed node; LNC, lower nodal 
cells; MNC, mid-nodal cells; ON, open node; Pß, penetrating bundle; P/I NE, posterior/inferior 
nodal extension; TAVRB, termination of the AV ring bundle; 1'C, transitional cells; TT, tendon 
of Todaro; TV, tricuspid valve. Modified from Medkour et al. (1998). 
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node cannot be determined, because on the atrial side the transition between nodal and atrial 
tissue is gradual and no sharp boundary can be detected (Tawara, 2000). 
Furthermore, Tawara found a similar continuity between the nodal region and the 
opening of the coronary sinus (Tawara, 2000), while others demonstrated that this area could 
behave as a pacemaker in special cases (Koch, 1909; Wit & Cranefield, 1977). The triangle of 
Koch contains multilayered and complex morphological structures that anatomically and 
functionally form a continuum between the atrium and the bundle of His (Anderson & Ho, 
2000). 
Besides the complex structure of the AV node, the use of different nomenclature for 
sub-divisions of the AV node by different investigators has made it difficult to correlate tissue 
structure, cell types and electrophysiological recordings. Thus, it is helpful to compare the 
nomenclature used in this study and that used in other studies. Fig. 1.1B shows anatomical land 
marks and sub-divisions of the AV node. Sub-divisions shown in green are defined in this study 
and sub-divisions shown in blue represent those used in other studies. There are differences 
concerning the transitional zone and the compact node. Conventionally, the term transitional 
zone refers to all approaches to the AV node. However, as explained in detail in chapter 3 (see 
section 3.4.4), the transitional zone in this study corresponds to the anterior/superior approach to 
the AV node. Conventionally, the term compact node refers to a group of compactly arranged 
nodal cells (within the insulated bundle in the rabbit). However, in this study, a more useful 
division (based on histology) was a division into the open node (not insulated) and the enclosed 
node (insulated). The precise border of the compact node, the open node and the enclosed node 
cannot be made easily. 
Apart from the fact that the AV node normally forms the only link between the atria and 
ventricular specialised conduction system, three different functional characteristics distinguish 
the AV node: 1) the AV node conducts the impulse slowly, thereby causing a delay between the 
activation of the atria and ventricles. Because of this so-called AV nodal delay, the contractions 
of the atria and ventricles are coordinated (Tawara, 2000). 2) The AV node is capable of 
blocking impulses on their way from the atria to ventricles, when these occur prematurely or at 
a rapid rate, thus protecting the ventricles from too rapid rhythms and to a certain extent from 
irregularities in rhythm (Lewis, 1925). 3) The AV node may serve as a pacemaker to the 
ventricles when the SA node fails or when conduction block between the atria and AV node 
develops (Watanabe & Dreifus, 1968; James et al., 1979; Janse & Tranum-Jensen, 1981; 
Dobrzynski et al., 2003). 
The relative importance of the functions of the AV node differs in large and small 
mammalian hearts. In small mammals, synchronisation of atrial and ventricular contractions is 
the major function of the AV node, whereas protection from rapid atrial arrhythmias may be its 
most important function in large mammals. For example, it is clear that in small mammals, 
where conduction time in the ventricular conduction system may take no more than 2-5 ms, an 
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AV nodal delay is necessary to ensure that ventricular contraction does not begin before atrial 
contraction has ended (Altman & Dittmer, 1971; Meijler, 1985). 
1.2. Electrophysiology of the AV node 
1.2.1. The difficulties in correlating morphological cell types with 
electrophysiological recordings 
Although different authors usually use different nomenclature, the AV nodal region is 
most frequently described as encompassing transitional cells, mid-nodal cells, and lower nodal 
cells (Fig. 1.2) (Janse et al., 1978; Billette & Amellal, 2000). Early microelectrode studies 
showed that based on activation times and the action potential characteristics, the cells of the 
AV node are frequently described as atrionodal (AN), nodal (N), and nodal-His (NH) (Fig. 1.2) 
(de Carvalho & de Almeida, 1960). 
As noticed by Tawara (2000), on the atrial side, the transition between nodal and atrial 
tissue is gradual and the boundaries of the compact node are not sharply defined. Furthermore, 
Tawara (2000) found similar continuity between the nodal region and the opening of the 
coronary sinus. Similarly, the electrical responses of the nodal cells are not unique. Thus, action 
potentials with low resting potentials, a slow upstroke and small amplitudes can be recorded 
from "nodal-like" cells that are found in the nodal approaches (Billette, 1987). 
AN cells are transitional cells. These cells are morphologically different from the 
working atrial cells and are widely spread within the nodal approaches and are intermingled 
with the even smaller nodal cells in the compact region (de Carvalho & de Almeida, 1960; 
Billette, 1987). There is no correlation between action potential types and the specific areas 
from which the responses are recorded. Paradoxically, the most typical nodal action potential 
has not yet been linked to the most typical nodal cell (Meijler & Janse, 1988). Although AV 
nodal cells now can be enzymatically dissociated and the electrical properties of cells isolated 
from the AV node have been studied, the precise region from which they were isolated is 
unknown (Munk et at, 1996; Workman et at, 2000). The difficulties in providing precise 
morphological electrophysiological descriptions are in part the result of the lack of appropriate 
techniques for simultaneous examination of the electrical responses and the structure of the 
same cells (Meijler & Janse, 1988). 
1.2.2. Dual pathway electrophysiology and AV nodal reentry 
The AV node is activated by atrial wavefronts travelling via the terminal part of the 
crista terminalis and interatrial septum (Amellal & Billette, 1996). Although the specialised 
components of the AV node communicate with the atrial myocardium through connections 
running in virtually all directions (Sanchez-Quintana et al., 1997), the dual pathways refer to 
posterior/inferior and anterior/superior sites. These two major inputs have been specifically 
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Figure 1.2 The morphological divisions of the AV node of the rabbit 
Diagrams show distribution of morphologically different cell types in rabbit AV node. 70/x: 
transverse section showing trilaminar appearance in the enclosed node. The position of' this 
section is demarcated by a bar in the bottom panel. Bottom: diagram indicates sites where 
typical transmembrane potentials were recorded. CS, coronary sinus; IAS, interatrial septum; 
IVS, interventricular septum; His, His bundle. From Janse et a!. (1978). 
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regarded as having special functional importance: the substrate for AV nodal reentry and 
usually targeted during ablation procedures (Schluter et at, 1991; Jazayeri et at, 1992; Keim et 
at, 1992; McGuire et at, 1993; Mitrani et al., 1993; Lo et at, 1995; Inoue et al., 1999). Results 
of ablation therapy provide convincing evidence of dual-pathway physiology; ablation carried 
out posteriorly to the compact node eliminates the slow pathway (Haissaguerre et at, 1989; 
Jazayeri et at, 1992; Jackman et at, 1992), whereas ablation carried out anterosuperiorly to the 
compact node eliminates the fast pathway (Epstein et at, 1989; Lee et al., 1991). 
Fig. 1.3 shows the dual pathway AV nodal electrophysiology model in the rabbit 
according to Mazgalev & Tchou (2000). The cells of the penetrating bundle in the rabbit extend 
posteriorly and inferiorly beneath the compact region, emerging into the atrial tissues where the 
cells, now called lower nodal cells, are no longer insulated and make contact with atrial tissue 
via an envelope of transitional cells. The inferior nodal extensions can be traced on the basis of 
histology into the vestibule of the tricuspid valve, providing the input to the node via the 
terminal crest (crista terminalis). The atrial cells do not communicate directly with the compact 
and/or lower nodal cells, but only through the intermediate transitional cells (Mazgalev et al., 
2001). 
The dual pathways, although generally similar, differ between species. In the rabbit 
(and other small animals including the rat), the compact node is predominantly part of the 
insulated penetrating bundle portion of the axis. In contrast, in the human (and other big animals 
including the dog), the compact node is part of the atrial component of the axis and is not 
insulated by fibrous tissue from the atrial myocardium. 
Although the transitional envelope and the lower nodal tracts are intermixed with fat 
and connective tissue, they are not electrically insulated (as in the His-Purkinje system). The 
atrial beat enters the AV node proper from several directions, the most prominent of which are 
the posterior approaches (crista terminalis), the superior septal approaches along the fosa ovalis, 
and the broad mid-septal approaches across the tendon of Todaro (Mazgalev et a1., 2001). 
While not isolated from each other, these connections result in a functionally highly 
inhomogeneous atrio-nodal transition. Thus, during sinus rhythm (with relatively long coupling 
intervals between beats) predominant is the wavefront formed along the anterior septal nodal 
input(s). It reaches the bundle of His first, generating the relatively brief basic conduction delay. 
In contrast, premature stimuli (with short coupling intervals) are blocked in these anterior 
approaches allegedly due to the relatively long refractoriness of the tissue and/or due to specific 
passive properties of the conducting fibers and their interconnections. Therefore, the short- 
coupled beats proceed along the posterior input approaches and, in general, require longer time 
to reach the bundle of His. Based on these properties and following a very simplified (and 
therefore approximate) morphological model, the posterior approaches are regarded as a domain 
of the so-called slow pathway, while the anterior septal input region hosts the fast pathway. 
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Figure 1.3 Schematic illustration of dual pathway AV nodal electrophysiology in the 
rabbit 
Dashed arrow, fast pathway; wavy arrow, slow pathway. AVN, AV node; CFI3, central fibrous 
body; CrT, crista terminalis; CS, coronary sinus, FO, fossa ovalis; IAS, interatrial septum; IVC, 
inferior vena Cava; Pß, penetrating bundle; TrV, tricuspid valve; TI', tendon of 'I'odaro. 
Orientation is shown by the "compass" (A, anterior; I. inferior; P, posterior; S, superior). 
Modified From Mazgalev & Tchou (2000a). 
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In summary, a short-coupled atrial stimulus may be blocked in the fast pathway 
(anterior septal input) while successfully propagating via the slow pathway (posterior input) 
toward the bundle of His. If this propagation is slow enough, the impulse may reenter the atrium 
retrogradely via the sufficiently recovered fast pathway, producing an echo-beat. The latter may 
then continue the same process leading to AV nodal reentrant tachycardia (AVNRT) (McGuire 
et al., 1991; Patterson & Scherlag, 1999). 
During typical AVNRT, anterograde atrial-His conduction that proceeds via the inferior 
portion of the reentry loop is substantially longer ("slow") than is the retrograde conduction via 
the superior, or "fast, " pathway. In addition, the relatively short delays observed within the node 
during sinus rhythm are thought to result from anterograde conduction through the fast pathway 
(Mazgalev et al., 2001). 
Although functionally we know the fast and slow pathways responsible for AV nodal 
dual pathway electrophysiology and reentry are important, we know little about the anatomical 
substrate underlying the two pathways. It is the electrophysiological properties of the two 
pathways that underlie the functional importance of the two pathways and, therefore, we need to 
understand ion channel expression in the two pathways (Sung et al., 1994; McGuire & Janse, 
1995; Billette, 2002). 
1.3. Gap junction channels 
1.3.1. Architecture 
Conduction of the cardiac impulse is dependent on both the active membrane properties 
of cardiac cells (generating the action potential) and the passive properties determined by 
architectural features of the myocardium. The influence of tissue architecture on conduction is 
determined principally by the size, shape and packing of individual myocytes and by the 
quantity, three-dimensional distribution and physiological behavior of the specialised 
intercellular junctions responsible for impulse propagation from cell to cell, the gap junctions 
(Peters & Wit, 1998). 
It has been reported that conduction is more rapid in the direction parallel to the 
myocardial cell axis than in the transverse direction, because of the lower resistivity of the 
myocardium in the longitudinal than the transverse direction. Gap junctional channels create 
continuity between the cytoplasmic compartments of abutting myocytes, but act as resistive 
discontinuities to the cytoplasmic current flow between the intracellular compartments of the 
cells (the "intracellular" conduction pathway). Longitudinal resistivity is lower than transverse 
resistivity because intracellular pathway encounters fewer cell boundaries per unit distance in 
the longitudinal than the transverse direction and the resistivity of the gap junctional membrane 
is several orders of magnitude higher than the cytoplasmic intracellular resistivity (Peters & 
Wit, 1998). In the myocardium, approximately half of all connections are side to side and half 
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are end to end (Hoyt et at, 1989; Luke & Saffitz, 1991). This means that there is a greater 
density of connections end-to-end than side-to side. 
The archetypal working myocytes of the ventricles and atria are elongated, branching, 
contractile cells, extensively interconnected by clusters of gap junctions organized in 
intercalated disks (Page, 1992; Peters et at, 1993; Peters et al., 1994; Severs et at, 2001). The 
myocytes in the atrial myocardium are slender and have less extensive intercalated disks and 
more lateral junctional contacts than their ventricular counterparts (Severs et al., 2001). The 
intercalated disks also contain two types of anchoring junction, the fascia adherens and 
desmosome, which mediate cell-to-cell linkage of the contractile filaments and the intermediate 
filament cytoskeleton, respectively. These anchoring junctions act in concert with the gap 
junctions to integrate cardiac mechanical, metabolic and electrical function (Sjöstrand & 
Andersson-Cedergren, 1960; Severs, 1990; Severs et at, 2001). 
Gap junctions are specialised regions of the intercalated disk (Sjöstrand & Andersson- 
Cedergren, 1960; Severs, 1990; Beyer, 1993; Bruzzone et al., 1996) in which integral proteins, 
connexins (Fig. 1.4), exist in hexameric units called connexons (Beyer, 1993), each of which 
possesses a 1.5- to 2-nm central pore (Flagg-Newton et al., 1979). The connexons in the 
abutting myocyte membranes (Fig. 1.4) align, and the pair forms a complete channel linking the 
cytoplasmic compartments, providing a relatively low-resistance pathway for the passage of 
ions and small molecules (up to =1 kD) (Imanaga et al., 1987) and for electrical propagation 
(Spray & Burt, 1990). 
In the mammalian heart, a connexin composed of 342 amino acid residues (Beyer et al., 
1987) with a molecular weight of 43,000 (connexin43 or Cx43) is the most abundant connexin 
and is abundant in the working ventricle and atrium. Two further isotypes, connexin40 (with a 
molecular weight of 40,000; Cx40) and connexin45 (with a molecular weight of 45,000; Cx45), 
are also expressed in a myocyte subtype and chamber-specific manner. 
In cells expressing more than one connexin type, however, a multiplicity of different 
arrangements involving heterotypic channels (those in which the connexin makeup of the 
component connexons differs), homotypic channels (in which the connexin makeup of the 
component connexons is identical) or heteromeric channels (in which the component connexons 
contain mixtures of connexins) is possible, the functional correlates of which are yet to be fully 
clarified (Severs et al., 2001). 
1.3.2. Gating and unitary conductance 
Gap junctional channels can exist in open or closed states. The proportion of channels 
that are in an open state and the physiological properties of the channel, such as selective ion 
permeability, unitary conductance and voltage sensitivity, are determined by the characteristics 
of the connexin isoforms composing the channel (Veenstra et al., 1994; Moreno et al., 1994; 
Beblo et al., 1995; Veenstra, 1996). 
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Figure 1.4 Model of a gap junction 
A, model of a gap junction. A gap junction consists of a cluster of channels. Each channel 
consists of a pair of connexons, one contributed from each plasma membrane. A connexon 
consists of six connexin molecules (connexin4O, 43 or 45 in the heart). B, molecular structure of 
one connexin. A connexin molecule consists of four transmembrane regions and amino and 
carboxy termini situated on the cytoplasmic side ofthe membrane. From Peters & Wit (1998). 
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The conductance of a single Cx43 channel in its main conductance state is 40 to 60 pS 
(Burt & Spray, 1988), but the physiological and potential pathophysiological significance of 
two other minor conductance states remains to be determined (Moreno et al., 1994; Bruzzone et 
at, 1996). The main unitary conductance of Cx40 is 150 to 200 pS, a value higher than that of 
Cx43. Selective expression of Cx40 in the atrial myocardium and His-Purkinje tissues may 
therefore facilitate rapid conduction in these tissues (Bruzzone et at, 1996). Cx45 has a low 
unitary conductance (22 and 36pS; Bruzzone et al., 1996). 
Gating of Cx43 channels is relatively insensitive to transmembrane voltage and Cx43 
channels are highly permeable to anions and cations and fluorescent dyes of different charge 
densities and molecular weights (Veenstra, 1996). In contrast, Cx40 and Cx45 channels are 
highly cation selective (Veenstra et al., 1994; Beblo et al., 1995; Veenstra, 1996) and Cx45 
gating is voltage-dependent. The dye Lucifer yellow, used in classic assays of junctional 
coupling, passes much more freely through Cx43 than Cx40 channels and not detectably 
through Cx45 channels (Veenstra et al., 1994; Beblo et al., 1995; Veenstra, 1996). 
1.3.3. Distribution in and around the AV node 
19 different connexin genes have been identified in the mouse genome (Willecke et al., 
2002) and the final count is likely to take us to well over 20. In mammalian heart, four main 
isotypes (Cx37, Cx40, Cx43 and Cx45) are expressed (Beyer et al., 1987; Willecke et al., 1991; 
Haefliger et al., 1992; Hennemann et al., 1992; Gros & Jongsma, 1996) and further isotypes 
such as Cx46 and Cx57 may also be present in trace amounts (Paul et al., 1991; Manthey et al., 
1999). 
Cx43 is predominantly found in large quantities in the ventricles and atria of all 
mammalian species (Gros & Jongsma, 1996; Severs et at, 1996). Cx40 is abundant in the atrial 
myocytes of most species, co-organized with Cx43 in the same junctional plaques, though 
working ventricular myocytes characteristically lack this connexin (Van Kempen et at, 1995; 
Vozzi et al., 1999). Cx40 is also abundant in the AV conduction system, i. e. the His bundle, 
bundle branches and Purkinje fibres, where it is implicated in facilitating fast conduction 
(Gourdie et at, 1993; Kanter et at, 1993; Bastide et at, 1993; Davis et al., 1994; Gros et at, 
1994). Cx45 is present only in very low quantities; this connexin is typically undetectable or 
barely detectable by immunocytochemistry in working ventricular myocytes, though slightly 
higher levels are present in the atrium (Coppen et al, 1998; Vozzi et al, 1999). Cx45 is 
preferentially expressed in the SA node and the AV conduction system (Coppen et al., 1998; 
Coppen et al., 1999; Severs et al., 2001). 
1.4. Ionic currents in the AV node 
Although the action potentials recorded from isolated cells can also be classified into 
AN, N and NH subgroups (Munk et al., 1996), direct juxtaposition of these groups to the groups 
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described in the intact heart (see section 1.2.1) is only approximate, because the isolation 
procedures are blind and do not permit the identification of the specific regions from which the 
isolated cells originate. Instead, isolated cells have been described based on their shape after 
isolation (ovoid or rod-shaped) (Munk et al., 1996). Ovoid cells have N- or NH-like action 
potentials showing post-repolarization refractoriness and no action potential abbreviation with 
increased frequency, less negative maximum diastolic potentials, faster diastolic-depolarization, 
and lower upstroke velocity than those in rod shaped cells. Rod-shaped cells display action 
potentials intermediate between ovoid cells and atrial cells (AN type) (Munk et al., 1996). Fig. 
1.5 shows action potentials recorded from single cells isolated from rabbit AV node. 
Several studies have reported ionic currents recorded during voltage clamp of isolated 
AV nodal cells (Taniguchi et al., 1981; Nakayama et al., 1984; Nakayama & Irisawa, 1985) or 
small preparations of AV nodal tissue (Nishimura et al., 1989). While voltage clamp studies 
have identified the presence of various ionic currents, there is still relatively little known about 
the distribution, nature and function of these currents in the various AV nodal cell types. 
However, something is known as described below. 
1.4.1. Na+ current 
A number of studies have attempted to resolve the nature of the ionic currents 
responsible for the action potential upstroke, a key determinant of AV nodal cell excitability. In 
the working myocarium, it has long been known that a voltage-dependent Na' current ('Na) is 
responsible for the action potential upstroke (Weidmann, 1955). However, it has been suggested 
that 'Na is either absent or reduced in the mid-nodal region (N cells). This hypothesis is 
supported by the observations that application of hyperpolarizing current to N cells did not 
result in an increase in the maximum upstroke velocity (Hoffman, 1961; Anderson et al., 1974) 
and that verapamil, D600 and Mn 2+ suppressed action potentials in the N region whereas TTX 
was without effect (Zipes & Mendez, 1973; Watanabe, 1981). In contrast, other groups have 
reported that application of a hyperpolarizing current resulted in an increase in the amplitude 
and maximum upstroke velocity of N cell action potentials (Shigeto & Irisawa, 1974) and the 
availability of the Na+ channel (Kokubun et al., 1982; Nakayama et al., 1984). Moreover, it was 
also reported that the action potential upstroke of AV nodal cells can be biphasic, with one 
component being TTX-sensitive (Ruiz-Ceretti & Zumino, 1976). However, it is still unclear as 
to the origin of the cells studied and which cell types, if any, lack Na' channels. In order to 
address these issues, patch clamp studies were undertaken by Munk et al. (1996) in different 
AV node cell types. 'Na appears to be absent in ovoid cells (Munk et al., 1996). In rod-shaped 
cells, 'Na is present, but it is much reduced compared with the levels in the working myocardium 
(Munk et al., 1996). Cells that lacked a significant 'Na also appeared to lack a significant 
transient outward K; current (Ito), but had a prominent If (hyperpolarization-activated inward 
current) (Munk et al., 1996). 
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Figure 1.5 Action potentials recorded from isolated AV nodal myocytes 
A-C, whole cell patch electrode recordings of AN-, N- and NH-like action potentials from 
isolated AV nodal myocytes of the rabbit. Calibration values in A apply to all panels. Modified 
from Munk et al. (1996). 
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1.4.2. Ca 2+ current 
Early studies on the intact AV node using various ion channel blocking agents such 
Mn2+, tetrodotoxin (TTX) and verapamil revealed that a slow inward current was present in AV 
nodal myocytes (Zipes & Mendez, 1973; Noma et al., 1980; Kokubun et al., 1982). This 
TTX-resistant slow inward current is consistent with the L-type Ca2+ current (Ice, ) originally 
described in atrial cells (Bean, 1985). Importantly, ICa, L was found to be present in single cells 
isolated from all nodal regions (Hancox & Levi, 1994; Munk et al., 1996). 
To date, little data exist concerning the role of T-type Ca 2+ current (Ica, T) in the AV 
node. The threshold of T-type Ca 2+ channels is more negative than that of L-type Ca2+ channels, 
making it well suited for participation in pacemaker activity in the SA node (Hagiwara et al., 
1988; Lipsius et al., 2001). 
1.4.3. Transient outward K{' current 
Using the whole cell voltage clamp technique, I, o was observed in cells isolated from 
the AV nodal region (Nakayama & Irisawa, 1985); however, the nodal region from which the 
cells were isolated was not determined. More recently, I, o has been reported to be variably 
expressed in AV nodal cells (Munk et al., 1996). Io was observed in combination with 'Na in 93 
% of rod-shaped cells, presumably isolated from the transitional cell region, but in only 24 % of 
ovoid-shaped cells, presumably isolated from the mid-nodal cell region. 4, alone was found in 
-40 % of ovoid-shaped cells. Taken together, this indicates that the majority of I, o, similar to 'Na, 
is relegated to the AN region and to a certain population of cells in the N region. 
4-aminopyridine, a blocker of I, o, inhibits spontaneous AV node action potentials, which 
is consistent with a role for Ira in AV node pacemaking (Mitcheson & Hancox, 1999). It, 
elimination in transgenic mice causes AV block (Guo et al., 2000). 
1.4.4. Delayed rectifier K{' current 
A major repolarizing current in AV nodal myocytes is the delayed rectifier K+ current, 
IK (Noma et al., 1980). Contrary to the SA node, where both I and IK, (the rapidly and slowly, 
respectively, activating delayed rectifier K+ currents) are important, the inward rectifier 
properties and relatively negative activation range of this current are consistent with 1y alone 
(Sanguinetti & Jurkiewicz, 1991). Iy activation contributes to AV node repolarization and IV, 
deactivation to diastolic depolarization (Hancox & Mitcheson, 1997). 
1.4.5. Inward rectifier K{' currents 
Inwardly rectifying K' current channels are critical for establishing the resting 
membrane potential of cardiomyocytes and thus are independently critical in determing the 
upstroke velocity of the action potential and hence conduction velocity. Furthermore, they carry 
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a small but significant outward current during the late stages of the action potential, thus 
contributing to final repolarization (Nichols & Lopatin, 1997). 
A family of genes encoding inwardly rectifying K+ channels (Kir) has been identified. 
There are at least six Kir subfamilies (Kirl-6), classified according to similarities in amino acid 
sequence. To date, only Kir2 (IRK-type) (Kubo et al., 1993) and Kir3 (GIRK-type) 
(Krapivinsky et al., 1995a) transcripts have been found in the heart. Heterologously expressed 
Kir2 channels exhibit time- and voltage-dependent rectification almost indistinguishable from 
that of native inward rectifier K+ current (IKI), which is abundant in atria and ventricles, but 
largely absent from the AV node. The absence of IK) in the AV node is consistent with the 
relatively positive maximum diastolic potential in the AV node. 
Conversely, the ACh-sensitive K+ current (IK, ncn; GIRK-type) is known to be a critical 
modulator of atrial, SA and AV nodal excitability (Wickman & Clapham, 1995). In the heart, 
the channel for IK, Ach is a heteromultimer of two subunits, Kir3.1 (GIRK1) and Kir3.4 (GIRK4). 
IK, nch depresses heart rate by hyperpolarizing pacemaker cells in the SA and AV nodes by 
binding to type 2 muscarinic receptors activating pertussis toxin-sensitive G proteins (Clapham 
& Neer, 1997). The active Gp, subunits (released from the G protein) directly bind and activate 
the J' 
, ch channel 
(Krapivinsky et al., 1995b). Importantly, IK ash also mediates the effects of 
adenosine (Belardinelli et al., 1995). Adenosine binds to type I purinergic receptors, in turn 
catalyzing the G protein complex dissociation enabling Gpy subunits to directly activate IK Ach. 
Adenosine administration results in a concentration-dependent decrease in the duration 
and amplitude of action potentials of AN and N cells (Clemo & Belardinelli, 1986). In N, but 
not in AN cells, adenosine also depresses the upstroke velocity of the action potential (Clemo & 
Belardinelli, 1986). At high concentrations, adenosine completely abolishes N cell action 
potentials (Clemo & Belardinelli, 1986). In contrast, adenosine has no effect on NH cell action 
potentials (Clemo & Belardinelli, 1986). The mechanism by which adenosine depresses action 
potentials of AN and N cells is most likely its effect on IK, ach, and/or inhibition of cyclic 
adenosine monophosphate (cAMP) production, which results in a decrease in ICa, L and If 
(Belardinelli et al., 1995; Martynyuk et al., 1995). 
1.4.6. Pacemaker current 
Noma et al. (1980) first demonstrated the presence of If in the AV node. Kokubun et al. 
(1982) observed this current in 20 % of their AV nodal specimens. Similarly, Hancox & Levi 
(1994) reported the absence of this current in 80 - 90 % of the isolated AV nodal cells they 
analyzed. Conversely, Habuchi et al. (1995) reported that If was present in 90 % of the AV 
nodal cells they studied. In the study of Munk et al. (1996), approximately 90 % of the ovoid- 
shaped cells displayed a relatively large If that was activated at relatively positive potentials in a 
range that could affect excitability and pacemaker activity, whereas If was present in 10 % of 
rod-shaped cells. If density in ovoid cells was also 25-fold larger than that in rod-shaped cells. 
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This is consistent with the much greater ovoid cell pacemaker activity (Munk et al., 1996). 
Thus, it would appear that there is a heterogeneous regional distribution of If in the AV nodal 
region. 
1.4.7. Na+/Ca2+ exchanger 
Studies in working myocardial cells indicate that the Na+/Ca2+ exchange current (INa-ca) 
is significant in the repolarizing phase of the action potential (Hryshko, 2004). Hilgemann 
(1989) demonstrated that INC. a-is an important inward current in the negative potential range of 
the cardiac action potential. Modelling studies of the SA node suggest that INa. ca contributes to 
the action potential configuration and pacemaker activity (Wilders et al., 1991). Bodganov et al. 
(2001) have more recently shown experimentally a role of INa-ca in pacemaker activity in the SA 
node. A recent report has indicated that INa. ce is present in AV nodal cells and exhibits a similar 
profile to that in ventricular cells (Convery & Hancox, 2000). 
1.5. Na+ channel expression in the AV node 
1.5.1. Voltage-gated Na+ channel isoforms 
Voltage-gated Na+ channels are responsible for action potential initiation and 
propagation in excitable cells, including nerve, muscle, and neuroendocrine cell types. They are 
also expressed at low levels in non-excitable cells, where their physiological role is unclear. Na+ 
channels consist of an a subunit, which is approximately 260 kDa, and auxiliary ß subunits 
(Catterall, 2000). The pore-forming a subunit is sufficient for functional expression, but the 
kinetics and voltage-dependence of channel gating are modified by the ß subunits, and these 
auxiliary subunits are involved in channel localization and interaction with cell adhesion 
molecules, the extracellular matrix, and the intracellular cytoskeleton. The a subunits are 
organized in four homologous domains (I-N), each of which contain six transmembrane a 
helices (S1-S6) and an additional pore loop located between the S5 and S6 segments (Fig. 1.6). 
The pore loops line the outer, narrow entry to the pore, whereas the S5 and S6 segments line the 
inner, wider exit from the pore. The S4 segments in each domain contain positively charged 
amino acid residues at every third position. These residues serve as gating charges and move 
across the membrane to initiate channel activation in response to depolarization of the 
membrane. The short intracellular loop connecting homologous domains III and IV serves as 
the inactivation gate, folding into the channel structure and blocking the pore from the inside 
during sustained depolarization of the membrane. 
A variety of different Na' channels has been identified by electrophysiological 
recording, biochemical purification, and cloning (Goldin, 2001). The functional properties of 
the known Na+ channels are similar. Despite their similarity of function, the Na+ channels were 
originally named in many different ways, with no consistent nomenclature for the various 
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Figure 1.6. Transmembrane organization of Na' channel subunits 
The primary structures of the subunits of the voltage-gated Na' channel are illustrated as 
transmembrane-folding diagrams. Cylinders represent probable a-helical segments. Bold lines 
represent the polypeptide chains of each subunit, with length approximately proportional to the 
number of amino acid residues in the brain sodium channel subtypes. The extracellular domains 
of the (31 and ß2 subunits are shown as immunoglobulin-like folds. `P, sites of probable N- 
linked glycosylation; P, sites of demonstrated protein phosphorylation by protein kinase A 
(circles) and protein kinase C (diamonds); shaded, pore-lining S5-P-S6 segments; white circles, 
the outer (EEDD) and inner (DEKA) rings of amino residues that form the ion selectivity filter 
and tetrodotoxin binding site; + +, S4 voltage sensors; Ii in shaded circle, inactivation particle in 
the inactivation gate loop; open shaded circles, sites implicated in forming the inactivation gate 
receptor. Sites of binding of a- and ß-scorpion toxins and a site of interaction between a and (31 
subunits are also shown. From Catterall (2000). 
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isoforms. To eliminate confusion resulting from the multiplicity of names, a standardized 
nomenclature was developed for voltage-gated Na' channels (Goldin et al., 2000). It uses a 
numerical system to define subfamilies and subtypes based on similarities between the amino 
acid sequences of the channels. In this nomenclature system, the name of an individual channel 
consists of the chemical symbol of the principal permeating ion (Na) with the principal 
physiological regulator (voltage) indicated as a subscript (Nav). The number following the 
subscript indicates the gene subfamily (currently only Nail), and the number following the full 
point identifies the specific channel isoform (e. g., Navl. 1). This last number has been assigned 
according to the approximate order in which each gene was identified. 
The nine mammalian Na' channel isoforms that have been identified and functionally 
expressed are all greater than 50 % identical in amino acid sequence (Table 1.1). The Na' 
channel sequences vary continuously, without defining separate families. By this criterion, all of 
the nine Na+ channel isoforms may be considered members of one family. 
Based on analysis of amino acid sequence alignment and measurement of evolutionary 
distance from each isoform (Goldin et al, 2000), Na1.1, Na1.2, Na1.3 and Na, 1.7 are the most 
closely related because their genes are all located on human chromosome 2q23-24 (Table 1.1). 
All four of these Na+ channels are highly TTX-sensitive and are broadly expressed in the central 
nervous system. Na1.5, Na,, 1.8 and Na,, 1.9 have a common evolutionary origin because of the 
location of their genes on human chromosome 3p21-24 (Table 1.1). These Na' channels are 
TTX-resistant to varying degrees, due to changes in amino acid sequence at a single position in 
the pore region of domain I (in case of Na, 1.5, there is a cysteine instead of an aromatic residue, 
Fozzard & Hanck, 1996), and they are expressed in heart and dorsal root ganglion neurons. 
Na,, 1.4, expressed primarily in skeletal muscle, and Na, 1.6, expressed primarily in the central 
nervous system, are different from the other two closely related groups of Na' channel genes. 
The location of the genes encoding these two Na' channels on chromosomes 17q23-25 and 
12q 13 can be the result of distant evolutionary origin (Table 1.1). 
1.5.2. The identification of Na+ channel isoforms in the heart 
Relatively TTX-insensitive Na1.5 is known to the predominant Na+ channel isoform in 
the heart. However, a neuronal Na' channel (Na1.1) has been reported in the SA node in the 
newborn rabbit (Baruscotti et al., 1997). Neuronal Na' channels are also present in the adult 
heart: multiple neuronal Na' channel isoforms (Na,, 1.1, Na1.3 and Na, 1.6), as well as Na1.5, 
are expressed in adult mouse ventricular myocytes and are involved in excitation-contraction 
coupling (Maier et al., 2002). In addition, TTX-sensitive neuronal Na' channel isoforms have 
been shown to be expressed in the adult mouse and adult rat SA node and block of the channels 
has been shown to lead to a slowing of the heart rate in the isolated mouse heart (Maier et al., 
2003). Recently, Lei et al. (2004) showed that in the mouse SA node Na,, 1.1 and Na1.5 are 
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involved in pacemaking, but only Na1.5 is involved in action potential propagation. The 
distribution of neuronal Na' channel isoforms in the AV node is unknown. 
1.5.3. AV conduction block associated with SCN5A mutations 
Alterations in Na' channel expression and function are known to have severe effects on 
excitability. In the nervous system, mutations in Na' channel a and ß subunits cause epilepsy 
and febrile seizures (Wallace et al., 1998; Wallace et al., 2001). In the heart, mutations in the 
gene encoding Na1.5 cause inherited hyperexcitability syndromes, including long QT 
syndrome type III and Brugada syndrome, which can lead to sudden cardiac death (Keating & 
Sanguinetti, 2001). Recently, various naturally occurring mutations of Na, 1.5 have been 
associated with familial cases of AV conduction block (Schott et al., 1999; Lupoglazoff et al., 
2001; Kyndt et al., 2001) or slowing of AV conduction (Tan et al., 2001; Wang et al., 2002). In 
addition, heterozygous mutant mice lacking one copy of the Na1.5 gene have impaired AV 
conduction (as well as other cardiac conduction defects) (Papadatos et al., 2002). 
1.6. Aim of thesis 
Although there is abundant histological and electrophysiological data concerning AV 
node (Mazgalev & Tchou, 2000a), it has been difficult to correlate electrophysiological 
recordings and distinct cell types (Anderson, 1972; Anderson et al., 1974; Tranum-Jensen & 
Janse, 1982; McGuire et al., 1996). AV nodal cells can now be enzymatically dissociated and 
studied individually. However, the tracking of a cell from its original anatomic location to the 
experimental bath has not yet been possible and, therefore, the cell origin has still to be 
postulated from its shape and ionic characteristics (Munk et al., 1996; Workman et al., 2000). It 
may be possible to solve this problem using immunohistochemistry to show the expression of 
different ion channels in the different cell types of the AV node. The aim of the thesis is to 
investigate by immunohistochemistry the distribution of cardiac and neuronal Na' channel 
isoforms in and around the AV node of the rat. In addition, the histology of the rat AV node and 
the distribution of other marker proteins (including Cx43 and the channel responsible 
pacemaker current, If, ) were studied in parallel. 
Chapter 2 
Materials and methods 
A number of different techniques were used in the present study; these included 
preparation of AV and SA node tissue, atrial and ventricular myocyte isolation, 
electrophysiology, histological staining, immunocyto- or immunohisto-chemistry and confocal 
microscopy. Immunocyto- or immunohisto-chemistry and confocal microscopy were the 
principal techniques used and this chapter describes in detail these techniques. This chapter also 
outlines the other techniques. More details are given in the corresponding chapters. 
2.1. Preparation of AV and SA node of the rat 
2.1.1. Solutions 
Carbonate buffered Tyrode solution contained (mM): NaCI 93; NaHCO3 20; Na2HPO4 
1; KCI 5; CaC12 2; MgSO4 1; sodium acetate 20; glucose 10; insulin 5 units/ml; equilibrated 
with 95 % 02 and 5% CO2 to give pH 7.4. 
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2.1.2. Dissection of tissue 
Wistar rats weighing 250-300 g were killed humanely by Dr. M. Yamamoto according 
to the United Kingdom Animals (Scientific Procedures) Act, 1986 and the heart was quickly 
removed and pinned onto a dissection chamber containing oxygenated bicarbonate-buffered 
Tyrode solution at 37°C. The right atrium and the AV septum were cut away from the ventricles. 
Then, the right atrium was opened by a longitudinal incision through the tricuspid valve and 
into the superior vana cava. The SA and AV nodes were identified from their anatomical 
landmarks (Fig. 2.1). The opened right atrium was divided into the intercaval region for the SA 
node and the atrioventricular junction for the AV node (Fig. 2.1) 
2.2. Preparation of atrial and ventricular myocytes of the rat 
2.2.1. Solutions 
Isolation solution contained (mM): NaCl 130; KCl 5.4; MgCI2 1.4; NaHZPO4 0.4; 4-(2- 
hydroxyethyl)piperazine-1-ethanesulfonic acid (HEPES) 5; glucose 10; taurine 20; creatine 10; 
titrated to pH 7.3 with NaOH 
2.2.2. Isolation procedure 
Cells were isolated as described by Shui et al. (1997) with a few minor modifications. 
Adult male Wistar rats weighing 250-300 g were killed by cervical dislocation by Dr. Z. Shui 
according to the United Kingdom Animals (Scientific Procedures) Act, 1986. The heart was 
removed and was washed in isolation solution and then retrogradely perfused via the aorta at a 
flow rate of 10 ml min-' on a Langendorff apparatus. All perfusates were at 37°C. Initially the 
heart was perfused with isolation solution containing 0.5 mM Ca 2+ for 2-3 min to clear the heart 
of blood. The heart was then perfused with Ca 2+ free isolation solution containg 100 µM 
ethylene glycol-bis(2-aminoethylether)-N, N, N; N'-tetraacetic acid (EGTA) for 4 min. Finally, 
the heart was perfused with enzyme solution for 6-10 min. Enzyme solution consisted of 
isolation solution with I mg ml'' collagenase (Worthington Biochemical, Lakewood, NJ, USA, 
Type II) and 0.1 mg ml"' protease (Type XIV, Sigma Chemical Co. ). Enzyme solution was 
recirculated through the heart. After perfusion with enzyme solution, the atria and ventricles 
were separated, finely chopped and added to an aliquot of enzyme solution to which was added 
I% (w/v) bovine serum albumin (BSA). Both atria and ventricles were separately digested with 
this solution (at 37°C) for several 15 min or 5 min periods, respectively. At the end of each 
period, the mixture was filtered through nylon gauze. The dissociated cells were then 
sedimented by centrifugation at 400 r. p. m. for 3 min. The supernatant was removed and the 
cells were resuspended in isolation solution. Both atrial and ventricular cells were kept at 4°C 
until use. 
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Figure 2.1 Dissected rat SA and AV nodes 
A, dissected rat SA node preparation. CT, crista terminalis; IVC, inferior vena cava; RA, right 
atrium free wall; SLP, septum; SVC, superior vena cava. 13, dissected rat AV node preparation. 
For Masson's trichrome and immunohistochemical staining, the AV node preparations was 
cryosectioned and divided into several levels at -500 µm intervals. Numbers indicate position 
of each level. Labels show conventional orientation (for more information, see chapter 3, 
section 3.4.5). CS, coronary sinus; A, anterior; 1, inferior; P. posterior; S, superior. Scale bars, I 
mm. 
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2.3. Freezing and cryosectioning of dissected AV and SA node of the 
rat 
Dissected AV or SA node preparations, still pinned to a silicon rubber base, were 
frozen with Jung tissue freezing medium (Leica instruments GmbH, Heidelberg, Germany) or 
10 % gelatin (Porcine type A, Sigma, Poole, UK) in isopentane cooled by liquid N2. Frozen 
tissues were secured on a cryostat chuck using Jung tissue freezing medium. The AV node 
preparation was serially sectioned perpendicular to the endocardium along the AV axis from the 
common bundle to the coronary sinus and the SA node tissue was serially sectioned 
perpendicular to the crista terminalis through the intercaval region at 10 µm thickness using a 
cryostat (CM1850; Leica Microsystems, Heidelberg, Germany) at -15°C. Among seven AV 
node preparations, three preparations were mainly used in this study. 300 to 500 tissue sections 
cryosectioned were divided at 525 ± 7.31 (one case shown in Fig. 2.1B) or 500 (two cases) µm 
intervals. Sets of sections were used for Masson's trichrome and immunohistochemical staining. 
After cryosectioning, the sections were mounted on Superfrost Plus slides (BDH, Poole, UK) 
and stored at -80 °C until use. 
2.4. Summary of AV node preparation studied 
As a major subject of this thesis, sets of 10 µm sections were cut perpendicular to the 
AV junction at -500 µm intervals from three AV node preparations. Data for Cx43 (chapter 4), 
desmoplakin (chapter 4), ANP (chapter 4), HCN4 (chapter 5), Na, 1.1 (chapter 6 and 7), Na, 1.3 
(chapter 6 and 7) and Na,, 1.5 (chapter 6 and 7) were obtained from all three preparations (except 
desmoplakin was studied in one preparation only and Na,, 1.1 and Na,, 1.3 were studied in two 
preparations only). In addition, similar data for Cx43, Na1.1 and Na1.3 were obtained from 
three other preparations and similar data for Na1.5 were obtained from one other preparation 
(level of the enclosed node only). Cx40 was studied in two preparations (chapter 8). Na, 1.2 and 
Na, 1.6 were studied in three preparations (level of the enclosed node only). Sagittal sections 
were cut from one preparation only (chapter 9). 
2.5. Histology 
In order to characterize the anatomy of the AV node, Masson's trichrome staining was 
used. Histological stains are made of compounds which absorb visible light differently and bind 
to different tissues to produce coloured tissue sections and thus increase the visibility of the 
sections (Sanderson, 1994). 
2.5.1. Solutions 
Bouin's fluid contained: saturated aqueous picric acid, 75 ml; 40 % formaldehyde, 25 
ml; glacial acetic acid, 5 ml. Celestine blue B contained: Celestine blue B, 2.5 g; ferric 
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ammonium sulphate, 25 g; glycerine, 70 ml; distilled water, 500 ml. The ferric ammonium 
sulphate was dissolved in the cold distilled water by stirring. The Celestine blue B was added to 
this solution and the mixture was boiled for a few minutes. After cooling, the stain was filtered 
and glycerine was added. The final stain should be usable for over 5 months. It had to be filtered 
before use. Cole's alum hematoxylin contained: hematoxylin, 1.5 g; saturated aqueous 
potassium alum, 700 ml; 1% iodine in 95 % alcohol, 50 ml; distilled water, 250 ml. The 
hematoxylin was dissolved in the distilled water (warmed) and mixed with the iodine solution. 
The alum solution was added, and the mixture brought to the boil and then cooled quickly and 
filtered. The solution was ready for immediate use. The solution may need filtering after 
storage. The quality of the nuclear staining begins to deteriorate after a few months. This 
deterioration is marked by the formation of a precipitate in the stored stain. At this stage, the 
stain should be filtered before use, and the staining time may need to be increased. The solution 
was filtered before use. Acid alcohol: I% HCI in 70 % ethanol. Acid fuchsin contained: acid 
fuchsin, 0.5 g; glacial acetic acid, 0.5 ml; distilled water, 100 ml. Phosphomolybdic acid 
contained: phosphomolybdic acid, 1.0 g; distilled water, 100 ml. Methyl blue contained: methyl 
blue, 2.0 g; glacial acetic acid, 2.5 ml; distilled water, 100 ml. 
2.5.2. Masson's trichrome staining 
The sections were taken from -80 °C storage and were dried at room temperature for 5 
min. After Embedding medium was removed (Table 2.1), the sections were fixed in Bouin's 
fluid for 15 min and were washed in 70 % ethanol three times (10 min each) to remove yellow 
fixatives. Then the sections were stained in Celestine blue B for 5 min and were rinsed in 
distilled water two to three times until colourless. The sections were stained in Cole's alum 
hemotoxylin for 5 min and were washed in running tap water for 15 min. At this stage, nuclear 
staining was checked at low power using a light microscope. If nuclear staining was too light, 
steps from Celestine blue B to Cole's alum hematoxylin staining were carried out again. If 
nuclear staining was too dark, the sections were differentiated in Acid alcohol for 5 s. The 
sections were washed in tap water and re-checked. Then the sections were washed in tap water 
for 2 min and stained in Acid fuchsin for 10 min. The sections were rinsed in distilled water and 
treated with phosphomolybdic acid for 5 min. The sections were drained and were stained with 
Methyl blue for 1.5 min. The sections were rinsed in distilled water and treated with 1% acetic 
acid for 2 min. The sections were then dehydrated in 70 % alcohol for 20 s, 90 % alcohol for 20 
s, and absolute alcohol for 2 min two times and were cleared in clear solvent two times (5 min 
each). Then, the sections were mounted with XAM mounting medium (BDH) (Bancroft & 
Gamble, 2002). 
2.5.3. Light microscopy 
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Table 2.1 Removal of embedding medium 
Medium OCT Gelatin 
Removing procedure 10 min in phosphate 30 min in PBS at 37°C 
buffered saline (PBS) at 
room temperature 
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Histological images were taken using a Leica Materials Workstation System, 
comprising a high performance personal computer, charge coupled device (CCD) camera and 
image acquisition board. Mosaic images of whole sections or regions of interest were 
constructed by an automatic facility of the system. 
2.6. Immunocytochemistry and immunohistochemistry 
The principle of immunocyto- or immunohisto-chemistry is to use specific primary 
antibodies to determine the sub-cellular location of proteins of interest in tissue sections or 
single cells (Fig. 2.2). To locate a protein of interest, the antibody binds to the protein's 
antibody-binding site, known as the epitope. The antibody bound to its binding site can be then 
detected by a selected secondary antibody conjugated, for example, to a fluorochrome (Fig. 2.2), 
which can be visualized by confocal microscopy. Polyclonal or monoclonal primary antibodies 
can be used. A polyclonal antibody is produced by injecting, into a host laboratory animal, a 
selected protein molecule and collecting serum samples. The collected serum samples contain 
antibodies to several regions of the molecule and also other antibodies produced by plasma 
cells, hence the name polyclonal. Because the serum samples also contain other antibodies 
produced by the animal, the antibody needs to be purified from other proteins in the serum 
samples in order to avoid non-specific labelling (Harlow & Lane, 1998). A monoclonal 
antibody is produced by hybridoma cells. Hybridoma cells are "immortal cells of the B-cell 
lineage" fused with isolated precursors of the plasma cells which only produce an antibody to 
one region of the molecule, hence the term monoclonal (Harlow & Lane, 1998). The great 
advantage of monoclonal antibodies is their absolute specificity for a single sequence (or 
epitope) on the antigen molecule. The problems associated with the multiple antibodies 
contained in a polyclonal antibody thus do not arise and immunolabelled preparations are 
usually very clean and labelling is specific. A possible disadvantage of a monoclonal antibody 
derives from its monospecificity. A polyclonal antibody is probably multivalent, consisting of 
antibodies to several regions of the antigen molecule, providing a strong detecting capacity. On 
the contrary, a monoclonal antibody, reactive with only one site on the molecule, may result in 
fewer antibody molecules being bound to the antigen and subsequently detected by the labelling 
method, resulting in weaker staining (Polak & Noorden, 2002). 
2.6.1. Primary antibodies used 
Use of primary antibodies raised from different host species makes it possible to 
undertake multiple immunolabelling by using sets of species-specific secondary antibody- 
detection systems, thereby permitting simultaneous visualization of the expression patterns of 
different combinations of proteins of interest. All primary monoclonal and polyclonal antibodies 
used during the course of the present study are summarised in Table 2.2 and are also referred to 
in relevant chapters. Among primary antibodies, the most important ones are Na' channel 
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o Antigen 1 
Antigen 2 
A Rabbit anti-antigen 1 antibody 
Goat anti-rabbit antibody conjugated to FITC 
A Mouse anti-antigen 2 antibody 
Goat anti-mouse antibody conjugated toTRITC 
Figure 2.2 Principles of immunocytochemistry 
Simultaneous or sequential double labelling by the double immunofluorescence labelling 
method is illustrated. Rabbit anti-antigen I antibody binds to antigen 1 and mouse anti-antigen 2 
antibody binds to antigen 2. The anti-antigen 1 antibody is then detected by goat anti-rabbit 
antibody conjugated to fluorescein isothiocyanate (FITC), whereas the anti-antigen 2 antibody 
is detected by goat anti-mouse antibody conjugated to tetramethyl rhodamine ("I'RITC). FITC 
and TRITC are fluorochromes. From Polak & Noorden (2002). 
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antibodies. The reason of use of rat as an experimental animal in this thesis is the availability of 
antibody only raised from rabbit. The antibodies were stored at - 20°C in small aliquots and 
were used approximately within a year from the date of delivery. Working solutions of 
antibodies were stored at 4°C and were used for one to several months depending on the type of 
antibody and frequency of the experiments carried out. 
2.6.2. Solutions 
PBS (pH 7.4, Sigma) and 10 % gelatin in PBS were used. The freezing agents, 
isopentane and liquid N2 were used. 
2.6.3. Fixatives 
Fixative is commonly used to preserve biological specimens. It preserves cellular 
components such as proteins by cross-linking end-groups of amino acids and coagulating the 
secondary and tertiary structures of proteins to form insoluble gels (Sanderson, 1994). 10 % 
neutral buffered formalin (Sigma) was used as a fixative. 
2.6.4. Immunocyto- and immunohisto-chemical agents 
For immunocyto- and immunohistochemistry, BSA (Sigma), normal donkey serum and 
Triton X-100 were used. 
2.6.5. Fixation of samples 
For tissue sections, before fixation, the sections were dried at room temperature for 5 
min and were fixed in 10 % neutral buffered formalin at room temperature for 30 min. For 
single cardiac myocytes, the cardiac myocytes were placed on pieces of coverslips coated with 
carbon (coverslips were placed in a flame) for 30 min, washed in PBS for 10 min and then fixed 
in 10 % neutral buffered formalin at room temperature for 15 min. To remove excess of fixative, 
both sections and myocytes were washed three times in PBS over 30 min. 
2.6.6. Treatment by Triton X-100 
The samples were treated with 0.1 % Triton X-100 in PBS at room temperature for 10 
min. In the case of Na, 1.5,0.3 % Triton X-100 was used. The purpose of treatment with Triton 
X-100 was to permeablise the cell membrane, thus allowing the penetration of the primary and 
secondary antibodies and other immunocyto- or immunohisto-chemical reagents to access the 
epitopes located on the cytoplasmic side. 
2.6.7. Blocking of non-specific sites 
To block non-specific sites and reduce background `noise', the samples were incubated 
with 10 % normal serum and 1% BSA in PBS. The incubation was carried out either overnight 
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at 4°C or for Ih at room temperature. The samples that were incubated with blocking solution 
were washed in PBS to prevent contamination of the primary antibody. 
2.6.8. Labelling with primary antibodies 
Primary antibodies were diluted in 1% BSA in PBS with (in case of Na1.5) or without 
(in all other cases) 10 % normal donkey serum. The samples were incubated with a suitable 
concentration of each primary antibody (see Table 2.2) in a humid box at -4°C overnight. 
2.6.9. Labelling with secondary antibodies 
To detect the primary antibody binding, the samples were then incubated with species- 
specific secondary antibody conjugated to a fluorochrome. In the case of multiple labelling 
experiments, a mixture of appropriate secondary antibodies was applied. Table 2.3 summarises 
the secondary antibodies used in this study. The secondary antibodies were diluted in I% BSA 
in PBS with (in case of Navl. 5) or without (in all other cases) 10 % normal donkey serum. The 
secondary antibody was applied for 1h at room temperature in the dark. For multiple labelling 
experiments, appropriate combinations of secondary antibodies were used. 
2.6.10. Washing and mounting of samples 
After application of the primary and secondary antibodies, the samples were thoroughly 
washed in PBS three times for 30 min. The samples were mounted under coverslips with the 
anti-fade reagent, Vectashield (#H-1000, Vector Laboratories, Peterborough, UK). 
2.6.11. Variations in the immunolabelling procedure 
In view of the many variables such as sample used, fixation, membrane 
permeabilisation, blocking, type of labelling, combination of primary and secondary antibodies, 
incubation time and temperature, the specific procedures for a particular investigation are 
described in the relevant chapters. 
2.6.12. Control experiments 
When either single or double labelling experiments with a particular primary antibody 
was carried out for the first time, the primary antibody in question was omitted or preincubated 
with the antigenic peptide. In immunocyto- and immunohisto-chemistry, an experiment without 
the primary antibody is a standard control experiment. This is done to ascertain the background 
labelling by the secondary antibody in the absence of the primary antibody and to confirm that 
the secondary antibody does not crossreact between species. For example, no signal was 
detected in atrial myocytes and myocardium on omission of primary antibody against Na1.1 
(Figs. 2.3B and 2.4C). Preincubation of the primary antibody with the antigenic peptide (to 
which the antibody was raised) is also a standard control experiment. This is done to confirm 
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Table 2.2 Summary of primary antibodies used 
Primary 
Host Recognition peptide (epitope) Supplier Dilution antibody and location of epitope 
Na 1 1 Rabbit Residues 465-481 of rat Na1.1 . , polyclonal 1 1: 100 
Na 2 1 Rabbit Residues 467-485 of rat Na,, 1.2 1  . polyclonal 1: 100 
Na, 1.3 Rabbit Residues 511-524 of rat Nar1.3 1 1: 100 polyclonal 
Rabbit Residues 493-511 of rat Na, 1.5; Na,, 1.5 
polyclonal 
intracellular loop domains 2 1: 30 
between I and II 
Rabbit Residues 1042-1061 of rat Na1.6 
polyclonal 
Na,, 1.6; intracellular loop 2 1: 100 
between domains II and III 
HCN4 Rabbit Residues 119-155 of human 2 1: 20 and 1: 100 polyclonal HCN4; intracellular N-terminus 
Cx40 Rabbit 19 Residues of mouse Cx40 C- 1 1: 2000 and polyclonal terminal cytoplasmic domain 1: 5000 
Cx43 Mouse Residues 252-270 of rat Cx43 1 1: 100 monoclonal 
Cx43 Rabbit Residues 363-382 of human Cx43 3 1: 100 polyclonal with an N-terminal added lysine 
NF160 Mouse Purified neurofilament polypepti- 1 1: 1000 monoclonal des. 
Mouse Residues 1-28 of human ANP ANP 
monoclonal 
(conjugated to KLH; carrier 4 1: 100 
protein) 
DP 1/II Mouse Bovine DP I and 2 5 Ready to use monoclonal 
1: Chemicon International Ltd., Harrow, UK 
2: Alomone labs, Jerusalem, Israel 
3: Sigma, Poole, UK 
4: Biogenesis Ltd., Poole, UK 
5: Progen (Biotechnik GmbH), Heidelberg, Germany 
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Table 2.3 Summary of secondary antibodies used 
Secondary antibody Host Supplier Dilution 
Anti-rabbit conjugated FITC Donkey 1,2 1: 100 
Anti-mouse conjugated FITC Donkey 1 1: 100 
Anti-mouse conjugated TRITC Donkey 2 1: 100 
Anti-mouse conjugated Cy3 Donkey 2 1: 400 
1: Jackson Immuno Research Laboratories Inc. 
2: Chemicon International, Ltd. 
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with primary 
antibody 
without 
primary antibody 
Figure 2.4 Control experiment 2 
A, C, sections from atrial myocardium. B, D, sections from liver. A and B were labelled with 
primary antibody to Na,, 1.1. C and D were labelled without primary antibody. Scale bars, 50 
µm. 
atrial muscle liver tissue 
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that the signal is the result of binding of the primary antibody to the specific epitope intended. 
For example, no signal was detected in Fig. 2.3C. As a comparison, Fig. 2.3A shows membrane 
labelling of NaI. I in an atrial myocyte (with the primary antibody and no antigen 
preincubation). The staining in the nucleus is assumed to be non-specific. 
A second type of control experiment was performed: an experiment in which the 
secondary antibodies were omitted while the primary antibodies were applied (for example, Fig. 
2.3D). In addition, a control experiment was carried out in which wrong secondary antibodies 
(to detect the primary antibody) were applied. No example of this is shown, but no labeling was 
detected in this type of control experiment. These control experiments confirmed that the 
labelling obtained was not due to non-specific binding of the primary antibody and only suitable 
secondary antibodies could detect the primary antibodies used. 
A third type of control experiment was to process sections from tissues in which the 
primary antibody should not bind, because the protein of interest is not expected to be 
expressed. Comparing labelling patterns from different tissue sections confirmed that the 
labelling of sections from a tissue of interest was specific. For example, anti-NaJ. 1 produced 
specific membrane labelling of Na1. I in atrial tissue sections, whereas it produced only 
background labelling in liver tissue sections in which Na1.1 is not expected to be expressed 
(Fig. 2.4). 
2.7. Confocal laser scanning microscopy 
The single or multiple immunolabelled tissue sections and cardiac myocytes were viewed by 
conventional epi-fluorescence and confocal laser scanning microscopy (CLSM). The principles 
of the CLSM are illustrated in Fig. 2.5. Labelling in tissue sections and cardiac myocytes was 
visualised using a laser scanning confocal microscope (TCS SP, Leica Microsystems or LSM 5 
Pascal, Carl Zeiss, NY, USA). 
2.7.1. Image formation 
Through x10, x20, x40 and x63 objectives lenses, the immunofluorescent signal was 
recorded via a photomultiplier tube (PMT). In the confocal system, in order to produce a whole 
image, the point of light from a laser is moved over the entire specimen in the objective's field 
of view line by line (in the x-y axis) by means of a scanning mirror (see Fig. 2.5). The 
arrangement of the illumination and detection pinholes assures that only signal from the focal 
plane reaches the detector and, unlike standard epi-fluorescence microscopy, in CLSM, out-of- 
focus rays coming from above and below the focal plane (see dashed lines in Fig. 2.5) are 
rejected and the produced image is clear with improved resolution of fine details (Sheppard & 
Shotton, 1997). 
The acquired images were digitized and displayed on computer monitors as 1024 x 
1024 pixels frames. To construct montages of an immunolabelled section, six to twelve single 
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Photomultiplier 
Confocal aperture 
Dichroic mirror 
Illuminating aperture 
Point source 
Objective lens 
Focal plane 
Specimen 
In-focus rays 
........................... Out-of-focus rays 
Figure 2.5 Principles of confocal microscopy 
The excitation light (black solid line) from the point source passes through the illumination 
aperture and an excitation filter (not shown). The excitation light is then reflected by the 
dichroic mirror and is focused by the objective lens to a diffraction-limited spot illuminated in 
the focal plane of the specimen. The spot of light is scanned in the x- and y-axis, line by line, in 
the field of view of the focal plane of the specimen by the scanning mirror. Emitted 
fluorescence (red solid line) from the focal plane, as well out-of-focus planes, from the 
specimen passes through the objective lens, dichroic mirror and emission filter (not shown). 
Only emitted fluorescence from the focal plane passes through the confocal aperture, and is 
collected by the detector (photomultiplier). Emission light from below and above the focal plane 
(dashed black lines) cannot pass through the confocal aperture, because these regions have 
different focal planes and are `attenuated' by the confocal aperture. From Sheppard & Shotton 
(1997) 
LLLuv üýýivt üý LIUI ART 
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images of the section were taken and then combined using Adobe Illustrator 9.0 (Adobe System 
Incorporated, San Jose, CA, USA). 
2.7.2. Scanning 
Single or double scanning was carried out via channels 1 and 2 of the CLSM system. In 
the case of double immunolabelling experiments, the fluorescence signals were scanned 
simultaneously or sequentially through the appropriate channels. Each channel was assigned to 
a particular fluorochrome as summarised in Table 2.4. Channel 1 was used to visualise green 
signal (FITC) and channel 2 was used to visualise red signal (TRITC, Cy3) on the computer 
screen. When the images from both channels were combined new colours were produced; 
co-localisation of green and red signal resulted in a yellow signal. 
2.7.3. Crosstalk 
In the case of double immunolabelling experiments, the CLSM system should be able to 
distinguish signal from different fluorochromes as the result of different excitation and emission 
wavelengths (Table 2.4) (Sheppard & Shotton, 1997). However, to check that crosstalk between 
different channels did not occur resulting in false-positive signal, sequential scanning of each 
channel was performed as previously described (Yeh, 1997). In addition, to exclude the 
possibility of crosstalk, single labelling experiments with individual antibodies on different 
types of samples were performed before double labelling experiments were carried out and 
compared. The labelling patterns in single and double labelling experiments were always 
identical (for example, Fig. 2.6). 
2.7.4. Storing and analysing images 
Images were taken as soon as possible after an experiment was finished (normally 
within one week). The images were stored on optical discs in TIFF format and were analysed 
and processed using graphics software, such as Corel Draw 10 (Corel Corporation, Ottawa, 
Ontario, Canada), Adobe Photoshop 7.0 (Adobe System Incorporated) and Adobe Illustrator 9.0 
(Adobe System Incorporated). Scion image release 4.0.3.2 (Scion Corporation, Frederick, USA) 
was used to quantify immunofluorescence. 
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Table 2.4 Excitation and emission wavelengths for detection of fluorochromes used 
Excitation Emission 
Fluorochrome Laser Channel 
wavelength (nm) wavelength (nm) 
FITC 496 518 Argon 1 
TRITC, Cy3 554/556 576/574 Krypton 2 
From Sheppard & Shotton (1997). 
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Figure 2.6 Crosstalk 
A, single labelling ofNal. 1(green signal from FITC) in rat atrium myocardium. 13, double 
labelling of Na,, 1.1 (green signal from FITC) and Cx43 (red signal from TRI'l'C) in rat atrial 
myocardium. Scale bars, 50 µm. 
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Chapter 3 
Histology of the AV node 
3.1. Introduction 
In the mammalian heart, the AV node is located in a triangular region, the triangle of 
Koch (Koch, 1909), with the apex being the membranous septum, the inferior border the 
attachment of the septal tricuspid leaflet, and the superior border a strand of fibrous tissue 
extending from the central fibrous body to the sinus septum above the ostium of the coronary 
sinus, known as the tendon of Todaro. 
As shown by Tawara in 1906 (Tawara, 2000), the AV conduction axis is a continuous 
system of histologically discrete cells. The achievement of Tawara was to show that the bundle 
of His commenced in a well-demarcated collection of histologically discrete atrial cells, which 
he christened the "knoten. " He also described transitional cells as approaching the compact AV 
node from all sides. These transitional cells interpose between the compact nodal cells and the 
atrial myocardium. In 1910, Aschoff (1910) and Monckeberg (1910) proposed criteria for 
discrete tracts of conducting cells in the hearts: the tracts should be insulated from the 
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neighboring myocardium, should be composed of cells discrete histologically from the adjacent 
myocardium, and should be traceable as continuous structures through serial sections. The 
descriptions of Tawara (2000) and the application of the criteria proposed by Aschoff (1910) 
and Monckeberg (1910) provide the basis for understanding the structure of the AV node. 
Histologically, in general, the AV node consists of a meshwork of cells that are 
approximately the size of atrial cells, but are smaller than ventricular cells (Bharati, 2000). The 
cytoplasm of the cells stains lightly, i. e. not as intensely as the surrounding atrial and ventricular 
cells (Bharati, 2000). There are spaces and mesothelial-like cells between the nodal cells 
(Bharati, 2000). The collagen and elastic content intermingling with the nodal cells is more 
copious than that of the atria and the ventricles (Bharati, 2000). There is some fat and a 
moderate to large amount of nerve fibres (Bharati, 2000). In essence, the AV conduction axis 
consists of histologically distinct cell types: 1) transitional cells between atrial myocardium and 
enclosed nodal cells; 2) enclosed node (possibly divided into midnodal cells and lower nodal 
cells); 3) cells of the penetrating AV bundle embedded within the central fibrous body (also 
called the bundle of His); and 4) the cells of the ventricular bundle branches. However, there is 
no sharp transition from one cell type to another type (Meijler & Janse, 1988). 
The transitional cells (cell type 1), whilst satisfying two of the criteria (Racker & 
Kadish, 2000; Mazgalev et al., 2001), are not insulated by fibrous tissue from the remainder of 
the atrial myocardium (unlike cell types 2- 4). Thus, the transitional cells do not constitute an 
anatomically discrete conducting tract, but they do constitute a functionally recognisable 
component of AV conduction. Thus, for example, they form the substrate for AV nodal reentry. 
3.2. Methods 
In order to characterise the anatomy of the AV node, Masson's trichrome staining was 
carried out on sections from throughout the the rat AV. The procedures involved in preparation 
of the tissue for histological examination are described in chapter 2 (section 2.1). The tissue 
sections were stained with Masson's trichrome as described in chapter 2 (section 2.5.2) and 
observed by light microscopy as described in chapter 2 (section 2.5.3). 
3.3. Results 
Among seven preparations, Masson's trichrome staining was carried out on three 
serially-sectioned preparations. Tissue sections were cut perpendicular to the tricuspid annulus. 
The number of 10 µm thick sections obtained was 300 to 500 from 10 mm of tissue. The main 
preparation was divided into 14 levels at -500 µm intervals (Fig. 2.1B). Low magnification 
montages of 14 Masson's trichrome stained sections from 14 levels of the main preparation are 
shown in Fig. 3.1. Fig. 3.1 shows the various divisions of the AV node: the posterior/inferior 
nodal extension, open node, enclosed node, common bundle and AV ring bundle. High 
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Figure 3.1 Low power images of 14 Masson's trichrome stained sections through the rat 
AV node 
Micrographs were taken using a xlO objective lens and montages of each section were 
constructed. The position of each section in the original AV node preparation is shown in Fig. 
2.113. AM, atrial myocardium; Ao, aorta; AoV, aortic valve; MV, mitral valve; TV, tricuspid 
valve; VM, ventricular myocardium. Scale bars, 0.5 mm. 
44 
STN x ,ý 
L 
C 
H 
J. 
I 
H 
c0 
wC 
M 00 
. r14 
'¢. _ 
> I- 
> 
. 
61 C 
c-oc, 
80(U °c 
-r- c 
vi 02 
E 
E 
Lri ö 
-92 a 
v 
a0 
0 
UÖ 
'-c Q 
> 
45 
magnification montages of Masson's trichrome stained sections through the AV junctional 
region are shown in Figs 3.2 and 3.3. The various divisions of the AV node are demarked with 
black solid or dotted lines. In Masson's trichrome staining, connective tissue is stained blue and 
myocytes are stained red. Compared to the surrounding atrial and ventricular myocardium, the 
myocytes in the nodal tissue were generally stained a lighter red, were smaller, and were loosely 
packed. Based on histology, the boundary between nodal tissue and the surrounding working 
myocardium is not clear. However in this thesis, the boundary of the nodal tissue was not solely 
based on histological staining. The definition and boundary of the nodal tissue will be given in 
the following chapters, which are concerned with ion channel expression as determined by 
immunohistochemical staining. 
3.3.1. Posterior/inferior nodal extension 
Fig. 3.4 shows the posterior/inferior nodal extension in the Masson's trichrome stained 
section at the 4th level of the main preparation (Fig. 2.1 B). The posterior/inferior nodal 
extension is located on the right (left in the figure) side of the ventricular myocardium and is in 
close proximity to the atrial myocardium (Fig. 3.4A). Fig. 3.4B shows a high magnification 
image of the posterior/inferior nodal extension. The posterior/inferior nodal extension was 
demarked with black solid line and was located on the root of tricuspid valve and it was 
separated from the ventricular myocardium by fat cells (adipocytes) and connective tissue 
(centrial fibrous body) (Fig. 3.4B). Compared to the surrounding atrial and ventricular 
myocardium, the myocytes in the posterior/inferior nodal extension were stained a lighter red, 
were smaller, and were loosely packed (Fig. 3.4B). Fig 3.5 shows another example of Masson's 
trichrome staining of the posterior/inferior nodal extension in a different preparation and shows 
similar architecture. 
3.3.2. Open node 
Fig. 3.6 shows the open node in a Masson's trichrome stained section at the 7th level of 
the main preparation (Fig. 2.1B). The open node was situated on the summit of the ventricular 
myocardium and was in contact with the atrial myocardium (Fig. 3.6A). Compared to the 
ventricular myocardium, the width of atrial myocardium was very narrow at the junctional 
region (Fig. 3.6A). Fig. 3.6B shows a high magnification image of the open node. The open 
node was separated from the ventricular myocardium by connective tissue (Fig. 3.613). The open 
node was in contact with the root of the tricuspid valve and atrial myocardium (Fig. 3.6B). The 
myocytes in the open node were generally stained a lighter red than the ventricular muscle and 
were more loosely packed than the surrounding atrial and ventricular myocardium (Fig. 3.6B). 
In addition to the myocytes of the open node, there was another group of nodal-like myocytes 
above the tricuspid valve (Fig. 3.6B). These myocytes will be referred to as transitional cells 
and together with the posterior/inferior nodal extension are part of a continuous structure (the 
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Figure 3.2 High magnification images of Masson's trichrome stained sections (at levels 1 to 
7) through the AV junctional region 
Micrographs were taken at high magnification of the AV junctional region. Every section is the 
same as in Fig. 3.1. AM, atrial myocardium; ON, open node; P/I NE, posterior/inferior nodal 
extension; TC, transitional cells; TV, tricuspid valve; VM, ventricular myocardium. Scale bars, 
200 µm. 
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Figure 3.3 High magnification images of Masson's trichrome stained sections (at 
levels 8 to 
14) through the AV junctional region 
Micrographs were taken at high magnification of the AV junctional region. Every section 
is the 
same as in Fig. 3.1. AM, atrial myocardium; Ao, aorta; AoV, aortic valve; CB, common 
bundle; 
EN, enclosed node; ON, open node; P, posterior; P/I NE, posterior/inferior nodal extension; 
TAVRB, termination of the AV ring bundle; TV, tricuspid valve; VM, ventricular myocardium. 
Scale bars, 200 µm. 
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Figure 3.4 Masson's trichrome staining of the posterior/inferior nodal extension 
A, low-magnification montage of Masson's trichrome stained section at level 4 (see 
Figs. 3.1 
and 3.2). Scale bar, 0.5 mm. B, high-magnification micrograph of Masson's trichrome staining 
of the posterior/inferior nodal extension. B corresponds to the framed area in A. Scale 
bar, 200 
µm. AM, atrial myocardium; VM, ventricular myocardium. 
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Figure 3.5 Another example of Masson's trichrome staining of the posterior/inferior nodal 
extension 
A, low-magnification montage of Masson's trichrome staining. Scale bar, 1 mm. B, high- 
magnification micrograph of Masson's trichrome staining. B corresponds to the framed area in 
A. Scale bar, 200 µm. AM, atrial myocardium; VM, ventricular myocardium. 
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Figure 3.6 Masson's trichrome staining of the open node 
A, low-magnification montage of Masson's trichrome stained section at level 7 (see Figs. 3.1 
and 3.2). Scale bar, 0.5 mm. B, high-magnification micrograph of Masson's trichrome staining 
of the open node. B corresponds to the framed area in A. Scale bar, 200 µm. AM, atrial 
myocardium; VM, ventricular myocardium. 
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AV ring bundle) around the tricuspid annulus. Although the zone of transitional cells was 
depicted (Figs 3.6 and 3.7), it is hard to distinguish the zone of transitional cells and the open 
node solely with histological staining, especially at the level of the open node. The explanation 
on the edge of the zone of transitional cells will be given in the following chapters. Fig. 3.7 is 
another example of Masson's trichrome staining of the open node in a different preparation and 
shows similar architecture. 
3.3.3. Enclosed node 
Fig. 3.8 shows the enclosed node in a Masson's trichrome stained section at the 9th 
level of the main preparation (Fig. 2.1B). The enclosed node was situated at the centre of the 
junctional region on the summit of the ventricular myocardium (Fig. 3.8A). Fig. 3.8B shows a 
high magnification image of the enclosed node. The enclosed node consisted of an ovoid group 
of myocytes, which were separated from the surrounding atrial and ventricular muscle by 
connective tissue (stained blue; Fig. 3.8B). The myocytes in the enclosed node were stained a 
lighter red than the surrounding atrial and ventricular muscle (Fig. 3.8B). As already appeared 
in the level of the open node (Figs 3.6 and 3.7), there was zone of transitional cells above the 
tricuspid valve (Fig. 3.8B). Fig 3.9 shows another example of the enclosed node in a different 
preparation and shows similar architecture. As an anatomical landmark, the mitral valve is 
shown in Fig. 3.9, along with other common landmarks. 
3.3.4. Common bundle 
Fig. 3.10 shows the common bundle in a Masson's trichrome stained section at the 11th 
level of the main preparation (Fig. 2.1B). As an anatomical landmark, the aorta is shown in Fig. 
3.10. At this level, nodal-like myocytes existed in three separate regions, i. e. the common 
bundle in framed area C, the zone of the transitional cells also in framed area C and the 
termination of the AV ring bundle in framed area B in Fig. 3.1 OA. In this study, nodal myocytes 
were situated around the tricuspid annulus and as stated above the ring structure is referred to as 
the AV ring bundle. The AV ring bundle started with the common bundle/the enclosed node and 
the zone of the transitional cells, continued around the tricuspid annulus and terminated above 
the common bundle as shown in Fig. 3.1OA. Fig. 3.1OB shows a high magnification image of 
the termination of the AV ring bundle above the common bundle. Compared to the atrial 
myocardium, myocytes in the termination of the AV ring bundle were stained a lighter red. Fig. 
3.10C shows a high magnification image of the common bundle region. The common bundle 
was situated in the middle of the junctional region and it was separated from the atrial 
myocardium by connective tissue. From Fig. 3.1OC it is uncertain that the common bundle was 
in direct contact with the ventricular myocardium - again it was perhaps separated from the 
ventricular myocardium by connective tissue. The common bundle consisted of a triangle of 
pale red-staining myocytes. In this region, the zone of transitional myocytes was again present 
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Figure 3.7 Another example of Masson's trichrome staining of the open node 
A, low-magnification montage of Masson's trichrome staining. Scale bar, 1 mm. B, high- 
magnification micrograph of Masson's trichrome staining. B corresponds to the framed area in 
A. Scale bar, 200 µm. AM, atrial myocardium; VM, ventricular myocardium. 
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Figure 3.8 Masson's trichrome staining of the enclosed node 
A, low-magnification montage of Masson's trichrome stained section at level 9 (see Figs. 3.1 
and 3.3). Scale bar, 0.5 mm. B, high-magnification micrograph of Masson's trichrome staining 
of the enclosed node. B corresponds to the framed area in A. Scale bar, 200 µm. AM atrial 
myocardium; VM, ventricular myocardium. 
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Figure 3.9 Another example of Masson's trichrome staining of the enclosed node 
A, low-magnification montage of Masson's trichrome staining. Scale bar, 1 mm. B, high- 
magnification micrograph of Masson's trichrome staining. B corresponds to the framed area in 
A. Scale bar, 200 µm. AM, atrial myocardium; VM, ventricular myocardium. 
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Figure 3.10 Masson's trichrome staining of the common bundle 
A, low-magnification montage of Masson's trichrome stained section at level 11 (see Figs. 3.1 
and 3.3). Scale bar, 0.5 mm. B, C, high-magnification micrographs of Masson's trichrome 
staining of the termination of the AV ring bundle and the common bundle, respectively. B and 
C correspond to the framed areas in A. Scale bar, 200 µm. AM, atrial myocardium; CB, 
common bundle; CT, connective tissue; TAVRB, termination of AV ring bundle; TC, 
transitional cells; VM, ventricular myocardium. 
TAVRB AM 
B 
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-ý Aorta 
64 
above the tricuspid valve (Fig. 3.10C), but it was smaller than at the level of the enclosed node 
(compare Figs 3.8B and 3.10C). Fig. 3.11 shows another example of Masson's trichrome 
staining in the common bundle in a different preparation, but the section does not include the 
termination of the AV ring bundle. 
3.3.5. Termination of the AV ring bundle 
Fig. 3.12 shows the termination of the AV ring bundle in a Masson's trichrome stained 
section at the 14th level of the main preparation. As anatomical landmarks, the aorta and aortic 
valve are shown in Fig. 3.12A. The termination of the AV ring bundle is situated in the atrio- 
ventricular junctional region. Fig. 3.12B shows a high magnification image of the termination of 
the AV ring bundle. As discussed in the previous section, the termination of the AV ring bundle 
consisted of lighter red stained nodal myocytes, which were separated from neighbouring 
ventricular myocardium by connective tissue and fat cells. Fig 3.13 shows another example of 
the termination of the AV ring bundle in a different preparation. 
3.4. Discussion 
3.4.1. Rat AV node histology 
Tawara (2000) was the first to describe the morphology of the AV node in the hearts of 
several species. Rather than describing differences, he emphasized the similarities of this 
structure in various hearts to support his main hypothesis that the AV node is the only electrical 
connection between the atria and ventricles. Now, it is well established that the contractions of 
the adult mammalian heart begin in the SA node, spread over the right and left atria, reach the 
AV node, and then spread by way of the His-Purkinje fibre to the ventricles (Meijler & Janse, 
1988). 
Tawara (2000) examined the hearts of the dove, rat, guinea-pig, rabbit, cat, dog, sheep, 
calf and human and found in all these species essentially the same structure in the anterior part 
of the base of the interatrial septum. He described a spindle-shaped compact network of small 
cells. It must be emphasized that in addition to this compact node, Tawara (2000) also described 
what we now call "transitional cells". Transitional cells are distinguished from atrial cells by 
their smaller size, their pale staining reaction, and by the fact that they are separated from each 
other by connective tissue septa. 
The architecture of the rat AV node is similar to that of other species. The endocardial 
conduction elements of the ventricles of animals can be well differentiated or poorly 
differentiated. Small mammals including rat and rabbit have poor differentiation (Truex & 
Smythe, 1965). Copenhaver (1981) reported that the special conduction tissue in the rat is not as 
easily demonstrated as that of the pig and dog and that no continuous pathways of 
cholinesterease-expressing cardiac muscle fibres from the SA node to the AV node can be 
identified (Copenhaver, 1981). 
65 
Figure 3.11 Another example of Masson's trichrome staining of the common bundle 
A, low-magnification montage of Masson's trichrome staining. Scale bar, 0.5 mm. B, high- 
magnification micrograph of Masson's trichrome staining. B corresponds to the framed area in 
A. Scale bar, 200 µm. AM, atrial myocardium; VM, ventricular myocardium. 
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Figure 3.12 Masson's trichrome staining of the termination of the AV ring bundle 
A, low-magnification montage of Masson's trichrome stained section at level 14 (see Figs. 3.1 
and 3.3). Scale bar, 0.5 mm. B, high-magnification micrograph of Masson's trichrome staining 
of the termination of the AV ring bundle. Scale bar, 200 µm. AM, atrial myocardium; Ao, aorta; 
AoV, aortic valve; TAVRB, termination of AV ring bundle; VM, ventricular myocardium. 
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1 mm 
ring bundle 
A, low-magnification montage of Masson's trichrome staining. Scale bar, 1 mm. 13, high- 
magnification micrograph of Masson's trichrome staining. Scale bar, 200 µm. AM, atrial 
myocardium; Ao, aorta; AoV, aortic valve; TAVRB, termination of AV ring bundle; VM, 
ventricular myocardium. 
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3.4.2. Comparison with previous histological investigations of the rat AV node 
There have been previous histological investigations of the rat AV node (Truex & 
Smythe, 1965; Copenhaver, 1981). My data agree with previous investigations in several 
aspects: first, the AV nodal cells shows the same histological characteristics (size, colour, shape, 
arrangement of cells). Second, the AV node consists of histologically different regions: 1) 
posterior/inferior nodal extension consisting of nodal cells and surrounded by connective tissue 
or fat tissue (Figs. 3.4 and 3.5); 2) open node consisting of nodal cells receiving atrial inputs 
along its upper and posterior margins (Figs. 3.6 and 3.7); 3) enclosed node consisting of nodal 
cells surrounded by a collar of fibrous tissue formed by the fibrous annulus and an extension 
from the central fibrous body (Figs. 3.8 and 3.9). Fibres overlying this fibrous collar end in the 
base of the septal tricuspid valve leaflet and do not make contact with the underlying cells of the 
enclosed node (Figs. 3.8 and 3.9); 4) the zone of transitional cells separated by connective tissue 
from the enclosed node and common bundle (Figs. 3.8-3.11); and 5) common bundle consisting 
of nodal cells surrounded by connective tissue (Figs. 3.10 and 3.11). Finally, the conduction 
axis outside of the enclosed node is not clear (Truex & Smythe, 1965; Copenhaver, 1981). 
However, the AV ring bundle above the common bundle was not observed in earlier 
studies (Truex & Smythe, 1965; Copenhaver, 1981). The AV ring bundle observed in'the 
present study consisted of nodal (or nodal-like) cells (Figs. 3.12 and 3.13). 
3.4.3. What is the AV node? 
It is surprising that despite extensive and accurate description (Tawara, 2000), 
confusion has arisen subsequently concerning the definition of the AV node as given by 
morphologists and electrophysiologists. The latter tend to define the AV node as the "area 
where the functional delay between atria and ventricles occurs" and the former as the knot of 
densely packed small cells, described by Tawara as knoten (Hoffman, 1971). 
The need of electrophysiologists for a broadened definition of the AV node arose from 
the fact that significant events in atrial-His conduction occur outside of the enclosed node. 
Furthermore, a posterior/inferior extension, which is made of nodal tissue, lies just above the 
insertion of the tricuspid valve beneath the coronary sinus ostium and likely plays a critical role 
in the slow AV nodal pathway and acts as the junctional pacemaker. Furthermore, the AV ring 
bundle along the tricuspid annulus, investigated in this study, also lies outside of the enclosed 
node. 
3.4.4. The definition of transitional cells 
As discussed so far, the AV junctional area including the triangle of Koch contains 
multilayered and complex morphological structures that anatomically and functionally form a 
continuum between the atrium and the bundle of His. A major source of confusion in 
delineating the sub-regions of the nodal area is related to the smooth transitions between regions 
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and the lack of clear morphological/histological features that would easily distinguish between 
transitional mid-nodal, and lower nodal cells for example. The result is that different 
investigators have used different nomenclature for the same structures. According to the most 
common nomenclature used, the AV junctional area can be described as encompassing 
transitional cells, specialsed nodal cells (AV node), lower nodal cells, and the penetrating AV 
bundle (bundle of His) (de Carvalho & de Almeida, 1960; Meijler & Janse, 1988). The term 
"transitional cells" is used broadly to describe the approaches from the working atrial 
myocardium to the AV node. Most frequently recognized are the posterior (inferior) and 
anterior (superior) approaches (Bharati, 2000). The posterior approaches serve as a bridge with 
the atrial myocardium at the coronary sinus ostium, while the anterior approaches merge with 
the AV node closer to the apex of the triangle of Koch. A third, middle group of transitional 
cells has also been identified (Anderson et at, 1974; Antz et at, 1998). They account for the 
nodal connections with the septum and the left atrium. 
In the present study, I also use the terms, "transitional cells" and "posterior/inferior 
nodal extension". Although electrophysiological recordings have not been carried out in this 
study, the former may correspond to the anterior (superior) approach and the latter may 
correspond to the posterior (inferior) approach. In this study, unlike in previous studies, I have 
used immunolabelling of markers, gap junctions and ion channels to identify these different 
structures (see chapters 4-5 and 7-9). The AV node is a specialsed conducting tissue and, 
therefore, it is right that the expression of ion channels should be used to define it. 
3.4.5. Posterior/inferior nodal extension? 
In the classic AV nodal topographic approach, the His bundle has an anterior location, 
the coronary sinus is posterior, towards the heart base is considered superior, and towards the 
heart apex is considered inferior. However, this simple practical terminology is inaccurate with 
respect to AV node orientation within orthogonal axes of the human thorax (Cosio et al., 1999). 
When the heart is opened through the right atrium and viewed in an attitudinally correct 
position, then the part of the right atrium containing the AV node (the triangle of Koch) has its 
apex pointing upwards. In classic conventional descriptions, however, the triangle of Koch is 
usually illustrated with its apex pointing to the right. Although this provides a realistic 
orientation of the AV junction within the thorax, some investigators find it complicates AV 
nodal description (Billette, 2002). The term `posterior/inferior nodal extension' is used in the 
present study. 
Chapter 4 
Immunohistochemical markers of the AV node 
4.1. Introduction 
The aim of the work described in this chapter was to localise the nodal cell region in 
serial AV node sections from rat using confocal microscopy with immunohistochemical 
`markers': Cx43, DP, and ANP. 
4.1.1. Cx43 
The predominant connexin of the heart, found in abundance in the adult working 
ventricle and atrium in all mammalian species, is Cx43 (Severs et al., 2001). In addition, two 
other major connexins expressed are in the heart, Cx40 and Cx45 (Gros & Jongsma, 1996; 
Severs et al., 2001). These connexins are constituents of gap junction channels and the primary 
function of gap junction channels is to provide electrical coupling between heart cells (Kumar & 
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Gilula, 1996; Bruzzone et al., 1996a; Bruzzone et al., 1996b). The architecture, gating and 
distribution of the gap junction channels are described in detail in chapter 1 (section 1.3). 
Nodal myocytes (both in the SA and AV nodes) are typically small, with a dearth of 
contractile elements and small, sparse, dispersed gap junctions (Severs et at, 2001). 
Furthermore, the medium conductance Cx43 is not expressed in the nodal myocytes and the 
small conductance Cx45 is expressed instead (Coppen et al., 1998; Coppen et al., 1999; 
Verheijck et al., 2001). These gap junction features correlate with poor electrical coupling, 
which, in the SA node, is linked to the ability of the SA node to drive the large mass of 
surrounding atrial tissue while remaining protected from its hyperpolarizing influence, and, in 
the AV node, to a slowing of conduction, which ensures sequential contraction of the atria and 
ventricles (Severs et al., 2001). Cx43 can be considered to be a marker for the SA and AV 
nodes: the absence of Cx43 in the SA and AV nodes enables the SA and AV nodal tissues to be 
easily distinguished from the surrounding atrial and ventricular myocardium. 
4.1.2. DP 
It is well known that the adherens junctions and desmosomes, which are responsible for 
mechanical coupling of cardiac myocytes, are closely juxtaposed to the gap junctions at the 
intercalated discs (Peters et al., 1994; Angst et al., 1997). DP is a desmosomal plaque protein 
and is present in all cardiac myocytes (Gutstein et al., 2003; Cheng & Koch, 2004). 
4.1.3. ANP 
A 28 amino acid peptide hormone (Flynn et al., 1983), ANP is one of a family of 
natriuretic peptides that play an important homeostatic role in preserving cardiovascular 
function and body fluid balance (Antunes-Rodrigues et al., 2004). Specific heart granules that 
comprise the storage site for ANP have been detected in the atria of numerous mammals (Cantin 
& Huet, 1975; de Bold et al., 1981). ANP released from atrial myocytes circulates to the 
kidneys and causes diuresis and natriuresis (Forssmann et al., 1998; DiBona, 2000). The 
natriuretic peptides act at the cell membrane through three types of receptors (NPR-A, NPR-B 
and NPR-C) (Maack, 1992). NPR-A and NPR-B, but not NPR-C, have an intracellular 
guanylate cyclase domain that generates cyclic guanosine monophosphate (cGMP) from GTP; 
cGMP activates protein kinase G in the brain and the periphery (Akamatsu et al., 1993; 
Favaretto et al., 1997; Jankowski et al., 1998; Soares et al., 1999; Jankowski et al., 2000; 
Jankowski et al., 2001). In contrast, NPR-C performs a clearance receptor function by binding 
the peptides (Maack et al., 1987; Maack, 1992). ANP is well known to be abundantly expressed 
in atrial myocardium and not in the conduction tissue (Benvenuti et al., 1997). ANP is absent in 
the SA and AV nodes and ventricular myocardium. Because of this distribution, it can be used 
as a marker for nodal myocytes. 
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4.2. Methods 
4.2.1. Dissection of AV node tissue 
Wistar rats weighing 250-300 g were sacrificed and the hearts were collected as 
described in chapter 2 (section 2.1.2). The AV node was dissected as described in chapter 2 
(section 2.1.2 and shown in Fig. 2.1). 
4.2.2. Immunohistochemistry 
The general immunohistochemistry procedures are described in chapter 2 (section 2.6). 
Details of procedures (tissue fixation, membrane permeabilisation, blocking of non-specific 
sites, type of labelling, type of primary and secondary antibodies used, incubation time and 
temperature during incubation with antibodies, washing and mounting of tissue) are described 
here. The AV node tissue was prepared and cryosectioned as described in chapter 2 (section 2.1 
and 2.4). Prior to immunofluoresecnce labelling, sections were fixed in 10 % neutral buffered 
formalin at room temperature and washed three times in PBS over 30 min to remove excess 
fixative. Tissue sections were treated with 0.1 % Triton X-100 in PBS for 10 min at room 
temperature. Tissue sections were incubated with 10 % normal donkey serum and 1% BSA in 
PBS for 60 min at room temperature. Primary antibodies were diluted in 1% BSA in PBS. The 
tissue sections were incubated with a suitable concentration of each primary antibody in a 
humid box at -4°C overnight. Information on primary antibodies can be obtained from chapter 2 
(section 2.6.1 and Table 2.1). The secondary antibodies were diluted in I% BSA in PBS. The 
secondary antibodies were applied for Ih at room temperature in the dark. For multiple 
labelling experiments, combinations of secondary antibodies were used. Information regarding 
the incubation time and antibody concentration with the secondary antibodies can be obtained 
from chapter 2 (section 2.6.9 and Table 2.3). After application of the primary and secondary 
antibodies, the samples were thoroughly washed in PBS three times for 30 min. Then, the 
samples were mounted under coverslips with the anti-fade reagent, Vectashield. The 
immunolabelled tissue sections were viewed by confocal laser scanning microscopy and 
montages were constructed as described in chapter 2 (section 2.7). 
4.3. Results 
In this chapter, Cx43, DP and ANP labelling are used as immunohistochemical markers 
of the AV node. Immunolabelling of Cx43 was observed in three complete AV node 
preparations and data from two preparations are shown here. In addition, similar data for Cx43 
were obtained from three other preparations (region of the enclosed node only). 
Immunolabelling of ANP was observed in two complete AV node preparations and the data 
from both preparations are shown here. The DP immunolabelling shown here was obtained 
from one complete AV node preparation and similar data were obtained from another 
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preparation (enclosed node region only). Photographs of the two preparations used for the 
figures in this chapter and also chapters 5 and 7 are shown in Figs 2.1B and 4.6A. In the 
preparation shown in Fig. 2.113 (the main preparation studied), 14 levels at 525 ± 7.31 µm 
intervals were studied. In the preparation shown in Fig. 4.6A, five levels at 500 µm intervals 
were studied. The position of each level is marked in Figs. 2.1 B and 4.6A. 
Typically, Cx43 labelling was localised at intercalated disks in working myocardium. 
As desmosomes are juxtaposed to gap junctions, DP labelling was co-localised with Cx43 at 
intercalated disks. ANP labelling was detected in the cytoplasm of atrial myocytes. 
4.3.1. Posterior/inferior nodal extension 
Figs. 4.1 to 4.5 show immunolabelling of immunohistochemical markers in the 
posterior/inferior nodal extension in the 1st to 5th levels of the main preparation studied shown 
in Fig. 2.113. The posterior/inferior nodal extension, ringed in yellow, is located above the 
ventricular myocardium and fibrous annulus (or tricuspid valve), outlined in white, and beneath 
the atrial myocardium (Figs. 4.1 to 4.5). The atrial myocardium showed co-localisation of Cx43 
and DP at intercalated disks and intracellular ANP labelling (Figs. 4.1 to 4.5). The 
posterior/inferior nodal extension showed DP labelling only at intercalated disks (Figs. 4.1 to 
4.5). The fibrous annulus did not show fluorescence above background (Figs. 4.1 to 4.5). The 
ventricular myocardium showed co-localisation of Cx43 and DP at intercalated disks as in the 
atrial myocardium (Figs. 4.1 to 4.5). In summary, the posterior/inferior nodal extension is Cx43- 
negative, DP-positive and ANP-negative and can be distinguished from surrounding atrial 
myocardium, fibrous annulus and ventricular myocardium. 
Fig. 4.6A shows the second AV node preparation and the anatomical landmarks (tendon 
of Todaro, coronary sinus and tricuspid valve).. Fig. 4.6B shows a Masson's trichrome stained 
section at level 1 in the second preparation. Although the posterior/inferior nodal extension was 
located above the tricuspid valve, the shape of the section is different from sections from other 
preparations (Figs. 3.4 and 3.5) when freezing a preparation, tissue sometimes underwent 
folding. Fig. 4.6C shows a neighbouring section double labelled for Cx43 and ANP and the 
labelling pattern is similar to that from the main preparation (panel B in Figs. 4.1 to 4.5). Fig. 
4.7 shows a Masson's trichrome stained section and a neighbouring section double labelled for 
Cx43 and ANP at level 2 (posterior/inferior nodal extension) in the second preparation and the 
tissue architecture and the labelling pattern are similar as shown in Fig. 4.6. 
4.3.2. Open node 
Figs. 4.8 to 4.10 show immunolabelling of immunohistochemical markers in the open 
node in sections at levels 6 to 8 of the main preparation (Fig. 2.1B). The open node, ringed in 
yellow, is located above the ventricular myocardium and fibrous annulus (or tricuspid valve), 
outlined in white, and beneath the atrial myocardium (Figs. 4.8 to 4.10). The atrial myocardium 
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Figure 4.6 Cx43 and ANP distribution in the posterior/inferior nodal extension at level 1 in 
the second preparation 
A, AV node preparation. Numbers indicate the position of each level. Labels show landmarks. 
B, Masson's trichrome staining of section at level 1. C, adjacent section double labelled for 
Cx43 (green) and ANP (red); field of view corresponds to framed area shown in A. A, anterior; 
AM, atrial myocardium; CS, coronary sinus; I, inferior; P, posterior; S, superior; VM, 
ventricular myocardium. Scale bars, 1 mm (A and B) and 100 µm (C). 
82 
co 
Q 
of "" 
a 
a 
;u 
E 
E 
E 
E 
D CL 45 
Q) 70 m VI 
00 75 
1 
i 4 v' ` r+r1 + J 
a0 ý U 1 1= > N _ _ 
O 
iý 
"O 
OOw 
( 
O 
a- 
83 
Figure 4.7 Cx43 and ANP distribution in the posterior/inferior nodal extension at level 2 in 
the second preparation (Fig. 4.6A) 
A, Masson's trichrome staining of section at level 2. B, adjacent section double labelled for 
Cx43 (green) and ANP (red); field of view corresponds to framed area shown in A. AM, atrial 
myocardium; VM, ventricular myocardium. Scale bars, 1 mm (A) and 100 µm (13). 
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preparation studied (Fig. 2.111) 
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! section double labelled for ('\43 (green) and ANI' (red) AM. atrial mýi ardium. VM. 
ventricular myocardium. Scale harn, 200 µm. 
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showed co-localisation of Cx43 and DP at intercalated disks and intracellular ANP labelling 
(Figs. 4.8 to 4.10). The open node showed DP labelling only at intercalated disks (Figs. 4.8 to 
4.10). The fibrous annulus did not show fluorescence above background (Figs. 4.8 to 4.10). The 
ventricular myocardium showed co-localisation of Cx43 and DP at intercalated disks as in the 
atrial myocardium (Figs. 4.8 to 4.10). In summary, the open node is Cx43-negative, DP-positive 
and ANP-negative like the posterior/inferior nodal extension and can be distinguished from the 
surrounding atrial myocardium, fibrous annulus and ventricular myocardium. In addition to the 
nodal myocytes of the open node, nodal-like myocytes existed in two other separated regions, 
above the open node (Figs 4.8A and 4.9) and above the tricuspid valve (Figs. 4.8 to 4.10). These 
two regions will be referred to as the "bump" (Figs 4.8B and 4.9) and the zone of the 
transitional cells (Figs. 4.8 to 4.10). The open node, the collection of the cells in the "bump" and 
the transitional cells show the same immunolabelling by Cx43, DP and ANP (Figs. 4.8 to 4.10). 
The zone of transitional cells and the open node are not physically connected (Figs. 4.8 to 4.10). 
The definition and boundary of transitional cells will be given in the following chapters, which 
are concerned with Na' channel expression in the AV node junctional area. Fig. 4.11 shows 
double labelling of Cx43 and ANP of the open node at level 3 of the second preparation (Fig. 
4.6A). The pattern of labelling of Cx43 and ANP is similar to that shown in panel B in Figs. 4.8 
to 4.10. 
4.3.3. Enclosed node 
Figs. 4.12 and 4.13 show immunolabelling of the immunohistochemical markers in the 
enclosed node in sections at levels 9 and 10 of the main preparation (Fig. 2.1 B). The enclosed 
node, ringed in yellow, is located above the ventricular myocardium and fibrous annulus (or 
tricuspid valve), outlined in white, and beneath the atrial myocardium (Figs. 4.12 and 4.13). The 
atrial myocardium showed co-localisation of Cx43 and DP at intercalated disks and intracellular 
ANP labelling (Figs. 4.12 and 4.13). The enclosed node showed DP labelling only at 
intercalated disks (Figs. 4.12 and 4.13). The fibrous annulus did not show fluorescence above 
background (Figs. 4.12 and 4.13). The ventricular myocardium showed co-localisation of Cx43 
and DP at intercalated disks as in the atrial myocardium (Figs. 4.12 and 4.13). In summary, the 
enclosed node is Cx43-negative, DP-positive and ANP-negative like the posterior/inferior nodal 
extension and the open node and can be distinguished from the surrounding atrial myocardium, 
fibrous annulus and ventricular myocardium. The zone of the transitional cells again existed 
above the tricuspid valve (Figs. 4.12 to 4.13), but the bump had disappeared. Fig. 4.14 shows 
double labelling of Cx43 and ANP of the enclosed node at level 4 of the second preparation 
(shown in Fig. 4.6A). The pattern of labelling of Cx43 and ANP is similar to that shown in 
panel B in Figs. 4.12 and 4.13. 
4.3.4. Common bundle 
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Figs. 4.15 and 4.16 show immunolabelling of the immunohistochemical markers in the 
common bundle in sections at levels 11 and 12 of the main preparation (Fig. 2.1B). The 
common bundle, ringed in yellow, is located above the ventricular myocardium and fibrous 
annulus (or tricuspid valve), outlined in white, and beneath the atrial myocardium (Figs. 4.15 
and 4.16). The atrial myocardium showed co-localisation of Cx43 and DP at intercalated disks 
and intracellular ANP labelling (Figs. 4.15 and 4.16). The common bundle showed DP labelling 
only at intercalated disks (Figs. 4.15 and 4.16). The fibrous annulus did not show fluorescence 
above background (Figs. 4.15 and 4.16). The ventricular myocardium showed co-localisation of 
Cx43 and DP at intercalated disks as in the atrial myocardium (Figs. 4.15 and 4.16). In 
summary, the common bundle is Cx43-negative, DP-positive and ANP-negative like the 
posterior/inferior nodal extension, the open node and the enclosed node and can be 
distinguished from the surrounding atrial myocardium, fibrous annulus and ventricular 
myocardium. In addition to the myocytes of the common bundle, nodal-like myocytes existed in 
two other separate regions, i. e. the zone of transitional cells and the termination of the AV ring 
bundle (Figs. 4.15 and 4.16). The transitional cells again existed above the tricuspid valve as at 
previous levels (Figs. 4.12 and 4.13). The termination of the AV ring bundle was located above 
the common bundle and was separated from it by the zone of transitional cells and atrial 
myocardium (Figs. 4.15 and 4.16). Fig. 4.17 shows double labelling of Cx43 and ANP of the 
common bundle at level 5 of the second preparation (Fig. 4.6A). The pattern of labelling of 
Cx43 and ANP in the common bundle, the zone of transitional cells and the termination of the 
AV ring bundle is the same as in the main preparation. In addition to these regions, nodal-like 
myocytes also existed in the left bundle branch (Fig. 4.17). It is noteworthy that some myocytes 
of the left bundle branch express ANP (Fig. 4.17). 
4.3.5. Termination of the AV ring bundle 
Figs. 4.18 and 4.19 show immunolabelling of the immunohistochemical markers in the 
termination of the AV ring bundle in sections at levels 13 and 14 of the main preparation (Fig. 
2.1B). The termination of the AV ring bundle, ringed in yellow, is located at the AV junction 
(Figs. 4.18 and 4.19). Note that at levels 13 and 14 the common bundle can no longer be seen. 
The atrial myocardium showed co-localisation of Cx43 and DP at intercalated disks and 
intracellular ANP labelling (Figs. 4.18 and 4.19). The termination of the AV ring bundle 
showed DP labelling only at intercalated disks (Figs. 4.18 and 4.19). The fibrous annulus did 
not show fluorescence above background (Figs. 4.18 and 4.19). The ventricular myocardium 
showed co-localisation of Cx43 and DP at intercalated disks as in the atrial myocardium (Figs. 
4.18 and 4.19). In summary, the termination of the AV ring bundle is Cx43-negative, DP- 
positive and ANP-negative like the posterior/inferior nodal extension, the open node, the 
enclosed node and the common bundle and can be distinguished from the surrounding atrial and 
ventricular myocardium. 
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preparation (Fig. 4.6A) 
A, section double labelled for Cx43 (green) and DP (red). U. section double labelled fier C'x43 
(green) and ANP (red). AM, atrial myocardium; VM, ventricular myocardium. Scale bars, 500 
µm. 
Figure 4.17 Cx43, DP and ANP distribution in the common bundle at level 5 in the second 
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4.4. Discussion 
In accordance with previous reports, DP labelling was observed in all myocytes 
throughout the AV node. As nodal myocytes are Cx43-negative and ANP-negative, DP 
labelling of nodal myocytes is useful to confirm the existence of myocytes in regions where 
there is no labelling of Cx43 and ANP (the fibrous annulus, for example, is also Cx43-negative 
and ANP-negative). 
In the atrial and ventricular myocardium, Cx43 and DP labelling was co-localised at the 
intercalated disks, whereas in the nodal cell regions of the AV junction Cx43 labelling was 
absent, but DP labelling was present. The absence of Cx43 labelling and presence of DP 
labelling in the nodal cell regions of the AV junction, therefore, enabled the nodal cell regions 
to be distinguished from atrial myocardium, fibrous annulus and ventricular myocardium. In the 
rabbit AV node, a tract of Cx43-expressing myocytes has been reported in the lower half of the 
enclosed node (Nikolski et al., 2003; Ko et al., 2004). However, in rat, Cx43 was not detected 
in the enclosed as well as the other nodal cell regions (Figs. 4.12 to 4.14). The rat, therefore, 
differs from the rabbit in that the lower nodal cells do not express Cx43 (alternatively Cx43 was 
present, but below the detection limit of immunohistochemistry). 
In this chapter, labelling of Cx43 was carried out using mouse Cx43 antibody. A 
different Cx43 antibody raised in rabbit (data not shown) produced the same pattern of 
labelling. In this chapter, Cx43 and ANP or DP were labelled simultaneously (double labelling). 
It was checked that single labelling of Cx43 was not different from double labelling of Cx43 
and another target protein. It is concluded that the Cx43 antibody used was reliable and suitable 
for use on rat tissue. 
In agreement with previous reports (Skeper, 1989; Sola et al., 1990; Benvenuti et al., 
1997), ANP was present in the atrial myocardium, but absent in nodal tissues and ventricular 
myocardium (Figs. 4.1 to 4.19). There was an unexpected ANP labelling in the left bundle 
branch (Fig. 4.17). Back et al. (1986) reported ANP immunoreactivity in the sub-endocardial 
layers of rat ventricles, but they were unable to determine whether it resided in Purkinje cells or 
in ventricular cells. ANP has also been suggested to exist in a small proportion of the ventricular 
myocytes underlying the terminal ramifications of the ventricular conducting system (Skeper, 
1989). Thus, the finding of ANP in the left bundle branch is consistent with these reports. 
However, the functional role of ANP expression in left bundle branch observed in the present 
study or ANP expression in the Purkinje cells of the ventricular conducting system needs further 
investigation. It may be relevant to this issue that, under certain pathological conditions, 
general ventricular myocytes may express ANP (Ding et al., 1987) and early neonates may also 
express ANP within the ventricular myocardium (Scott & Jennes, 1987; Toshimori et al., 1987). 
In conclusion, Cx43-negative, DP-positive and ANP-negative nodal cells were 
distributed throughout the AV junction in a complex three-dimensional manner and can be 
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distinguished from the surrounding working myocardium and the fibrous annulus. 
Chapter 5 
HCN4 expression in the AV node 
5.1. Introduction 
The hyperpolarization-activated inward current (termed If, Ih or Iq) plays a key role in 
the initiation and modulation of cardiac and neuronal pacemaker depolarizations (Biel et al., 
2002). Several cDNAs encoding If channels have been isolated by molecular cloning (Kaupp & 
Seifert, 2001). The If channels were termed HCN channels because their gating requires 
membrane hyperpolarization instead of depolarization and, in addition, is modulated by binding 
of cAMP (DiFrancesco, 1993; Pape, 1996; Mitsuiye et al., 2000). 
HCN channel types can be classified on the basis of their activation kinetics. HCN1 is 
the fastest channel (time constant of activation, i, 25-300 ms) followed by HCN2 and HCN3 (i, 
180-500 ms) and HCN4. HCN4 is by far the slowest channel, displaying activation time 
constants ranging between a few hundred milliseconds at strongly hyperpolarized voltages (-140 
mV) up to several seconds at the normal resting potential (-70 mV) (Biel et al., 2002). 
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cAMP increases the activity of native and cloned If channels by accelerating activation 
kinetics in a voltage-dependent manner and by shifting the voltage of half-maximal activation to 
more positive values (Moosmang et al., 2001). Based on the systematic analysis of a series of 
deletion mutants and HCN1/HCN2 chimeras, Wainger et al. (2001) and Wang et al. (2001) 
have proposed a model to explain the action of cAMP. In this model, the cyclic nucleotide 
binding domain (CNBD) located at the C terminus fulfills the role of an autoinhibitory channel 
domain. In the absence of cAMP, the C terminus inhibits HCN channel gating by interacting 
with the channel core and thereby shifting the activation to more hyperpolarized voltages. 
Binding of cAMP to the CNBD relieves this inhibition. HCN2 and HCN4 channels show a large 
response to cAMP, because they are efficiently inhibited in the absence of cyclic nucleotide. In 
contrast, HCN1 is only weakly affected by cAMP, because in this channel the inhibitory effect 
of the CNBD is weak. Thus, HCN2 and HCN4 are set apart from HCN1 with regard to their 
activation kinetics and their response to cyclic nucleotides. 
Although HCN channels conduct both K+ and Na+, they are not non-selective. For 
example, HCN channels are almost impermeable to Li' and are even blocked by millimolar 
concentrations of Cs+. Similarly, divalent cations and anions do not pass through the channels 
(Ludwig et at., 1998; Gauss et al., 1998; Santoro et al., 1998). Although HCN channels carry an 
inward Na+ current under physiological conditions, the primary sequence of the HCN pore 
region is clearly related to that of highly selective K+ channels (Xue et al., 2002; Azene et al., 
2003). The motif of the K+ channel selectivity filter was found in the HCN channel pore region 
(Zhou et al., 2001; Xue et al., 2002; Azene et al., 2003). However, it is clearly not sufficient to 
confer selectivity for K;. 
In vertebrates, the HCN channel family comprises four members (HCN1-4). Whereas 
HCN3 seems to be specifically expressed in neurones (Ludwig et al., 1998; Moosmang et al., 
2001), the other three channels (HCNI, 2 and 4) have been detected in both heart and brain 
(Ludwig et al., 1998; Santoro et al., 1998; Shi et al., 1999; Ludwig et al., 1999; Moosmang et 
al., 2001). In murine and rabbit SA node, HCN4 is by far the predominant HCN channel type, 
suggesting that this particular isoform plays a key role in the generation of primary pacemaker 
potentials (Ishii et al., 1999; Moosmang et al., 2001). In addition to HCN4, low to moderate 
amounts of HCNI and HCN2 transcripts were detected in SA node (Shi et al., 1999; Moosmang 
et al., 2001). HCN channels are also present in atrial and ventricular myocytes. HCN2 is the 
only isoform in rabbit ventricle, and its mRNA expression is minimal (Shi et al., 1999; Ludwig 
et al., 1999). Low-level HCN expression in ventricle is consistent with the ventricle's lack of 
automaticity (Shi et at, 1999). These data suggest that HCN4 expression is associated with the 
spontaneously active cells of the conduction tissue, whereas HCN2 expression is associated 
with non-spontaneously-active myocytes. This conclusion is supported by the finding that HCN 
channel expression changes during embryonic development (Yasui et at, 2001). In early 
ventricular myocytes that beat spontaneously, HCN4 and HCN1 are predominantly expressed. 
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In late embryonic myocytes that have lost their ability to beat spontaneously, HCN2 becomes 
the principal isoform. 
The existence of If or HCN4 in the AV node is as certain as in the SA node. However, 
within the AV node, there is a discrepancy between If recording and HCN4 expression detected 
by immunohistochemistry. If has been recorded from ovoid and rod-shaped cells isolated from 
the rabbit AV node (Noma et at, 1980; Hancox & Levi, 1994; Habuchi et al., 1995; Munk et 
al., 1996). If is present in 95 % of ovoid cells versus 10 % of rod-shaped cells, and If density is 
25 fold larger in ovoid cells (Munk et al., 1996). However, Dobrzynski et al. (2003) based on 
immunohistochemistry reported that HCN4 expression was uniformly detected in the 
conduction tissue throughout the rabbit AV node. 
5.2. Methods 
The procedures of AV node tissue dissection are described in chapter 2 (section 2.1.2). 
The general immunohistochemistry procedures are described in chapter 2 (section 2.6). Details 
of procedures (tissue fixation, membrane permeabilisation, blocking of non-specific sites, type 
of labelling, type of primary and secondary antibodies used, incubation time and temperature 
during incubation with antibodies, washing and mounting of tissue) are described in chapter 4 
(section 4.2). 
5.3. Results 
As shown in the previous chapter, based on histological staining and 
immunohistochemical labelling, the AV node (within the triangle of Koch) can be divided into 
five regions: the posterior/inferior nodal extension, the open node, the enclosed node, the 
common bundle and the termination of the AV ring bundle. In this chapter, the distribution of 
HCN4 investigated by immunohistochemical staining in three AV node preparations is shown. 
In the third preparation, not previously shown in this thesis, 14 levels at 500 µm intervals were 
studied. Information on the main preparation (Fig. 2.1B) and the second preparation (Fig. 4.6A) 
was given in chapter 4 (section 4.3). Typically, HCN4 labelling was detected at the membrane 
of myocytes. 
5.3.1. Posterior/inferior nodal extension 
Fig. 5.1 shows immunolabelling of HCN4 in the posterior/inferior nodal extension at 
level 4 in the main preparation (Fig. 2.1 B), level 2 in the second preparation (Fig. 4.6A) and 
level 6 in the third preparation. The posterior/inferior nodal extension, outlined in yellow, is 
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Figure 5.1 HCN4 labelling in the posterior/inferior nodal extension 
106 
located above the ventricular myocardium and tricuspid valve and beneath the atrial 
myocardium (Fig. 5.1). Atrial and ventricular myocardium showed labelling of Cx43 at the 
intercalated disks, but did not show labelling of HCN4 (Fig. 5.1). The fibrous annulus, outlined 
in white, did not show fluorescence above background (Fig. 5.1). The posterior/inferior nodal 
extension did not show labelling of Cx43, but did show labelling of HCN4 at the outer cell 
membrane (Fig. 5.1). Putting the results of HCN4 and immunohistochemical markers (section 
4.3.1) together, the posterior/inferior nodal extension is Cx43-negative, DP-positive, ANP- 
negative and HCN4-positive. 
5.3.2. Open node 
Fig. 5.2 shows immunolabelling of HCN4 in the open node at level 8 in the main 
preparation (Fig. 2.1B), level 3 in the second preparation (Fig. 4.6A) and level 9 in the third 
preparation. The open node, outlined in yellow, is located at the centre of the montage, i. e. 
between the atrial myocardium and the ventricular myocardium, in which Cx43 labelling is 
abundant (Fig. 5.2). The open node showed HCN4 labelling at the outer cell membrane (Fig. 
5.2). Putting the results of HCN4 and immunohistochemical markers (section 4.3.2) together, 
the open node is Cx43-negative, DP-positive, ANP-negative and HCN4 positive. In addition to 
the open node, the zone of transitional cells, which is located above the tricuspid valve, is 
HCN4-positive and Cx43-negative (and also DP-positive and ANP-negative as shown in section 
4.3.2). 
5.3.3. Enclosed node 
Fig. 5.3 shows immunolabelling of HCN4 in the enclosed node at level 9 in the main 
preparation (Fig. 2.1B), level 4 in the second preparation (Fig. 4.6A) and level 10 in the third 
preparation. The enclosed node, outlined in yellow, is located at the centre of the montage, i. e. 
between the atrial and ventricular myocardium, in which Cx43 labelling is abundant (Fig. 5.3). 
The enclosed node showed the same labelling pattern as the open node, i. e. HCN4-positive and 
Cx43-negative (Fig. 5.3). Putting the results of HCN4 and immunohistochemical markers 
(section 4.3.3) together, the enclosed node is Cx43-negative, DP-positive, ANP-negative and 
HCN4 positive. As described in the previous section, the zone of transitional cells is also 
HCN4-positive and Cx43-negative (and also DP-positive and ANP-negative as shown in section 
4.3.3). 
5.3.4. Common bundle 
Fig. 5.4 shows immunolabelling of HCN4 in the common bundle at level 11 in the main 
preparation (Fig. 2.1 B) and level 11 in the third preparation. The common bundle, outlined in 
yellow, is located at the centre of the montage, i. e. between the atrial and ventricular 
myocardium, in which Cx43 labelling is abundant (Fig. 5.4). The common bundle 
107 
A-C, montages of sections double labelled lör IICN4 (green) and Cx43 (red) from three 
preparations. AM, atrial myocardium; VM, ventricular myocardium. Scale bars, 200 µm. 
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A-C, montages of sections double labelled for HCN4 (green) and Cx43 (red) from three 
preparations. AM, atrial myocardium; VM, ventricular myocardium. Scale bars, 200 µm. 
Figure 5.3 HCN4 labelling in the enclosed node 
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Figure 5.4 HCN4 labelling in the common bundle 
A, 13, montages of sections double labelled for IICN4 (green) and Cx43 (red) from two 
preparations. AM, atrial myocardium; VM, ventricular myocardium. Scale bars, 200 µm. 
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showed the same labelling pattern as the open node and the enclosed node, i. e. HCN4-positive 
and Cx43-negative (Fig. 5.4). Putting the results of HCN4 and immunohistochemical markers 
(section 4.3.4) together, the common bundle is Cx43-negative, DP-positive, ANP-negative and 
HCN4 positive. At this level, the zone of transitional cells again existed as in the two previous 
sections and the termination of AV ring bundle is also located vertically above the common 
bundle. Both the zone of transitional cells and the cells of the termination of the AV ring bundle 
are HCN4-positive and Cx43-negative (and also DP-positive and ANP-negative as shown in 
section 4.3.4). 
5.3.5. Left bundle branch 
Fig. 5.5 shows immunolabelling of HCN4 in the common bundle and the left bundle 
branch from two preparations. Fig. 5.5A corresponds to level 5 in the second preparation (Fig. 
4.6A). Although the section shown in Fig. 5.5B (from another preparation not one of the 
preparations mentioned above) was cut in a different plane to the section in Fig. 5.5A, the image 
has been rotated so as to be placed in the same orientation and the architecture of the tissue is 
similar to that in Fig. 5.5A. As already described in the previous section, the common bundle 
was Cx43-negative and HCN4-positive (and also DP-positive and ANP-negative as shown in 
section 4.3.5). In addition to the common bundle, HCN4-positive and Cx43-negative myocytes 
were located in the left bundle branch (Fig. 5.5). Unlike other HCN4-positve and Cx43-negative 
regions, the left bundle branch was not ANP-negative (as described in chapter 4, sections 4.3.5 
and 4.4). 
5.3.6. Termination of the AV ring bundle 
Fig. 5.6 shows immunolabelling of HCN4 in the termination of the AV ring bundle at 
level 14 in the main preparation (Fig. 2.113) and level 13 in the third preparation. The 
termination of the AV ring bundle, outlined in yellow, is located above the ventricular 
myocardium and beneath the atrial myocardium, in which Cx43 labelling is abundant (Fig. 5.6). 
In agreement with data shown in chapter 4 (section 4.3.6) and section 5.3.4, the termination of 
the AV ring bundle was Cx43-negative, DP-positive, ANP-negative and HCN4-positive (the 
same labelling pattern as other nodal myocytes). 
5.4. Discussion 
In this study, the distribution of HCN4 in the rat AV node was investigated. In 
agreement with a previous investigation (Dobrzynski et al., 2003), HCN4-positive, Cx43- 
negative cells were detected throughout the AV node and these cells correspond to nodal cells 
described as DP-positive and ANP-negative in chapter 4. There appears to be a perfect overlap 
of immunohistochemical markers and HCN4. The uniform distribution of HCN4 in nodal 
myocytes cannot explain the different electrophysiological properties of the different cell types 
A, ß, montages of sections double labelled for IICN4 (green) and Cx43 (red) from two 
preparations. AM, atrial myocardium; VM, ventricular myocardium. Scale bars. 200 µm. 
Figure 5.5 IICN4 labelling in the left bundle brancli 
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in the AV node. The distribution of Na' channel isoforms in the AV node (chapter 6 and 7) may 
provide clues to this mystery. The distribution of the largest conductance gap junction protein 
(chapter 8) may also be useful. 
Chapter 6 
Expression of Na+ channel isoforms in isolated atrial 
and ventricular myocytes and tissue sections 
6.1. Introduction 
Voltage-gated Na" channels are critical elements for action potential initiation and 
propagation in excitable cells, because they are responsible for the initial depolarization of the 
membrane (Goldin et al., 2000). For the delay and regulation of electrical impulse conduction 
between the atria and the ventricles, the absence of the cardiac Na' channel in some fraction of 
myocytes in the AV node is also important (Munk et at, 1996; Petrecca et at, 1997). 
As already explained in chapter 1 (section 1.5.2), recent studies have shown that some 
of the neuronal Na' channel isoforms are expressed in the heart and are functionally important 
(Maier et at, 2002; Maier et al., 2003; Lei et al., 2004). Na;, 1.1, Na, 1.3 and Na,, 1.6 are 
expressed in isoloated mouse ventricular myocytes (Maier et al., 2002). Na, 1.1 and Na, 1.3 are 
expressed in mouse SA node and Na1.1 is expressed in rat SA node (Maier et al., 2003). 
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However, the distribution of neuronal Na' channel isoforms in the AV node is unknown. Before 
discussing the distribution of Na' channel isoforms in the AV node in following chapter, Na` 
channel expression outside of the AV node is discussed in this chapter. Using subtype-specific 
antibodies and immunocyto- or immunohisto-chemistry, Na' channel isoforms are identified 
and localised in rat cardiac myocytes and myocardium. 
6.2. Methods 
6.2.1. Immunocytochemistry for Na+ channel isoforms in isolated atrial and 
ventricular myocytes 
The atrial and ventricular myocytes were isolated as described in chapter 2 (section 
2.2). The general immunocytochemistry procedures were similar to those described in chapter 2 
(section 2.6). The myocytes were placed on pieces of coverslips coated with flamed carbon for 
30 min and were then washed in PBS for 10 min, fixed in 10 % neutral buffered formalin at 
room temperature for 15 min and washed three times in PBS over 30 min to remove excess 
fixative. The myocytes were treated with 0.1 % (or 0.3 % for Na1.5) Triton X-100 in PBS for 
10 min at room temperature. The myocytes were incubated with 10 % normal donkey serum 
and 1% BSA, in PBS for 60 min at room temperature. Primary antibodies were diluted in I% 
BSA in PBS (or 1% BSA/ 10 % normal donkey serum in PBS for Na, 1.5). The myocytes were 
incubated with a suitable concentration of each primary antibody in a humid box at -4°C 
overnight. Information on three different Na1.5 antibodies and other primary antibodies are 
summarised in Table 6.1 and Table 2.1, respectively. The secondary antibodies were diluted 
with same manner as the primary antibodies. The secondary antibodies were applied for Ih at 
room temperature in the dark. Information on secondary antibodies can be obtained from 
chapter 2 (section 2.6.9 and Table 2.3). After application of the primary and secondary 
antibodies, the myocytes were thoroughly washed in PBS three times for 30 min. Finally, the 
myocytes were mounted under coverslips with the anti-fade reagent, Vectashield (Vector 
Laboratories). The myocytes were viewed by confocal laser scanning microscopy (section 2.7). 
6.2.2. Immunohistochemistry for cardiac Na+ channel isoforms in tissue sections 
The general immunohistochemistry procedures are described in chapter 2 (section 2.6). 
Details of procedures (tissue fixation, membrane permeabilisation, blocking of non-specific 
sites, type of labelling, type of primary and secondary antibodies used, incubation time and 
temperature during incubation with antibodies, washing and mounting of tissue) are described 
here. The AV node tissue was prepared and cryosectioned as described in chapter 2 (section 2.1 
and 2.3). Prior to immunofluorescence labelling, sections were fixed in 10 % neutral buffered 
formalin at room temperature and washed three times in PBS over 30 min to remove excess 
fixative. Tissue sections were treated with 0.3 % Triton X-100 in PBS for 10 min at room 
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Table 6.1 Summary of Na, 1.5 antibodies used 
Recognition peptide (epitope), 
Naý1.5 antibody Host Dilution 
location of epitope 
Alomone 
1.5, Residues 493-511 of rat Na, 
(Cohen, 1996; Rabbit 1: 30 
intracellular loop between domains I and II 
Kucera et al., 2002) 
Catterall Residues 1122-1137 of rat Na, 1.5, 
Rabbit 1: 30 
(Rogart et al., 1989) intracellular loop between domains II and III 
Dumaine Residues 1985-2000 of dog Na1.5, 
Rabbit 1: 30,1: 50 
(Haufe et al., 2005) intracellular, C-terminus 
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temperature. Tissue sections were incubated with 10 % normal donkey serum and I% BSA in 
PBS for 60 min at room temperature. Primary antibodies were diluted in 1% BSA/ 10 % 
normal donkey serum in PBS. The tissue sections were incubated with a suitable concentration 
of each primary antibody in a humid box at -4°C overnight. The secondary antibodies were 
diluted in 1% BSA/ 10 % normal donkey serum in PBS. The secondary antibodies were applied 
for Ih at room temperature in the dark. For multiple labelling experiments, combinations of 
secondary antibodies were used. Information regarding the incubation time and antibody 
concentration for the secondary antibodies can be obtained from chapter 2 (section 2.6.9 and 
Table 2.3). After application of the primary and secondary antibodies, the samples were 
thoroughly washed in PBS three times for 30 min. Finally, the sections were mounted under 
coverslips with the anti-fade reagent, Vectashield (Vector Laboratories). The immunolabelled 
tissue sections were viewed by confocal laser scanning microscopy and montages were 
constructed as described in chapter 2 (section 2.7). 
6.3. Results 
Immunohistochemistry was used to investigate the expression of neuronal and cardiac 
Na' channel isoforms in isolated atrial and ventricular myocytes and myocardium; the skeletal 
isoform, Na, 1.4, was not investigated. The expression of Na' channel isoforms in and around 
the AV node will be described in following chapters. 
6.3.1. Expression of neuronal Na+ channel isoforms 
To investigate whether neuronal Na+ channel isoforms are present in atrial and 
ventricular myocytes and myocardium, I used specific antibodies recognizing the specific 
neuronal a subunit isoforms, Na1.1, Na1.2, Na, 1.3 and Na, 1.6. 
6.3.1.1. Expression of neuronal Na' channels in isolated atrial myocytes 
Fig. 6.1 shows immunolabelling of neuronal Na' channel isoforms in isolated atrial 
myocytes. Na1.1 labelling was located at the outer cell membrane (Fig. 6.1A). The staining in 
the nucleus is assumed to be non-specific. Na, 1.2 and Na, 1.3 were not detected (Fig. 6.1B and 
C) - the fluorescence in Fig. 6.1B and C is assumed to be background only. Fig. 6.1D shows that 
there was labelling of Na, 1.6 around the nucleus. This labeling was not present when the 
antibody was preincubated with the antigenic peptide (data not shown) and this suggests that the 
labelling was specific. As already shown in chapter 2, there was no fluorescence above 
background in a control experiment in which no primary antibody was used (Fig. 2.3). 
6.3.1.2. Expression of neuronal Na' channels in isolated ventricular myocytes 
Fig. 6.2 shows immunolabelling of neuronal Na' channel isoforms in isolated 
ventricular myocytes. Na,, 1.1 labelling was located in the t-tubules (Fig. 6.2A, arrow 1) and the 
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intercalated disks (Fig. 6.2A, arrow 2) as well as at the outer cell membrane (Fig. 6.2A, arrow 
3). The staining in the nucleus is assumed to be non-specific (Fig. 6.2A). Na, 1.2 labelling was 
not detected (Fig. 6.2B). Na,, 1.3 and Na, 1.6 labelling was detected at t-tubules (Fig. 6.2C and 
D). There was no fluorescence above background in a control experiment in which no primary 
antibody was used (data not shown). Table 6.2 shows a summary of labelling of neuronal Na' 
channel isoforms in isolated atrial and ventricular myocytes. 
6.3.1.3. Expression of neuronal Na+ channels in atrial myocardium 
Fig. 6.3 shows double labelling of neuronal Na' channel isoforms and Cx43 in atrial 
myocardium. As already shown in chapter 4, Cx43 labelling exists at the intercalated disks in 
atrial myocardium (Fig. 6.3). Na1.1 labelling was located at the outer cell membrane (Fig. 
6.3A) and it is the same labelling pattern as in isolated atrial myocytes (Fig. 6.1A). There was 
also non-specific labelling of Na, 1.1 in the nucleus (Fig. 6.3A) as in isolated myocytes (Fig. 
6.1A). Na"1.2, Na1.3 and Navl. 6 were not detected in the atrial myocardium (Fig. 6.3B-D). As 
already shown in chapter 2, there was no fluorescence above background in control experiments 
in which no primary antibody was used (Fig. 2.4). 
6.3.1.4. Expression of neuronal Na+ channels in ventricular myocardium 
Fig. 6.4 shows double labelling of neuronal Na' channel isoforms and Cx43 in 
ventricular myocardium. As already shown in chapter 4, Cx43 labelling exists at the intercalated 
disks in ventricular myocardium (Fig. 6.4). Na1.1 labelling was located at the outer cell 
membrane and was also co-localised with Cx43 at the intercalated disks (Fig. 6.4A). There was 
also intracellular labelling at t-tubules (not clear in Fig. 6.4D) and non-specific labelling of the 
nucleus (clear in Fig. 6.4A). The labelling of Na,, l. l in ventricular myocardium is the same 
labelling pattern as in isolated ventricular myocytes (Fig. 6.2A). Na1.2 and Na1.3 labelling 
was either absent or weak in ventricular myocardium (Fig. 6.4B-C). Navl. 6 labelling was 
localised at t-tubules (Fig. 6.4D; for example see arrow) and was the same labelling pattern as in 
isolated ventricular myocytes. There was no fluorescence above background in control 
experiments (data not shown). Table 6.3 shows a summary of labelling of neuronal Na' channel 
isoforms in atrial and ventricular myocardium. 
6.3.2. Expression of the cardiac Na+ channel isoform 
In order to investigate the cellular or tissue localisation of the cardiac Na+ channel 
isoform (Na, 1.5), three independent antibodies were applied to isolated atrial and ventricular 
myocytes and myocardium. 
6.3.2.1. Expression of the cardiac Na+ channel in isolated ventricular myocytes 
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Table 6.2 Summary of labelling of neuronal Na+ channel isoforms in isolated myocytes 
Atrial myocytes Ventricular myocytes 
No. of hearts No. of cells No. of hearts No. of cells 
6 33 5 26 
Without 
peptide Membrane labelling 
Membrane, t-tubule and 
NaJ. 1 
intercalated disk labelling 
2 13 2 11 
id Wi h t pept e 
No labelling No labelling 
Without 27 8 2 F 10 
Naj. 2 peptide No labelling No labelling 
With peptide - - - - 
Without 5 40 5 
26 
peptide No labelling t-tubule labelling 
Na,, 1.3 
1 6 2 7 
With peptide 
No labelling No labelling 
4 24 5 22 
Without 
peptide No labelling except around t-tubule labelling 
.6 Na1 
nuclues 
2 9 3 13 
With peptide 
No labelling No labelling 
1 8 1 3 
No primary antibody 
No labelling No labelling 
All control experiments (preincubation of antibody with antigen or no primary antibody) 
showed background levels of immunolabelling. 
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A-D, high magnification images of double labelling of neuronal Na' channel isolorms (green, 
Na1.1, Na,, 1.2, Na,, 1.3 and Na, 1I. 6) and Cx43 (red) in atrial myocardium. Scale bar, 50 µm. 
I igure (.. i Neuronal iva channel ºsotorlns ºn atrial m ocardiuni 
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A-D, high magnification images of double labelling cif neuromal Na' channel isof rms (green, 
Na, 1.1, Na, 1.2, Na, 1.3 and Na, 1.6) and C'x43 (red) in ventricular myocardium. In I). the Mute 
arrow indiciatcs very weak striation of Na, 1.6. Scale bar. 50 µm. 
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Table 6.3 Summary of labelling of neuronal Na+ channel isoforms in myocardium 
No. of hearts Atrial myocardium Ventricular myocardium 
Membrane, intracellular 
NaJ. 1 5 Membrane labelling labelling (t-tubule) and 
intercalated disk labelling 
Naj. 2 3 No labelling No labelling 
Naj. 3 4 No labelling No labelling 
Intracellular (t-tubule) 
Na, 1.6 3 No labelling 
labelling 
No primary 6 No labelling No labelling 
antibody 
The control experiments (no primary antibody) showed background levels of 
immunolabelling. 
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Fig. 6.5 shows immunolabelling by two different Na1.5 antibodies in isolated 
ventricular myocytes. Although the epitopes against which these antibodies were raised are 
different (Table 6.1), both antibodies produced labelling at t-tubules in isolated ventricular 
myocytes. There is also labelling by the Catterall Na1.5 antibody at the intercalated disks (the 
bright green labelling, highlighted by arrow, in Fig. 6.5A). As the concentration of antibodies 
decreased from 1: 30 to 1: 100 and 1: 300, the immunofluorescence signal became weaker. Thus, 
the immunofluorescence signal produced by these antibodies is unlikely to be non-specific. 
6.3.2.2. Comparison of labelling by different cardiac Na+ channel antibodies in isolated 
atrial and ventricular myocytes 
Fig. 6.6 shows immunolabelling by three different Na, 1.5 antibodies in isolated atrial 
and ventricular myocytes. Labelling by the Alomone Na1.5 antibody was located at the outer 
cell membrane in isolated atrial myocytes and at t-tubules in isolated ventricular myocytes (Fig. 
6.6A). Labelling by the Catterall Na1.5 antibody was located at the outer cell membrane in 
isolated atrial myocytes (left panel in Fig. 6.6B). In an isolated ventricular myocyte, labelling by 
the Catterall Na, 1.5 antibody was located at t-tubules (right panel in Fig. 6.6B) and there was 
some intercalated disk labelling (highlighted by arrow in right panel of Fig. 6.6B). Labelling by 
the Dumaine Na,, 1.5 antibody was located at the outer cell membrane in isolated atrial myocytes 
and at t-tubules in isolated ventricular myocytes (Fig. 6.6C). In summary, there was surface 
labelling in isolated atrial myocytes and t-tubular labelling in ventricular myocytes. Note that 
intercalated disk labelling was only observed with the Catterall Na, 1.5 antibody. However, also 
note that in atrial cells there was some (or a hint of) intracellular striated labelling with all three 
antibodies. 
6.3.2.3. Comparison of labelling by different cardiac Na' channel antibodies in AV 
node tissue sections 
A comparison of labelling by three Na, 1.5 antibodies of AV node tissue sections is 
shown in Fig. 6.7. It has been reported that high levels of Na' channel immunofluorescence are 
observed in the atrial and ventricular myocardium, whereas the myocytes of the mid nodal cell 
region of the AV node are Na1.5-negative (Petrecca et at, 1997). Although I will address the 
complex distribution of Na' channel isoforms in the AV node in the following chapters, this 
characteristic labelling pattern is useful at this stage. In the low-magnification montage of 
labelling by the Alomone Na, 1.5 antibody in Fig. 6.7A, there is abundant labelling in the atrial 
and ventricular myocardium, but no labelling in the enclosed node (Fig. 6.7A). This is 
equivalent to the labelling pattern observed by Petrecca et al. (1997). The high-magnification 
images shown as insets in Fig. 6.7A show intracellular striated labelling in both the atrial and 
ventricular myocytes. In the case of the ventricular myocytes, the intracellular striated labelling 
could correspond to t-tubules, but this is unlikely to be the case of atrial myocytes, because the 
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Figure 6.7 Comparison of immunolabelling by different Na, 1.5 antibodies of AV node 
tissue sections 
A-C, labelling by Alomone, Catterall and Dumaine, respectively, Na,, 1.5 antibodies. Low- 
magnification montages are shown on the left and high magnification images are shown on the 
right. All antibodies were used at a concentration of 1: 30. AM, atrial myocardium; EN, enclosed 
node; ON, open node; VM, ventricular myocardium. Scale bars for montages (left): 400 µm 
(A), 200 µm (B) and 100 µm (C). Scale bars for high magnification images (right), 20 µm. 
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majority of atrial myocytes are reported to have no or only rudimentary t-tubules (Cohen, 1996). 
In the case of the atrial myocytes (and perhaps the ventricular myocytes) the striated labelling 
could correspond to channel protein before trafficked to and from the outer cell membrane (if 
the trafficking apparatus is organised in a striated manner) (Fig. 6.7A) (Zhou et at, 1998; 
Rahkila et at, 2001). Fig. 6.7B and C show low magnification montages and high- 
magnification images of labelling by the two other NaJ. 5 antibodies. The Catterall Na, 1.5 
antibody produced a similar pattern of labelling (at both the tissue and myocyte levels) as the 
Alomone Na1.5 antibody (Fig. 6.7A, B). The Dumaine Na1.5 antibody produced labelling of 
the atrial myocardium (the labelling was at the outer cell membrane) (Fig. 6.7C). The Dumaine 
Na,, 1.5 antibody produced no labelling in the enclosed node (apart from non-specific labelling 
of nuclei; Fig. 6.7C). Finally, the Dumaine Na1.5 antibody produced patchy labelling at the 
outer cell membrane of the ventricular myocardium; the patchness of labelling may be the result 
of limited or no access of the antibody to the large mass of ventricular myocardium. In 
summary, there was abundant intracellular striated labelling in the atrial and ventricular 
myocardium and no labelling in the enclosed node by the Alomone and Catteral Na, 1.5 
antibodies, whereas the Dumaine Nav1.5 antibody produced outer cell membrane labelling in 
the atrial myocardium, no labelling in the enclosed node and patchy outer membrane labelling 
in the ventricular myocardium. 
6.3.2.4. Control experiments for the Alomone Na, 1.5 antibody 
Based on the data presented in this chapter, the Alomone Na1.5 antibody was chosen 
for subsequent studies. In order to confirm whether labelling of this antibody was genuine or 
not, control experiments were carried out. Control experiments either without the primary 
antibody or with preincubation of the antibody with the antigenic peptide did not produce 
immunofluorescence above background in sections through the enclosed node (Fig. 6.8). Fig. 
6.9 shows another control experiments for the Alomone Na, 1.5 antibody. As the concentration 
of the antibody was decreased, the intensity of the immunofluorescence became weaker as 
expected. Putting these results together, it is concluded that the Alomone Na1.5 antibody is a 
reliable antibody. 
6.4. Discussion 
6.4.1. Expression of neuronal Na+ channel isoforms 
Naj. 1 labelling was present in atrial and ventricular myocytes and myocardium (Figs. 
6.1 and 6.3). The labelling was in the outer cell membrane in atrial myocytes and myocardium 
(Figs. 6.1 and 6.3). The labelling was localised in intercalated disks, the outer cell membrane 
and in the cytoplasm (presumably t-tubular labelling) in ventricular myocytes and myocardium 
(Figs. 6.2 and 6.4). In atrial and ventricular myocytes and myocardium, there was also a 
presumably non-specific labelling of the nuclei (Figs. 6.1-6.4). Na, 1.2 labelling was absent in 
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Figure 6.8 Control experiments for the Alomone NaJ. 5 antibody 
A. low magnification montage of section containing the enclosed node double labelled for 
Na, 1 5 (green) and Cx43 (red). The Alomonc Na, 1.5 antibody was used. B, low magnificat * 
montage of an adjacent section double labelled for Na, 1.5 (green) and Cx43 (red). 11e 
procedure for labelling Na, 1.5 with the Alomone NaJ .5 antibody was 
followed, but the pnman 
antibody was not added. C. low magnification montage of an adjacent section double labelled 
for Na. 1.5 (green) and Cx43 (red). In this experiment, prior to the incubation of the sects »14h 
the Alomone antibody for Nav l . 
5. the antibody was preincubated with the antigenic peptde. 
AM, atrial myocardium; IN. enclosed node; VM, %entricular myocardium. Scale bars. 200 tr n 
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AM VM 
1: 30 
1: 50 
1: 100 
1: 200 
1: 500 
1: 1000 
Figure 6.9 Control experiment with a series of concentrations of the Alomone Na, 1.5 
antibody on atrial and ventricular myocardium 
Applied antibody concentrations are shown on Iclt. AM, atrial myocardium; VM, ventricular 
myocardium. Scale bar, 50 µm. 
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atrial and ventricular myocytes and myocardium (Figs. 6.1-6.4). Na1.3 and Na1.6 labelling 
was not detected in atrial myocytes and myocardium (Figs. 6.1 and 6.3). There was Na1.3 and 
Na, 1.6 labelling at t-tubules in isolated ventricular myocytes (Fig. 6.2), but Na, 1.3 labelling was 
not observed in ventricular tissue sections under my experimental conditions (Fig. 6.4). The 
reason for the absence of t-tubular labelling of Na, 1.3 in tissue sections is uncertain. A possible 
explanation is that the access of the antibody to the epitope in tissue section is limited, unlike in 
isolated myocytes. Generally, the experience of our laboratories is that antibodies have better 
access to the epitope in isolated myocytes than in tissue sections (Dobrzynski et al., 2000). 
Malhotra et al. (2001) using a specific antibody for Na,, 1.1, called SP11, reported that 
Na1.1 labelling is detected at t-tubules in the mouse heart. Maier et al. (2002) using specific 
commercial antibodies reported that the neuronal Na+ channel isoforms, Na, 1.1, Na1.3 and 
Na1.6, are localised in t-tubules in mouse ventricular myocytes. However, we observed Na1.1 
labelling at the surface membrane and intercalated disks as well as in the t-tubules in isolated rat 
ventricular myocytes. A possible explanation of this discrepancy may be the difference in 
species. 
6.4.2. Expression of the cardiac Na+ channel isoform 
The intracellular localisation of Na1.5 labelling is uncertain. Cohen (1996) reported 
that Na, 1.5 labelling was in the surface membrane and in the cytoplasm in both atrial and 
ventricular myocardium of rat. The labelling in the cytoplasm was striated and, therefore, could 
correspond to the t-tubular system, although atrial myocytes have no or only rudimentary 
t-tubules. Although the striated labelling could correspond to Na, 1.5 being trafficked to and 
from the surface membrane, labelling at the intercalated disk was stronger than in the surface 
membrane and t-tubular system with the Na, 1.5 antibody, which recognises peptide rHI, 
corresponding to residues 492-511 of the a subunit of rat Na, 1.5 (Cohen, 1996). This antibody 
is nearly identical to the Alomone Na, 1.5 antibody (which recognises residues 493-511 of the a 
subunit of rat Na1.5, Table 6.1) used in this study. Kucera et al. (2002) observed Na, 1.5 
labelling at the intercalated disk in cultures of neonatal rat ventricular myocytes with antibody 
which recognises peptide rHl, corresponding to residues 492-510 of the a subunit of rat Na, 1.5. 
This antibody is also nearly identical to the Alomone Na, 1.5 antibody (Table 6.1). Maier et al. 
(2002) only observed Na, 1.5 labelling at intercalated disks in mouse ventricular myocytes with 
Na, 1.5 antibody that recognises peptide SHI, corresponding to residues 1122-1137 of the a 
subunit of rat Na, 1.5 (i. e. the Catterall Na, 1.5 antibody, Table 6.1) and argued that rHl antibody 
used in the study of Cohen (1996) would also have recognised Na1.3, based on a BLAST 
amino acid sequence search. 
In the present study, three independent Na,, 1.5 antibodies were used (Table 6.1). These 
antibodies produced similar labelling in isolated atrial and ventricular myocytes (Fig. 6.6). 
There was striated intracellular labelling in rat ventricular myocytes and myocardium by all 
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three antibodies (Figs. 6.6 and 6.7) except in the case of the Dumaine Na, 1.5 antibody and rat 
ventricular myocardium (Fig. 6.7). This is in agreement with Cohen (1996), but in contrast to 
Kucera et al. (2002) and Maier et al. (2002). This difference could be due to a difference in 
antibody, because the SH1 antibody was used both in this study and by Maier et al. (2002). The 
difference could be a species difference, because rat was used both in this study and the study 
by Cohen (1996), whereas mouse was used by Maier et al. (2002). Finally, the difference could 
be result of two pools of Na, 1.5 (one at the intercalated disk and one at or next to the t-tubules) 
and different procedures being required to access the pools. In the present study, labelling in rat 
atrial myocytes at the surface membrane by all three antibodies was observed (Fig. 6.6). In 
contrast, in the present study, intracellular striated labelling was observed in rat atrial 
myocardium when the Alomone and Catterall (but not the Dumaine) antibodies were used (Fig. 
6.7). The intracellular striated labelling is consistent with the result of Cohen (1996) on rat atrial 
myocardium. The difference between labelling of atrial myocytes and myocardium in the 
present study could once again be the result of different pools of Na, 1.5 in a cell that require 
different conditions to access. It is noteworthy that there was a hint of intracellular striated 
labelling in atrial myocytes (Fig. 6.6). The intracellular striated labelling in atrial myocardium is 
possibly the result of Na, 1.5 being trafficked to and from the membrane. 
Before deciding whether the Alomone Na, 1.5 antibody would be used for the remainder 
of the study or not, control experiments were carried out: preadsorption of the primary antibody 
with the antigenic peptide and the omission of the primary antibody (Fig. 6.8). All control 
experiments produced background levels of immunofluorescence. In proportion to the Alomone 
Na, 1.5 antibody concentration, the intensity of the immunofluorescence varied (Fig. 6.9). These 
results are consistent with the Nav1.5 labelling by the Alomone antibody being genuine. 
In order to confirm the specificity of the Alomone Na, 1.5 antibody, Na, 1.5 with GFP 
was transfected into HEK-293 cells by Dr. S. Xu. Na, 1.5 labelling by the Alomone antibody 
was only observed in transfected HEK-293 cells (data not shown). In addition, Western blot 
analysis was carried by Dr. S. Jones. Using the Alomone Naj. 5 antibody, the expression of 
Na,, 1.5 in rat ventricular myocardium was detected and there was a single band at the correct 
molecular weight (data not shown). 
Na1.5 has been reported to be absent from the mouse SA node using the Catterall 
Na1.5 antibody (Maier et at, 2003; Lei et al., 2004). Consistent with this, in the present study, 
Na1.5 labelling was not detected in the centre of SA node using the Alomone antibody (Figs. 
10.3 and 10.4). The Alomone Navl. 5 antibody is therefore, assumed to be selective and 
effective. 
Chapter 7 
Na+ channel expression in the AV node 
7.1. Introduction 
The cardiac voltage-gated Na' channel isoform (Na, 1.5) is known to play a major role 
not only in the initiation of the action potential, but also in action potential conduction in the 
heart (Schram et al., 2002). It has been reported that neither membrane hyperpolarization nor 
the addition of TTX modifies the upstroke phase of the action potential in the AV node, leading 
to the proposal that the action potential of AV node cells is generated by a slow current system 
(i. e. ICa, L) and that these cells do not express functional Na+ channels (Meijler & Janse, 1988). 
However, other investigators have shown that hyperpolarization can increase the upstroke 
velocity of the action potential and render some AV node preparations sensitive to TTX 
(Kokubun et al., 1982). Therefore, it is unclear whether the slow action potential upstroke in the 
AV node is due to a voltage-dependent inactivation of Na+ channels or the absence of Na+ 
channels in these cells. There may also be a gradation of Na+ protein expression as one proceeds 
from the peripheral nodal region to the central nodal region: the upstroke velocity of the action 
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potential is low in the compact part of the AV node, >20 V/s (Billette, 1987; Patterson & 
Scherlag, 2002), as compared to that in the atrial muscle (150 - 300 V/s; Schram et al., 2002; 
Patterson & Scherlag, 2002). In the fast and slow pathways into the AV node the upstroke 
velocity is intermediate (41 or 60 V/s; Patterson & Scherlag, 2002) between that in the compact 
node and atrial muscle. 
Petrecca et al. (1997) previously reported a lack of or a low density of Na+ channels in 
mid-nodal region using a Na+ channel antibody generated against a conserved region of the 
Naj subfamily and this can explain the slow upstroke, low amplitude and low conduction 
velocity of the action potential in the compact AV node. However, besides Na1.5, some 
neuronal Na' channel isoforms have been recently reported to be expressed in mouse ventricular 
myocytes and adult rat and mouse SA node. The neuronal Na+ channels have a physiological 
function at both sites: a role in excitation-contraction coupling in the ventricular myocardium 
and as a pacemaker current in the SA node (Maier et al., 2002; Maier et al., 2003). The 
expression and distribution of Na' channel isoforms in the AV node has not been determined. 
The previous investigation of Na+ channel distribution in the rabbit AV node by Petrecca et al. 
(1997) did not use an antibody against a specific Na' channel isoform. 
7.2. Methods 
The general immunohistochemistry procedures are described in chapter 2 (section 2.6). 
Details of procedures for neuronal and cardiac Na' channel isoforms are given in chapter 6 
(section 6.2.2 and 6.2.3, respectively). 
7.2.1. Semi-quantitative assessment of immunofluorescence 
The relative level of Na1.5 expression was determined in a semi-quantitative manner 
with Scion image (release: Alpha 4.0.3.2). The image displayed levels of pixel intensity ranging 
from 0 to 255 on a linear scale. In order to compare intensities of different regions throughout 
the AV node tissue sections, all measured intensities in one section were divided by the highest 
intensity value (from the ventricular myocardium) and converted into a percentage. 
7.3. Results 
Immunohistochemistry was used to investigate the distribution of neuronal and cardiac 
Na' channel isoforms in the AV node. The skeletal isoform, Na, 1.4, was not investigated. 
7.3.1. Expression of neuronal Na+ channel isoforms 
To investigate whether neuronal Na' channel isoforms are present in the AV node, I 
used specific antibodies raised against Na, 1.1, Na1.2, Na, 1.3 and Na,, 1.6. Among three 
complete serial sectioned preparations, Na, 1.1 and Na,, 1.3 were studied in two preparations. In 
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addition, similar data for Na1.1 and Na1.3 were obtained from three other preparations (level 
of the enclosed node only). Na,, 1.2 and Na1.6 were not detected in atrial and ventricular 
myocardium (chapter 6). Furthermore, these isoforms were not detected in the nodal myocytes 
of the AV node in sections from three hearts (data not shown). Thus these isoforms will not be 
considered further. 
7.3.1.1. Expression of Na,, 1.1 in the AV node 
Fig. 7.1 shows high magnification images of Na1.1 labelling in different regions at 
levels 4 (B), 8 (A and C), 9 (D and E), 10 (I) and 11 (F and H) of the main preparation studied 
(Fig. 2.1B) (except left bundle branch; at level 5 of the second preparation, Fig. 4.6A). Similar 
data were obtained from the second preparation (Fig. 4.6A). In accordance with data from 
isolated myocytes shown in chapter 6 (section 6.3.1), Na, 1.1 labelling was located at the cell 
membrane in the atrial myocardium (Fig. 7.11). In the ventricular myocardium, Na1.1 labelling 
was located at the cell membrane and also co-localised with Cx43 at the intercalated disks (Fig. 
7.1A). There was also a non-specific labelling of nuclei. Naj. I labelling was also present in the 
posterior/inferior nodal extension and the zone of transitional cells (Fig. 7.1 B and D). The 
absence of Cx43 in these regions suggests that myocytes in these regions differ from myocytes 
in the atrial and ventricular myocardium. There was no Na1.1 labelling (apart from the non- 
specific labelling of nuclei) in the open node, enclosed node, common bundle and termination 
of the AV ring bundle (Fig. 7.1C, E, F and H, respectively). The absence of Na, 1.1 as well as 
Cx43 in these regions suggests that the myocytes in these regions differ from myocytes in the 
posterior/inferior nodal extension and the zone of transitional cells. Although Na1.1 labelling 
was absent in the conduction tissue from the open node to common bundle, Na1.1 was 
expressed in the left bundle branch (Fig. 7.1 G). 
7.3.1.2. Expression of Naj. 3 in the AV node 
Whereas Cx43 was absent, there was labelling of Na,, l. 3 in the enclosed node from two 
different preparations (Fig. 7.2, left panels). In accordance with data already shown in chapter 6 
(section 6.3.1), there was no labelling of Na1.3 in the atrial and ventricular myocardium (Fig. 
7.2). Neurofilamentl6O (NF160) is a neuronal cytoskeleton protein. The right panels in Fig. 7.2 
show adjacent sections double labelled for Na,, 1.3 and NF160 and Na"1.3 and NF160 were co- 
localised in the enclosed node. The co-localisation ofNa, 1.3 and NF160 labelling demonstrates 
that Na, 1.3 was only expressed in nerve fibres and nerve cell bodies innervating the enclosed 
node (i. e. not in the nodal myocytes; Fig. 7.2). 
Fig. 7.3 shows double labelling of Na1.3 and Cx43 in different regions at levels 4,8,9, 
11 and 13 of the main preparation (Fig. 2.1B). Similar data were obtained from the third 
preparation (not shown). To facilitate comparison, high-magnification images of the yellow 
framed areas in Fig. 7.3 were taken (Fig. 7.4). As already shown, there was no labelling of 
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Figure 7.1 NaJ. 1 labelling in the different regions of the AV node in the main preparation 
(Fig. 2.1 B) 
High-magnification images of double labelling for Nä, 1.1 (green) and Cx43 (red) in different 
regions of the AV node. AM, atrial myocardium; CB, common bundle, FIN, enclosed node; 
LBB, left bundle branch: ON, open node; P/I NE, posterior/inferior nodal extension; i'AVRB, 
termination of the AV ring bundle; TC, transitional cells; VM, ventricular myocardium. Scale 
bar, 50 µm. 
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Figure 7.2 Co-localisation of Na, 1.3 and neurolilament in the enclosed node 
Iligh-magnification images of' double labelling in the enclosed node tier Na, 1.3 (green) with 
Cx43 (red, left) and NFI60 (red, right). Where the Na, 1.3 and NI-I6O labels are co-localised, 
there is a yellow colour. Yellow ringed areas represent the enclosed node. AM, atrial 
myocardium; F, N, enclosed node, VM. ventricular myocardium. Scale har. 100 µm. 
Nav1.3/Cx43 
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Figure 7.3 Na, 1.3 labelling in the different regions of the AV node 
A-E, montages of sections double labelled for Na. 1.3 (green) and Cx43 (red) in different 
regions of the AV node. The posterior/inferior nodal extension is shown in A, the open node 
is 
shown in B, the enclosed node is shown in C, the common bundle is shown in D and the 
termination of the AV ring bundle is shown in E. High magnification images of the yellow 
framed areas are shown in Fig. 7.4. Framed areas are numbered according to the sequence of 
images in Fig. 7.4. AM, atrial myocardium; CB, common bundle; EN, enclosed node; LBB, 
left 
bundle branch; ON, open node; P/I NE, posterior/inferior nodal extension; TAVRB, termination 
of the AV ring bundle; TC, transitional cells; VM, ventricular myocardium. Scale bars, 100 µm 
(A and B) and 200 µm (C to E). 
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Figure 7.4 Na, 1.3 labelling in the different regions of the AV node 
I ligh-magnification images cif double labelling fier Na, 1.3 (green) and ('x43 (red) in different 
regions of the AV node. White arrowheads designate nerve cell bodies labelled fier Na, 1.3 in 13, 
1) and 11. AM, atrial myocardium: C13, common bundle: II. N, enclosed node: 1.1313, left bundle 
branch: ON, open node: P/I NI?, posterior/inferior nodal extension: 'I AVRI3, termination ol'the 
AV ring bundle: 'I C, transitional cells: VM, ventricular myocardium. Scale bars. 50 pm. 
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Na1.3 in atrial and ventricular myocardium (the dull green labelling in Fig. 7.4A and I is 
background only). Na1.3 labelling was present but much less abundant in the posterior/inferior 
nodal extension and the zone of transitional cells (Fig. 7.4B and D). Na1.3 labelling was 
abundant in the open node, enclosed node and common bundle (Fig. 7.4 C, E and F). There was 
little or no labelling in the termination of the AV ring bundle and left bundle branch (Fig. 7.4G 
and H). 
7.3.2. Expression of the cardiac Na+ channel isoform, Na,. 1.5 
In order to investigate expression of the cardiac Na' channel isoform in the AV node, 
the Alomone Na1.5 antibody was used on sections from three serially sectioned preparations. 
Data from the main main preparation (Fig. 2.113) and the third preparation are shown here. 
Similar data were obtained from the second preparation. Also similar data for Na, 1.5 were 
obtained from one other preparation (level of the enclosed node only). 
7.3.2.1. Posterior/inferior nodal extension 
Fig. 7.5 shows immunolabelling of Na1.5 in the posterior/inferior nodal extension from 
two different preparations. Fig. 7.5A shows a section at level 4 in the main preparation (Fig. 
2.1B) and Fig. 7.5B shows a section at level 3 in the third preparation. The posterior/inferior 
nodal extension, ringed in yellow in Fig. 7.5B, is located above the ventricular myocardium and 
tricuspid valve and beneath the atrial myocardium. There was dense labelling of Na,, 1.5 in the 
atrial and ventricular myocardium (Fig. 7.5). As already shown in chapter 4 (section 4.3.1), 
Cx43 was absent in the posterior/inferior nodal extension (Fig. 7.5B). There was labelling of 
Na1.5 in the posterior/inferior nodal extension (but weaker than that in the atrial and 
ventricular myocardium) (Fig. 7.5). As expected, there was no labelling of Na1.5 in connective 
tissue (Fig. 7.5A). A high-magnification image of the framed area in Fig. 7.5A (labelled 2) is 
shown in Fig. 7.11 B. 
7.3.2.2. Open node 
Fig. 7.6 shows immunolabelling of Na, 1.5 in the open node from two different 
preparations. Fig. 7.6A shows a section at level 7 in the main preparation (Fig. 2.1 B) and Fig. 
7.6B shows a section at level 7 in the third preparation. The open node is located at the centre of 
the montage, i. e. between the atrial and ventricular myocardium, in which Na, 1.5 labelling is 
abundant. As already shown in chapter 4 (section 4.3.1), the open node and the zone of 
transitional cells (ringed in yellow in Fig. 7.6) are Cx43-negative (Fig. 7.6B). There was little or 
no labelling of Na, 1.5 in the open node (Fig. 7.6). The "bump", ringed in yellow, was localised 
far above the open node in Fig. 7.6A. As shown in Fig. 7.6, the "bump" is Navl. 5-negative. As 
shown previously (Fig. 4.9), the "bump" is also Cx43-negative, DP-positive and ANP-negative. 
Thus, labelling in the "bump" is same as in the open node, the enclosed node, the common 
A, montage of Na,, 1.5 (green) labelled section at level 4 in the main preparation (Fig. 2.1 B). B, 
montage of Na,, 1.5 (green) and Cx43 (red) double labelled section at level 3 in the third 
preparation. A high magnification image of the yellow framed area (labelled 2) in A is shown in 
Fig. 7.1 1 B. AM, atrial myocardium; VM, ventricular myocardium. Scale bars, 200 µm. 
H igure 7.5 Na, 1. 
-S 
labelling in the posterior/inferior nodal extension 
146 
A, montage of Na,, 1 .5 
(green) labelled section at level 7 in the main preparation (Fig. 2.1 B). I3, 
montage of Naj. 5 (green) and Cx43 (red) double labelled section at 
level 7 in the third 
preparation. High magnification images of the yellow framed areas (labelled 
I and 3) in A are 
shown in Fig. 7.1 ]A and C, respectively. AM, atrial myocardium: VM. ventricular myocardium. 
Scale bars, 200 µm. 
Figure 7.6 Na, 1.5 labelling in the open node 
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bundle, and the termination of the AV ring bundle (see next sections). However, the 
continuation of the "bump" to other parts of the preparation (for example, the level of the 
enclosed node or the common bundle) is not certain. In addition to the termination of the AV 
ring bundle, the surprising appearance of the "bump" may be an example of the exceptional 
structural complexity of the AV node. In the zone of transitional cells, there was labelling of 
Na1.5 - it was generally weaker than that in the atrial and ventricular muscle (as in the case of 
the posterior/inferior nodal extension, Fig. 7.5) (Fig. 7.6). The zone of transitional cells and the 
posterior/inferior nodal extension are part of the AV ring bundle around the tricuspid annulus. 
High-magnification images of the framed areas in Fig. 7.6A (labelled 1 and 3) are shown in Fig. 
7.11A and C, respectively. 
7.3.2.3. Enclosed node 
Fig. 7.7 shows immunolabelling of Na1.5 in the enclosed node from two different 
preparations. Fig. 7.7A shows a section at level 9 in the main preparation (Fig. 2.1B) and Fig. 
7.7B shows a section at level 9 in the third preparation. The enclosed node, ringed in yellow in 
Fig. 7.7B, is located in the centre of the tissue between the atrial and ventricular myocardium, in 
which Na1.5 and Cx43 labelling is abundant (Fig. 7.7). The enclosed node shows the same 
labelling pattern as the open node, i. e. Na1.5-negative and Cx43-negative (Fig. 7.7). The zone 
of transitional cells exists again above the tricuspid valve and shows the same labelling pattern 
as the zone of transitional cells in the open node region (Fig. 7.7). High-magnification images of 
the framed areas in Fig. 7.7A (labelled 4 and 5) are shown in Fig. 7.11D and E, respectively. 
7.3.2.4. Common bundle 
Fig. 7.8 shows immunolabelling of Na, 1.5 in the common bundle region from two 
different preparations. Fig. 7.8A shows a section at level 11 in the main preparation (Fig. 2.1B) 
and Fig. 7.8B shows a section at level 10 in the third preparation. The common bundle, ringed 
in yellow in Fig. 7.8B, is located between the atrial and ventricular myocardium, in which 
Na, 1.5 and Cx43 labelling is abundant, close to the tricuspid valve (Fig. 7.8). At this level, 
Na1.5 labelling was present, but less abundant (as compared to the labelling in the atrial and 
ventricular myocardium), in the zone of transitional cells and absent from the common bundle 
and the termination of the AV ring bundle (Fig. 7.8). At this level, Cx43 labelling was absent in 
the zone of transitional cells, the common bundle and the termination of the AV ring bundle as 
expected (Fig. 7.8B). A high-magnification image of the framed area in Fig. 7.8A (labelled 6) is 
shown in Fig. 7.11F. 
7.3.2.5. Left bundle branch 
Fig. 7.9 shows immunolabelling of Na, 1.5 in the common bundle and the left bundle 
branch from two different preparations. Fig. 7.9A shows a section at level 5 in the second 
Figure 7.7 Na,, 1.5 labelling in the enclosed node 
A, montage of Na,, 1.5 (green) labelled section at level 9 in the main preparation (I, ig. 2.111). 11, 
montage of Na, l. 5 (green) and C'x43 (red) double labelled section at lcvcl 9 in the third 
preparation. I ligh magnification images of the yellow framed areas (labelled 4 and 5) in A are 
shown in Fig. 7.111) and I;, respectively. AM, atrial myocardium; VM, ventricular myocardium. 
Scale bars, 200 µm. 
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Figure 7.8 Na%. 1.5 labelling in the common bundle 
A, montage of Na, 1.5 (green) labelled section at level II in the main preparation (Fig. 2.113). B. 
montage of Na, l. 5 (green) and Cx43 (red) double labelled section at level 10 in the third 
preparation. A high magnification image ofthe yellow framed area (labelled 6) in A is shown in 
Fig. 7.1 IF. AM, atrial myocardium; VM. ventricular myocardium. Scale bars. 200 µm (A) and 
100 p. m (B). 
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preparation (Fig. 4.6A). Although the adjacent sections shown in Fig. 7.9B and C from another 
preparation (not one of three serially-sectioned preparations) were cut parallel to the tricuspid 
valve, the architecture is similar to that in Fig. 7.9A. The common bundle is located between the 
atrial and the ventricular myocardium, in which Na,, 1.5 and Cx43 labelling is abundant (Fig. 
7.9). For the sake of comparison, the common bundle with the left bundle branch double 
labelled for HCN4 and Cx43, already shown in Fig. 5.5B, is shown again in Fig. 7.9B. Whereas 
HCN4 labelling was present in both the common bundle and the left bundle branch (Cx43 was 
not expressed in both regions, Fig. 7.9B), Na, 1.5 was not expressed in the common bundle, but 
was expressed in the left bundle branch, 1.5 mm from the common bundle (Fig. 7.9A and Q. A 
high-magnification image of the framed area in Fig. 7.9A (labelled 7) is shown in Fig. 7.11G. 
7.3.2.6. Termination of the AV ring bundle 
Fig. 7.10 shows immunolabelling of Na1.5 in the termination of the AV ring bundle 
from two different preparations. Fig. 7.10A shows a section at level 13 in the main preparation 
(Fig. 2.1B) and Fig. 7.1OB shows a section at level 11 in the third preparation. The termination 
of the AV ring bundle, ringed in yellow in Fig. 7.10, is located between the atrial and 
ventricular myocardium, in which Na1.5 and Cx43 labelling is abundant, and shows the same 
immunolabelling pattern as the open node, the enclosed node and the common bundle, i. e. it is 
Na,, 1.5-negative and Cx43-negative (Fig. 7.10). High-magnification images of the framed areas 
in Fig. 7.1OA (labelled 8 and 9) are shown in Fig. 7.1 IH and I, respectively. 
7.3.2.7. Summary of expression of Na,, 1.5 in the AV node 
Figs. 7.11 and 7.12 summarise the results in this chapter. As already shown in chapter 6 (section 
6.3.2), there was abundant labelling of Na1.5 in atrial and ventricular myocardium (Fig. 7.1 IA 
and I). As normalized by the intensity in the ventricular myocardium, the intensity in the atrial 
myocardium was 84 ± 10 % (Fig. 7.12). Na,, 1.5 labelling was present, but less abundant in the 
posterior/inferior nodal extension and the zone of transitional cells (Fig. 7.11B and D) and 
normalized expression levels were 45 ±2 and 44 ± 12 %, respectively (Fig. 7.12). There was no 
or a reduced level of expression in the open node, the enclosed node, the common bundle and 
the termination of the AV ring bundle (Fig. 7.11 C, E, F and H) and the degree of expression 
was semi-quantified as 27 ±9% in the open node, 22 ±4% in the bump, 30 ±8% in the 
enclosed node, 35 ± 13 % in the common bundle and 24 ±8% in the termination of the AV ring 
bundle (Fig. 7.12). These regions showed a lower level of expression than the posterior/inferior 
nodal extension and the zone of transitional cells. Significant differences to the 
posterior/inferior nodal extension and the zone of transitional cells are shown with asterisks (* 
and **: P<0.05 vs P/I NE and TC, respectively; Fig. 7.12). It is interesting that the expression 
in the common bundle was slightly higher than in the enclosed node or the open node. This may 
represent onset of Na, 1.5 expression in the distal part of the conduction axis. The level of 
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Figure 7.10 Na, 1.5 labelling in the termination of the AV ring bundle 
A, montage of Na, l. 5 (green) labelled section at level 13 in the main preparation (I' T. 2.113). 13. 
montage of Na,, 1.5 (green) and Cx43 (red) double labelled section at level 11 in the third 
preparation. High magnification images of the yellow framed areas (labelled 8 and 9) in A are 
shown in I'ig. 7.1 111 and 1, respectively. AM, atrial myocardium; "I'AVRI3. termination of the 
AV ring bundle; VM, ventricular myocardium. Scale bars, 200 µm (A) and 100 µm (13). 
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Figure 7.11 Na, 1.5 labelling in the different regions of the AV node 
High-magnification images of the different regions of the AV node labelled for Na1.5 (green) 
(G shows a section double labelled for Navl. 5, green, and Cx43, red). The yellow ringed areas 
shown in C and G highlight transitional cells and the left bundle branch, respectively. AM, atrial 
myocardium; CB, common bundle; EN, enclosed node; LBB, left bundle branch; ON, open 
node; P/I NE, posterior/inferior nodal extension; TAVRB, termination of the AV ring bundle; 
TC, transitional cells; VM, ventricular myocardium. Scale bar, 50 gm. 
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Figure 7.12 Semi-quantitative assessment of Na, 1.5 expression in the different regions of 
the AV node 
The bar graph illustrates Na1.5 expression in the different regions of the AV node. Intensity of 
the different regions in a particular Na1.5-labelled section was normalized by the intensity in 
ventricular myocardium. Data are represented as mean ± SEM. *P<0.05 vs P/I NE; ** P< 
0.05 vs TC (student's t-test). Number of levels and number of preparations are shown in the 
middle of each bar. AM, atrial myocardium; CB, common bundle; EN, enclosed node; LBB, left 
bundle branch; ON, open node; P/I NE, posterior/inferior nodal extension; TAVRB, termination 
of the AV ring bundle; TC, transitional cells; VM, ventricular myocardium. 
AM P/INE BUMP ON TC EN CB BB TAVRB VM 
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Na1.5 expression in the left bundle branch was 74 ±5% (Fig. 7.12). This is higher than in the 
common bundle and approximately the same as in the ventricular myocardium. 
Comparison of Figs. 7.1 and 7.11 shows that, qualitatively, the expression pattern of 
Nal. 1 is the same as that of Na1.5. However, due to non-specific nuclear labelling, semi- 
quantitative assessment of Nal. 1 expression in the different regions of the AV node is not 
possible. 
7.4. Discussion 
7.4.1. Relation to previous studies 
Petrecca et al. (1997) previously reported evidence of a lower level of expression of Na, 
channels in the mid-nodal cells of rabbit. However, an antibody raised against a portion of the 
conserved inter-domain 3-4 region of the Na1 subfamily of Na' channels was used and, 
therefore, Petrecca et al. (1997) could not discriminate between different Na` channel isoforms. 
The possibility of the existence of neuronal Na' channel isoforms in the AV node was not 
expected (Petrecca et al., 1997). Although Petrecca et al. (1997) reported the expression of Na' 
channels in lower nodal cells, I observed the absence of all Na* channel isoforms throughout the 
enclosed node (both mid-nodal and lower nodal cells). Furthermore, the labelling in the atrial 
myocardium in the study of Petrecca et al. (1997) was sparse and this raises doubts concerning 
the veracity of the labelling. 
7.4.2. The roles of Na+ channels in AV node electrophysiology 
As explained in chapter 1 (section 1.2.1), the cells of the AV junction are frequently 
described as atrionodal (AN), nodal (N) and nodal-His (NH) (Mazgalev et al., 2001). The 
maximum upstroke velocity of the action potential in these cells is substantially lower than in 
the atrium or His bundle. Moreover, within the triangle of Koch, the upstroke velocity of the N- 
type cell is slower than that of the AN or NH-type cell (McGuire et al., 1996; Patterson & 
Scherlag, 2002). This is in keeping with my findings, because some Na" channels are expressed 
in the zone of transitional cells (44 f 12 %, Fig. 7.12; possibly AN cells) and the 
posterior/inferior nodal extension (45 ±2 Fig. 7.12; containing, possibly, AN cells), whereas 
no Na+ channels are expressed in the open node and enclosed node (27 ±9% and 30 ±8%, 
respectively, Fig. 7.12; containing, possibly, N cells). The reduced level of Na' channel 
expression in the enclosed node explains the slow-rising upstroke of the action potential here. 
The mid-level of expression of NaJ. 1 (not quantified) and Na, 1.5 in the zone of transitional 
cells and the posterior/inferior nodal extension explains the faster upstroke velocity here. The 
conduction velocity of the AV node is low and this is responsible for the delay between the 
activation of the atria and ventricles in the cardiac cycle. The reduced level of Na, 1.5 and 
Na1.1 from the open node to the proximal left and right bundle branches will, at least, 
contribute to the low conduction velocity. 
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7.4.3. Other roles for neuronal Na+ channels in conduction tissue? 
As already reported in the SA node (Dobrzynski et al., 2003), Na1.3 labelling was only 
observed in nerve fibres and nerve cell bodies innervating the nodal myocytes. Although there is 
a rich innervation by the autonomic nervous system of both the SA and AV nodes, the 
innervation of the two nodes seems to be different. From a study of the canine heart, the SA 
node is especially responsive to parasympathetic regulation, whereas the AV conduction is 
preferentially sensitive to sympathetic adrenergic regulation (Randall, 1988). The exact 
distribution and destination of these nerves are still uncertain. 
One of the interesting findings in this study is the distribution of Na, 1.3 in the AV node. 
Na, 1.3 is expressed in nerve fibres and cell bodies rather than myocytes. Na, 1.3 labelling is 
absent in the atrial and ventricular myocardium, present (but not abundant) in the specialised 
pathways into the AV node (posterior/inferior nodal extension and the zone of transitional cells) 
and abundant in the open and enclosed nodes. Therefore, innervation appears to be controlling 
AV conduction at the point at which conduction will be the most severely constrained by the 
absence of Na,, 1.5 and Na1.1. 
Besides the presence of Nar1.1 in the posterior/inferior nodal extension and the zone of 
transitional cells, Na,, l. 1 is expressed in the left bundle branch. It is well known that Na+ 
channels exist from the distal part of the common bundle until the terminal Purkinje fibres and 
contributes to the high upstroke velocity and long duration of the action potential in the 
His-Purkinje system (Carmeliet, 1987). The role of Na,, l. l in the left bundle branch needs 
investigation. 
Chapter 8 
Cx40 expression in the AV node 
8.1. Introduction 
8.1.1. The contribution of gap junctions to atrial-AV nodal conduction 
Activation of cardiac contraction requires an orderly spread of electrical excitation from 
one myocyte to the next throughout the heart. Gap junctions are essentially clusters of 
transmembrane channels that connect the cytoplasmic compartments of neighbouring myocytes, 
forming sites of low resistance electrical coupling and conduits for the direct exchange of small 
molecules and ions. 
Particularly in the enclosed node, a reduced level of or an absence of high-conductance 
gap junction channel isoforms (Cx43 and Cx40; Severs et al., 2001) and the presence of a low 
conductance isoform (Cx45; Severs et al., 2001) can explain the slow conduction through the 
AV node (Shaw & Rudy, 1997). As already described in the previous chapter (section 7.4.2), 
the absence of Na1.5 and Na, 1.1 from the open node to the proximal left and right bundle 
branches will, at least, also contribute to the low conduction velocity of the AV node. However, 
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it has been suggested that the contribution of Na' channels to slow conduction is lower than that 
of connexins, because a reduction of Na' conductance can produce only a three-fold reduction 
in conduction velocity, whereas a decrease in coupling by connexins can cause a 100-fold 
reduction (Shaw & Rudy, 1997). 
In this chapter, the distribution of Cx40 in the rat AV node is investigated from the 
point of view of AV conduction. It is widely accepted that Cx40 expression is scant or absent in 
the working ventricular myocardium of most mammals and Cx40 is mainly expressed in the 
atria and the His-Purkinje system, in which rapid conduction occurs (Gourdie et al., 1993; 
Kanter et al., 1993; Bastide et al., 1993; Davis et al., 1994; Gros et al., 1994; Van Kempen et 
al., 1995; Gros & Jongsma, 1996; Vozzi et al., 1999). 
8.1.2. Mid-nodal and lower nodal cells 
In the enclosed node, mid-nodal cells and lower nodal cells can be discriminated from 
each other. The "typical" AV nodal cells constitute the so-called mid-nodal or compact node 
region. These are the cells forming a dense discoid-shaped network for which Tawara coined 
the term "node" (Tawara, 2000), now always used for description of the entire region. In 
addition to being closely packed together (i. e. compact), the mid-nodal cells are typically small, 
have random orientation (DeFelice & Challice, 1969) and contain few nexuses (Kawamura & 
James, 1971). Lower nodal cells start posteriorly/inferiorly as a thin bundle of small cells that 
make scarce contacts with transitional cells. Closer to the enclosed node, one can recognise 
larger individual bundles separated by fibrous tissue, and as the lower cells progress even more 
anteriorly/superiorly they form, without any sharp boundary, the bundle of His. The above 
description has been originally proposed for the rabbit heart (Anderson et al., 1974), although 
similar subdivisions have been observed in other species as well (Truex & Smythe, 1965; Truex 
& Smythe, 1967; Anderson et al., 1975). 
8.2. Methods 
The general immunohistochemistry procedures are described in chapter 2 (section 2.6). 
Details of procedures (tissue fixation, membrane permeablisation, blocking of non-specific 
sites, type of labelling, type of primary and secondary antibodies used, incubation time and 
temperature during incubation with antibodies, washing and mounting of tissue) are also 
described in chapter 4 (section 4.2). As Cx40 antibody can detect Cx43 protein in tissue sections 
(data not shown), a very low concentration of Cx40 antibody was used (1: 2000 or 1: 5000) to 
avoid misleading results. 
8.3. Results 
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Fig. 8.1 shows high magnification images of Cx40 labelling in the AV conduction axis 
in the second preparation (Fig. 4.6A). Cx40 was expressed in the enclosed node (only in the 
lower half; Fig. 8.1A), common bundle (Fig. 8.1B), and left bundle branch (Fig. 8.1C). The high 
abundance of Cx40 in these areas contributes to the fast conduction in the His-Purkinje system. 
Fig. 8.2 shows high maginification images of Cx40 labelling in other sub-regions in the 
AV node in the same preparation. In accordance with previous reports (Van Kempen et al., 
1995; Vozzi et al., 1999), Cx40 was absent in ventricular myocardium, but present in the atrial 
myocardium (Fig. 8.2A and F). Compared to the labelling in the conduction axis (Fig. 8.1), 
Cx40 labelling in the atrial myocardium was quite weaker. In the part of AV conduction axis, 
there was Cx40-negative areas from the posterior/inferior nodal extension to the enclosed node 
(upper part) (Figs. 8.2B-D and 8.1A). The termination of the AV ring bundle was also Cx40- 
negative (Fig. 8.2E). 
8.4. Discussion 
From the open node to the proximal left and right bundle branches, the medium 
conductance gap junction protein, Cx43, is not expressed or poorly expressed (chapter 4, 
sections 4.3.2-4.3.5), although from the enclosed node to the left and right bundle branches 
(and, presumably, onto the terminal Purkinje fibres) the high conductance gap junction isoform, 
Cx40, is expressed (Fig. 8.1). In the open node and part of the enclosed node, Cx40 is not 
expressed (Figs. 8.2C and 8.1A, upper half of the enclosed node) and Cx43 is either not or 
poorly expressed (chapter 4, sections 4.3.2 and 4.3.3) and instead the low-conductance gap 
junction protein, Cx45, is expressed (Dobrzynski et al., 2003) and this pattern of expression, at 
least, is expected to contribute to the low conduction velocity of the AV node. 
In the compact AV node of the rabbit, Mazgalev et al. (2001) has described distinct 
electrophysiologies in the mid and lower nodal cells. Does this correspond to the mid 
Cx40-negative nodal cells and lower Cx40-positive nodal cells in this study (Fig. 8.1A)? In the 
rabbit the lower nodal cells express Cx43 rather than Cx40 (Dobrzynski & Greener, 
unpublished data). 
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Figure 8.2 The absence of Cx40 labelling in other sub-regions of the AV node (outside of 
the AV conduction axis) in the second preparation (Fig. 4.6A) 
High magnification images of Cx40 (green) in different sub-regions of the AV node are shown. 
AM, atrial myocardium; ON, open node; P/I NE, posterior/inferior nodal extension; i'AVRI3, 
termination of the AV ring bundle; TC, transitional cells; VM, ventricular myocardium. Scale 
bar, 50 µm. 
Chapter 9 
Expansion to the AV ring bundle (around the tricuspid 
annulus) 
9.1. Introduction 
Advances in the radiofrcqucncy therapy of AVNRT with preservation of AV 
conduction have revived interest in the detailed morphology of the AV node and its atrial inputs 
(Schluter et al., 1991; Jazaycri et a!., 1992; Kcim et al., 1992; Decker, 1994). For instance, in 
patients with AVNRT, a "slow pathway" is considered part of the rccntrant circuit and catheter 
ablation near the coronary sinus orifice is the most favoured and highly successful approach 
(Mitrani et al., 1993; Jazayeri & Akhtar, 1993; Sousa et al., 1994). 
Many experimental (mostly electrophysiological) and clinical observations support the 
idea that reentry involves not only the compact AV node but also atrial tissue (Lin et al., 1994; 
Wu et al., 2001) and the posterior/inferior nodal extension 0 laissagucrre et al., 1992; Mcdkour 
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et a!., 1998; Inoue & Becker, 1998). The posteriorrnferior nodal extension could be the slow 
pathway. 
Nodal-like cells from the posterior/inferior nodal extension continue around the 
tricuspid annulus and form the AV ring bundle (McGuire et a!., 1994; Thery el a!., 1994; 
Uchida et a!., 1998; Xie et al, 2004). The existence of this ring of conduction tissue was shown 
by earlier anatomical studies in the 1970's (Anderson & Taylor, 1972; Anderson, 1972). Some 
morphological studies have recently found that some bundles and collections of cells with 
different morphological characteristics and arrangements exist in the AV junctional area, and 
connect with the compact AV node in humans and in some animals (Inoue & Becker, 1998; 
Anderson & Ho, 1998). Inoue & Becker (1998) reported that rightward posterior and leftward 
posterior extensions showed similar cellular and architectural characteristics as those of the 
compact AV node. The cells in the extensions were small and closely packed, with an 
interweaving architecture and, occasionally, a distinct node-like cellular arrangement. This 
specialised conduction tissue outside the triangle of Koch is assumed to be a remnant of the AV 
canal tissue demonstrated in embryonic hearts (Arguello et a!., 1986). Clearly, this tissue 
remains present into adult life, because Mcguire et a!. (1994) reported electrophysiological 
evidence for a ring of nodal-like cells around the tricuspid annulus in mature dog heart. 
Although Mcguire et al. (1996) reported a lack of Cx43 in AV junctional cclls around 
both the tricuspid and mitral valves, the expression pattern of proteins responsible for 
conduction in these cells has not been investigated. The aim of the experiments described in this 
chapter was to investigate the expression pattern of ion channels (especially N3* channels) and 
gap junction channel isoforms in the AV ring bundle around the tricuspid valve. The part of the 
AV ring bundle of the tricuspid valve opposite the AV node was investigated. 
9.2. Methods 
The general immunohistochemistry procedures are described in chapter 2 (section 2.6). 
Details of procedures for each probe arc described in previous chapters (DP, ANP and Cx43, 
section 4.2; 1 ICN4, section 5.2; Na' channels, section 6.2; Cx40, section 8.2). 
9.3. Results 
To investigate the expression of various ion channels including some Na` channel 
isoforms (N41.1 and Na1.5) and gap junction channels in the AV ring bundle. sections %%-crc 
cut along the sagittal plane. The position of the cutting plane is shown as a dotted line in rig. 
11. IC. 
9.3.1. Anatomy and histology of the AV ring bundle 
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Fig. 9.1 shows Masson's trichrome staining of a `four chamber section'. Because all 
four chambers in the heart can be seen, sections cut along the sagittal plane are called `four 
chamber sections'. Fig. 9.1B shows a high magnification image of the framed area in A: the 
common bundle (and the zone of transitional cells) is on one side (in box D) and the AV ring 
bundle is on the opposite side (in box Q. As already described in chapter 3 (sections 3.3.3 and 
3.3.4), the common bundle was situated in the middle of the AV junctional region (box D in 
Fig. 9.1B) and it was separated from the atrial and ventricular myocardium (stained red) by 
connective tissue (stained blue). Compared to the surrounding atrial and ventricular 
myocardium, the myocytes in the AV ring bundle and the common bundle (boxes C and D, 
respectively, in Fig. 9.1B) were stained a lighter red, were smaller, and were loosely packed. 
9.3.2. Immunolabelling of immunohistochemical markers and HCN4 
Fig. 9.2 shows immunolabelling of immunohistochemical markers (Cx43, DP and 
ANP) and HCN4 in the common bundle and the AV ring bundle on the opposite side of the 
tricuspid valve to the AV node in adjacent sections. The common bundle, yellow ringed, is 
located above the ventricular myocardium and beneath the atrial myocardium (Fig. 9.2B, D and 
F). Atrial myocardium showed co-localisation of Cx43 and DP at intercalated disks (Fig. 9.2B) 
and intracellular ANP labelling (Fig. 9.2D). The common bundle showed DP labelling at 
intercalated disks and HCN4 labelling at the outer cell membrane (Fig. 9.2B and F). Ventricular 
myocardium showed co-localisation of Cx43 and DP at intercalated disks as in atrial 
myocardium (Fig. 9.2B). As already described in chapters 4 and 5 (sections 4.3.4 and 5.3.4), the 
common bundle is Cx43-negative, DP-positive, ANP-negative and HCN4-positive. In addition 
to the myocytes of the common bundle, nodal-like myocytes existed in the other yellow ringed 
areas (the zone of transitional cells and the AV ring bundle (lateral side)) (Fig. 9.2). The 
expression pattern in the AV ring bundle on the lateral side was the same as that in the zone of 
transitional cells and the common bundle: DP-positive, Cx43-negative, ANP-negative and 
HCN4-positive (Fig. 9.2). 
9.3.3. Immunolabelling of Na' channel isoforms 
Fig. 9.3 shows immunolabelling of Na, l. l and Na, 1.5 in the common bundle, the zone 
of transitional cells next to the common bundle and the AV ring bundle (lateral side) in adjacent 
sections. As already described in chapter 7 (section 7.3.2.4), all these structures, ringed in 
yellow, are located between the atrial and ventricular myocardium, in which Na, 1.1, Na1.5 and 
Cx43 labelling are abundant (Fig. 9.3B and D). Na1.1 and Na, 1.5 labelling was present, 
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Figure 9.1 Anatomy and histology of a four chamber section 
A, low-magnifi cation montage of Masson's trichrome stained section which was cut along with 
sagittal plane (the cutting plane is shown as a dotted Iine in Fig. 11.1C). The section was 
provided and stained by Dr. M. Yamamoto. B, zoomed image of framed area in A. Framed 
areas C and D are regions of interest. AS, atrial septum; CT, crista terminalis; LA, left atrium; 
LV, left ventricle; MV, mitral valve; RA, right atrium; RV, right ventricle; SVC, superior vena 
cava; TV, tricuspid valve; VS, ventricular septum. Scale bars, I mm (A) and 400 µm (B). 
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Figure 9.2 Labelling of immunohistochemical markers in a four chamber section 
Left (A and B), middle (C and D) and right (E and F) panels show montages of sections double 
labelled for Cx43 (green) and DP (red), Cx43 (green) and ANP (red), and HCN4 (green) and 
Cx43 (red), respectively. Sections were provided by Dr. M. Yamamoto. Top (A, C, and E) and 
bottom (B, D, and F) panels correspond to the framed areas in Fig. 9.1 (C and D, respectively). 
AM, atrial myocardium; CB, common bundle; TC, transitional cells; VM, ventricular 
myocardium. Scale bars, 200 µm. 
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provided by Dr. M. Yamamoto. Top (A and C) and bottom (11 and 1)) panels correspond to the 
framed areas in Fig. 9.1 (C and 1), respectively). AM, atrial myocardium; ('11, common bundle; 
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but less abundant (as compared to the surrounding working myocardium), in the zone of 
transitional cells and the AV ring bundle (lateral side), but was not present in the common 
bundle (Fig. 9.3). Cx43 labelling was absent in the zone of transitional cells, the AV ring bundle 
(lateral side) and the common bundle (Fig. 9.3). The expression pattern in the AV ring bundle 
(lateral side) was the same as that in the zone of transitional cells, but different from that in the 
common bundle; the AV rung bundle (lateral side) was Na1.1-positive (Fig. 9.3A), Na1.3- 
positive (not abundant; data not shown) and Na,, 1.5-positive (Fig. 9.3C). 
9.3.4. Immunolabelling of the large conductance connexin isoform, Cx40 
Fig. 9.4 shows immuolabelling of Cx40. As already described in chapter 8 (section 8.3), 
Cx40 was abundantly expressed in the common bundle, but it was not present in the zone of 
transitional cells (Fig. 9.4). Fig. 9.4 shows that Cx40 was also not present in the AV ring bundle 
(lateral side). 
9.4. Discussion 
Cx43 has been reported to be absent in the AV junctional cells (the AV ring bundle) 
around both the tricuspid and mitral valves (McGuire et al., 1996). In this study, Cx43 labelling 
was also not detected in the AV ring bundle (lateral side). The expression of the other 
immunohistochemical markers (DP, ANP and HCN4) in the AV ring bundle (lateral side) was 
the same as in the common bundle (Fig. 9.2). 
In this chapter, the distribution of different Na+ channel isoforms in the AV ring bundle 
is shown for the first time. The labelling pattern of Na' channel isoforms (Nal. 1 and Naj. 5, 
Fig. 9.3) and Cx40 (Fig. 9.4) in the AV ring bundle (lateral side) is the same as that in the zone 
of transitional cells next to the common bundle, but is different from that in the common 
bundle. Such a difference in labelling pattern makes it possible to classify different cell types 
around the tricuspid annulus (an area larger than the triangle of Koch). This issue is discussed in 
detail in chapter 11. 
The presence of a ring of nodal-like cells around the tricuspid annulus is supported by 
electrophysiological evidence. Mcguire et al. (1994) reported that the ring of nodal-like cells 
was not part of the compact AV node. Xie et al. (2004) reported that the action potential 
characteristics of the AV ring bundle were similar to those of the AV node, Although the 
repolarization characteristics in the AV ring bundle were different from those in the AV node. 
The distribution of the ion channels responsible for repolarization may provide a clue to the 
electrophysiology of this specialised region, but this is outside of the scope of the present 
study. 
171 
Cx-ifl 
Montage of a wet Mm Iahc Uc i for (. 4O i jn ii ºA and h carteapssid in Atrwý J www in I io Y1 
(C mid 1). r opmnvi, ) %Ws n um prart4id b) tk M Va wow ilw p wrW rww 
Ilumaccncc n twk&mund fh+nranc+c. the ant) p umw ('%10 Idt win )Ark u, of as 
in the common bwsdk AM. anal m)t dwo. (Y/. c--' lrwär. It'. tbrl c ik 
VM. ventruulw myocwdn+m %cak N w. 200 Wm 
Chapter 10 
The different architecture of the SA node 
10.1. Introduction 
10.1.1. SA node: a heterogenous tissue 
The SA node is a complex and inhomogeneous tissue in terms of cell morphology and 
electrophysiological activity. There are two models of the cellular organization of the SA nodc: 
the gradient and mosaic models (Verheijck et at, 1998; Boyett et a!., 2000). 
In favour of the gradient model, action potentials recorded from the centre of the rabbit 
SA node have a more positive take-off potential, slower upstroke, longer duration and less 
negative maximum diastolic potential than action potentials recorded from the periphery; the 
intrinsic pacemaker activity of the centre is also slower than that of periphery (Boyctt et d, 
1999; Kodama & Boyett, 1985; Bleeker et a!., 1980). Between the centre and periphery, there is 
a smooth gradient in action potential properties. Similar heterogeneities of the action potential 
characteristics have been observed in isolated SA nodal myocytes (Ilonjo et a!., 1996). 
Furthermore, cell size also increases from the centre to the periphery of the SA node (Bleeker et 
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at, 1980; Boyett et at, 2000) and there are significant correlations between the densities of 'N 
4-AP sensitive current, rapidly activating delayed rectifier K+ current (ir 
,, 
), slowly activating 
delayed rectifier K+ current hyperpolarization-activated inward current (if), L-type Cat' 
current (icý, L) and cell capacitance (a measure of cell size) in rabbit SA node cells (Honjo et al., 
1996; Honjo et al., 1999; Lei et al., 2000; Lei et al., 2001; Musa et al., 2002). Besides 
electrophysiological evidence, the expression patterns of several proteins relevant to the 
excitability of the SA node including gap junction channels and various Ca2+ handling proteins 
(L-type Ca2+ channel, Na+-Ca2+ exchanger, sarcoplasmic reticulum Ca 2+ release channel, and 
sarcoplasmic reticulum Ca 2+ pump) vary from the centre to the periphery of the SA node (I lonjo 
et al., 2003; Musa et al., 2002). 
However, there are other reports which support the mosaic model. In the rabbit SA 
node, Verheijck et al. (1998) reported that there exists a substantial number of atrial cells (as 
well as SA node cells) even in the centre of the SA node, and the ratio of atrial cells: SA node 
cells gradually increases from the centre of the SA node to the periphery and morphological 
differences in the SA node cells are not associated with differences in action potential 
configuration and pacemaker activity. Based on these results, the mosaic model was suggested, 
in which there is a random mix of the two cell types and the ratio of atrial cells: SA node cells 
increases from the centre to the periphery of the SA node. Dobrzynski et al. (2005) recently 
showed that contrary to the gradient model and consistent in part with the mosaic model, there 
is a mix of atrial and SA node myocytes in the periphery. 
Thus, according to the gradient model there is a gradual transition in morphology and 
electrophysiological properties of SA nodal myocytes from the centre to the periphery of the SA 
node. In contrast, according to the mosaic model, there is a variable mix of atrial and SA nodal 
myocytes from the centre to the periphery; each cell type has nearly constant morphological and 
electrophysiological properties. It is possible that elements of both models arc correct. 
10.1.2. Centre and periphery of the SA node 
The action potential is usually first initiated in the centre of the SA node (distant from 
the surrounding atrial myocardium). Normally, the function of the periphery of the SA node (at 
the border of the SA node with the atrial muscle) is to conduct the action potential from the 
centre to the surrounding atrial muscle, although it can take over the role as the leading 
pacemaker site (Boyett et al., 2000). 
Many studies have reported that Cx43, the predominant connexin in the heart, is absent 
in the centre of the SA node (Verheule et at, 2001; Davis et al., 1994; Dobrzynski et at, 2001; 
Coppen et al, 1999). Dobrzynski et al. (2005) recently distinguished between the ccntrc and 
periphery of the SA node using SA node specific markers: middle (160/165. kDa) ncurofliament 
(NF-M) and ANP. The periphery of the SA node was NF-M-positive, ANP-negative and Cx43- 
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positive, whereas the centre of the SA node was NF-M-positive, ANP-negative, and Cx43- 
negative. 
10.1.3. The expansion of the SA node 
Early histological studies reported that the SA node is only found at the junction 
between the superior vena cava and the right atrium (Truex et al., 1967; James, 1961). However, 
it has been reported that electrophysiologically the SA node occupies a larger area than does the 
histological distribution of the SA node (Betts et al, 2002; Kalman et al., 1995; Boineau et al., 
1988; Boineau et al., 1980). Consistent with this, other histological studies have shown that the 
SA node is a more extensive structure than originally thought and runs from the superior vena 
cava alongside the crista terminalis towards the inferior vena cava (Sanchez-Quintana et al., 
2002). SA nodal myocytes, as identified by the presence of HCN4 and Cx45, are also found in 
the interatrial groove in the vicinity of the right superior pulmonary vein (Dr. M. Yamamoto, 
unpublished observations). 
10.1.4. Gap junction channel expression in the SA node 
Gap junction channels are the basis of intercellular coupling (Beyer et al., 1990). Nodal 
myocytes are small, with a reduced amount of contractile elements and small, sparse, dispersed 
gap junctions. The latter correlates with poor electrical coupling, which, in the SA node, is 
important for the ability of the SA node to drive the large mass of surrounding atrial tissue while 
remaining protected from its hyperpolarizing influence (Severs et at, 2001). 
It is widely accepted that Cx43 is absent in the centre of the SA node (Verheule et at, 
2001; Dobrzynski et al, 2001; Davis et al., 1994; Coppen et al., 1999). Other connexins 
(possibly Cx40 and certainly Cx45), expressed in heart, are major components of the very small 
gap junctions of the SA node (Coppen et al., 1999; Kwong et al., 1998). 
10.1.5. Na'' channel expression in the SA node 
Recent studies have shown that Na, 1.5 is not only the Na` channel isoform in the adult 
heart and neuronal isoforms are also present (Maier et al., 2002; Maier el al., 2003). Some work 
in this chapter was published in a paper concerning the presence of neuronal Na` channels and 
absence of Na1.5 in the SA node (Maier et al., 2003). 
It was recently reported that the distribution of Na1.5 is complex in the mouse SA 
node: Na, 1.5 was not expressed in small SA nodal cells (likely to be from the centre of the SA 
node) and in the region of the SA node located in the intercaval region (the centre). I lowevcr, 
Na,, 1.5 was expressed in large SA nodal cells (likely to be from the periphery of the SA node) 
and in the region of the SA node located on the endocardial face of the crista tcrminalis (the 
periphery) (Lei et at, 2004). 
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10.2. Methods 
The general immunohistochemistry procedures are described in chapter 2 (section 2.6). 
Details of procedures for each probe are described in previous chapters (DP, ANP and Cx43, 
section 4.2; HCN4, section 5.2; Na+ channels, section 6.2). SA node tissue sections, cut along 
perpendicular to the crista terminalis, as well as four chamber sections, cut along the sagittal 
plane, were used. 
10.3. Results 
10.3.1. Immunolabelling of immunohistochemical markers: the discrimination 
between the the centre and periphery of the SA node 
To discriminate between the centre and periphery of the SA node, Cx43, ANP and 
HCN4 were used as immunohistochemical markers. Cx43 is expressed in the atrial myocardium 
and in the periphery of the SA node, but is absent in the centre of the SA node. ANP is 
expressed in the atrial myocardium, but is absent in the SA node. IHCN4 is the principal isoform 
responsible for the pacemaker current, If, and is known to be present throughout the SA node, 
but not in the atrial myocardium (Boyett et at, 2003). DP is a component of desmonsomes 
(which mediate cell-to-cell linkage of the intermediate filament cytoskeleton) and is expressed 
in all myocytes (atrial myocardium and SA node). 
Typical immunolabelling of immunohistochemical markers in SA node tissue sections 
is shown in Fig. 10.1. Fig. 10.1 shows immunolabelling of Cx43, ANP and IICN4 as well as 
Masson's trichrome staining of a four chamber section. Fig. 10.1A shows the gross anatomy of 
section (already shown in Fig. 9.1A) and Fig. 10.1B shows a high magnification image of the 
framed area in A. The SA node tissue appears lighter in colour (Fig. 10.1 B). ANP labelling was 
largely a mirror image of HCN4 labelling: SA node tissue showing IICN4 labelling showed no 
ANP labelling, whereas atrial myocardium showing no HCN4 labelling showed ANP labelling 
(Fig. 10.1). As expected, there was no Cx43 labelling in the centre of SA node, but there was 
labelling in the atrial myocardium (Fig. 10.1). However, Fig. 10. IC shows that there was Cx43 
labelling in the periphery of SA node. The centre of the SA node was Cx43-ncgativc, ANN 
negative and HCN4-positive, whereas the periphery of the SA node was Cx43-positive, ANN 
negative and IICN4-positive (Fig. 10.1). In addition to the SA node in the intcrcaval region 
(Fig. 10.1C and E), there was another region in which nodal myocytes occupied: the intcratrial 
groove (Fig. 10.1 D and F). 
Fig. 10.2 shows another example of labelling of immunohistochcmical markers in a SA 
node tissue section. SA node sections were cut perpendicular to the crista terminalis through the 
SA node and were immunolabelled by Dr. H. Dobrzynski. The labelling pattern was same as 
that in Fig. 10.1. It is noteworthy that the myocytes in the centre of the SA node arc small, 
Cx43-negative, ANP-negative and HCN4-positive; none of these are the attributes of atrial 
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chamber section 
A, Masson's trichromc stained section. U. roomed image of the framed area in A 'c. taon' %wrc 
provided and histologically stained by I)r. M. Yamamoto. C. I). montages of section douhlc 
labelled fror Cx43 (green) and ANP (red). F. F. montages of'section labelled for IICN4 (green). 
C to F correspond to the framed areas in B. AS. atrial septum; CI, crista tcrminalis; ctSAN. 
centre of the SA node; ppSAN, periphery of the SA node; RA, right atrium; SAN. SA ntxk; 
SVC, superior vcna cava. Scale bars. I mm (A). 300 µm (11). and I(X) µm (C - I-) 
Figure 10.1 Anatomy of and immunolabelling of inimunnt)istuchcnucul markrr. 111 a hiur 
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Figure 10.2 Labelling of immunohistochemical markers in a rat SA node tissue section 
A, montage of section double labelled for ANP (green) and Cx43 (red). B, montage of section 
labelled for HCN4 (green). Sections were provided and immunolabelled by Dr. H. Dobrzynski. 
CT, crista terminalis; SAN, SA node; SEP, interatrial septum; ctSAN, centre of the SA node; 
ppSAN, periphery of the SA node. Scale bars, 100 µm. 
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myocytes, and this is inconsistent with the mosaic model (there should be some atrial myocytes 
in the centre of the SA node according to the mosaic model). 
10.3.2. Immunolabelling of Na+ channel isoforms 
Immunolabelling of Na' channel isoforms in adjacent four chamber sections is shown 
in Fig. 10.3. Myocytes showing no Cx43 labelling show Narl. l labelling in Fig. 10.3A and B; 
Na1.1 was expressed in the centre of the SA node (Cx43-negative region) as well as in the 
surrounding myocardium (Cx43-positive). Myocytes showing no Cx43 labelling show no 
Na1.5 labelling in Fig. 103C and D, but Na1.5 and Cx43 were expressed elsewhere. Although 
the exact border of the periphery of the SA node is not certain, the presence of Naj. 5 in the 
periphery of the SA node is a possibility (the periphery of the SA node region is around the 
Cx43-negative region). 
Fig. 10.4 shows Na1.1 and Na1.5 labelling in SA node sections adjacent to those 
shown in Fig. 10.2. The Na, 1.1 labelling pattern is the same as shown in Fig. 10.3; Na1.1 was 
present throughout the tissue. The centre and periphery of the SA node region can perhaps be 
distinguished by considering the difference between IICN4 labelling (Fig. 10.213) and Nal. 5 
labelling (Fig. 10.413). The centre of the SA node is IICN4-positivc and Na1.5-negative, 
whereas the periphery is HCN4-positive and Na1.5-positive (Figs 10.2 and 10.4) As already 
reported in the mouse SA node (Maier er at, 2003; Lei et a!., 2004), the present study shows 
that Na, 1.5 is present in the periphery of the SA node of the rat (Fig. 10.413). 
Fig. 10.5 shows high magnification images of sections double labelled for Na, 'l. l and 
DP or Cx43. As already shown in chapter 4 (section 4.3), DP was expressed at the intercalated 
disks in all myocytes (Fig. 10.5). As already shown in Figs. 10.3 and 10.4, Na1.1 was present 
throughout the tissue (Fig. 10.5). In the right-middle panel in Fig. 10.5, there is no labelling of 
Cx43 in the SA node except in the SA node artery, whereas there is labelling of Na, 1.1 in the 
SA node myocytes. 
Fig. 10.6 shows Nar1.3 labelling in the SA node. Cx43 labelling (red in Fig. 10.6A) is 
largely absent, confirming that the tissue is SA node. There was no labelling of Na, 1.3 in SA 
node myocytes, but as already shown in chapter 7 (section 7.3.1.2), Na1.3 labelling was present 
in nerve fibres and nerve cell bodies innervating the nodal myoc)lcs. Fig. 10.613 shows 
co-localisation (yellow colour) of Na1.3 and NF160 in the SA node. 
Some parts of this study (Figs. 10.4A, 10.5 and 10.6) have already been published 
(Maier et aL, 2003). 
10.4. Discussion 
The SA and AV nodes are specialiscd tissues in the heart: the SA node is specialised for 
pacemaking (it is the pacemaker of the heart), %shcrcas the AV node is specialised for slow 
conduction of the action potential (to introduce a delay between atrial and ventricular activation 
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during the cardiac cycle). In order to fulfill their specialised functions, the SA and AV nodes 
have (i) a different pattern of expression of ion channels and, as a result, different action 
potential configurations (as compared to the working myocardium), (ii) poor electrical coupling 
between cells and (iii) specialised structures. 
At the single cell level, their electrophysiological activity is reasonably well understood 
(Schram et al., 2002; Irisawa et al., 1993). From the point of view of impulse generation and 
conduction, poor electrical coupling protects the SA node from the hypcrpolarizing influence of 
the surrounding atrial myocardium and, in case of the AV node, because of the resulting slow 
conduction, the poor electrical coupling ensures coordinated contractions of the atria and 
ventricles (Boyett el at, 2000; Severs et at, 2001). 
More than any other tissue in the heart, the SA and AV nodes are complex tissues and 
their function depends on the complexity. The SA and AV nodes are made up of nct vorks of 
histologically palely stained, small and slender cells closely packed in a dense matrix of fibrous 
tissue (Severs et at, 2001; Mazgalev el al., 2001). 1{owever, there arc gradual transitions from 
the centre of the nodes to the surrounding atrial myocardium (Blocker el a!., 1982; Masson- 
Pevet et at, 1984; Mazgalev et a!., 2001; Meijler & Janse, 1988; Tawara, 2000). The 
transitional areas, i. e. intermediate myocardium (myoc)Ies with a mixture of nodal and atrial 
properties), may be important physiologically. For example, the leading pacemaker site can 
move from the centre of the SA node to the periphery (or even further, to nodal cells in the 
interatrial groove) and the posterior/inferior nodal extension can drive AV junctional 
pacemaking (Kalman et al., 1995; Boyett el a!., 2000; Dobrzynski et a!., 2003; Yamamoto el 
a!., unpublished observations). Functionally important and complex phenomena in the SA and 
AV nodes include the non-radial spread of the action potential from the leading pacemaker site 
in the SA node, the block of conduction from the leading pacemaker site in the SA node 
towards the atrial septum, (which protects the SA node from reentry and invasion from action 
potentials from outside the SA node) and the dual inputs into the AV node responsible for AV 
transmission, respectively (Nikolski & Efimov, 2001; Jazayeri et (i!., 1992; Keim et a!., 1992; 
Patterson & Schcrlag, 1999; Lo et a!., 1995; Amcllal & Billette, 1996) (ßlcckcr el a!., 1982; 
ßoyctt ei OL, 1999). 
In this study, using immunohistochcmistry with antibodics against ion channcls and 
proteins important to the SA node structurally and functionally, different cell types %%crc 
identified in the rat SA node: the myoc)lcs in the ccntrc of the SA node are Cx43"ncgativc, 
ANI'-negative, IICN4-positive, Na. 1.1"positivc and Na, l. 5"ncgativc; the myoc)lcs In the 
periphery of the SA node arc Cx43-positive, ANP'"ncgativc, IICN4"positivc, Na. l. l"positivc 
and Na. 1.5-positivc; the atrial myoc)1cs arc Cx43-positivc, AN1'-positive, IICN4"ncgatih-c, 
Na. 1.1-positive and Na. 1.5-positivc. These results arc consistent %sith previous reports 
(Dobrzynski el at, 2005; Lei et at, 2004; Maier ei a/.. 2003). 
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The sub-regions in the SA and the AV nodes can be compared in terms of expression 
pattern. Cx43 was absent in the nodal myocytes in the AV node, whereas Cx43 was present in 
the periphery of the SA node (Figs 10.1 and 10.2). The existence of the Cx43 in the periphery of 
the SA node represents a gradual increase in electrical coupling, which is thought to be 
important in enabling the SA node to resist the hyperpolarizing influence of the atrial 
myocardium and yet still be able to drive the atrial myocardium. The absence of the Cx43 in the 
AV node may contribute to the slowing of conduction, shich makes sure the sequential 
contraction of the atria and ventricles (Severs et a!., 2001). 
The distribution of Narl. 1 and Nar1.5 differs in the SA and AV nodes. In agreement 
with previous reports (Maier et a!., 2003; Lei et a!., 2004), Na1.5 labelling was not detected in 
the centre of the SA node (Figs 103 and 4). Lei el a!. (2004) showed Na1.5 labelling in the 
periphery of the mouse SA node using the Cattcrall N41.5 antibody. In the present study, 
evidence of Na1.5 in the periphery of the rat SA node was obtained (Fig. 10.4). In the present 
study, in contrast of N41.5, NaI. I was observed throughout the SA node (Figs. 10.3 and 4). 
However, in the AV node, the distributions of Na1.1 and Na1.5 were the same. Both isoforms 
were expressed in the transitional cells and the postcrior/inferior nodal extension and both were 
not expressed in the enclosed node. As already discussed in chapter 7 (section 7.4.2), the 
expression of Na1.1 and Na1.5 in the transitional cells and posterior/inferior nodal extension 
may contribute the faster upstroke velocity of the action potential in these sub-regions and the 
absence of both isoforms in the enclosed node may contribute to the low upstroke velocity of 
the action potential in this sub-region. 
Chapter 11 
Summary 
I I. I. Summary: three different cell types in and around the AV node 
Table 11.1 summariscs the expression pattern in the diffcrcnt tissues in and around the 
AV node. Based on the expression pattern, three types of nodal cells %%crc identified: type I 
nodal cells wcrc present in the posterior/inferior nodal cxtcnsion, the zone of transitional cells 
and the AV ring bundle on the opposite side of the tricuspid valve to the AV node; type 2 nodal 
cells were expressed in the open node, enclosed node and the termination of the AV ring 
bundle; type 3 nodal cells only differed from type 2 nodal cells in their expression of Cx4O and 
were located in the enclosed node (lo%%cr part), common bundle and bundle branches. 
For all 14 levels investigated from the preparation shown in rig. 2.113. the distribution of the 
different tissues and the three types of nodal myocytes are summarised in Fig. 11. IA. 111c 
distribution of the three types of nodal myocytcs was mapped onto the original preparation (Fig. 
11.113). Figure 11.113 shows that the type I nodal myocytcs In the post criorrnfcrior nodal 
extension continued as the transitional cells adjacent to the open node; type 2 nodal myocytcs In 
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Figure 11.1 Summary of nodal tissue distribution in the rat AV junctional area 
A, diagrams summarising the distribution of different cell types in the 14 levels shown in B. 
Scale bars, 200 µm. B, summary of nodal tissue distribution in the main preparation studied. 
Numbers at the bottom of the panel show the position of the different levels studied. Labels in 
yellow and white show conventional orientation and correct orientation, respectively. Scale bar. 
1 mm. C, schematic diagram summarising nodal tissue distribution in the entire tricuspid 
annulus. The dotted line indicates the cutting plane of sagittal sections shown in chapters 9 and 
10. Light blue, type I nodal myocytes; green, type 2 nodal myocytes; purple, type 3 nodal 
myocytes. A, anterior; AM, atrial myocardium; Ao, aorta; AoV, aortic valve; CB, common 
bundle; CS, coronary sinus; EN, enclosed node; I, inferior; LNC, lower nodal cells; MNC, mid- 
nodal cells; MV, mitral valve; ON, open node; P, posterior; P/I NE, posterior/inferior nodal 
extension; S, superior; TAVRB, termination of the AV ring bundle; TT, tendon of Todaro; TV, 
tricuspid valve; VM, ventricular myocardium. 
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the open node projected into the enclosed node; type 2 nodal myocytes were also present in the 
termination of the AV ring bundle; type 3 nodal myocytes starting in the enclosed node 
continued in the common bundle. 
Figure 11. IC shows a schematic diagram of the whole of the AV ring bundle. Figure 
11.1 C shows that the posterior/inferior nodal extension and transitional cells are just one part of 
the AV ring bundle that projects around the tricuspid annulus and terminates above the AV 
node. Whereas much of the AV ring bundle is made up of type I nodal myocytcs, the 
termination of the AV ring bundle (above the AV node) is made up of type 2 nodal myocytes. 
The detail of the transition from type I to type 2 myocytes from the AV ring bundle to the 
termination of AV ring bundle (in the region between the dashed lines in Figure 11. IC) is not 
known. 
11.2. Discussion 
This study shows for the first time the distribution of different Na' channel isoforms at 
the AV junction including the tricuspid annulus. In addition, the finding of unexpected sub- 
regions (the termination of the AV ring bundle and the "bump") exemplifies the exceptional 
three-dimensional complexity of the AV node. The study has revealed a complex organisation 
of multiple cell types (including three types of nodal cells) at the AV junction that must be the 
substrate of the complex electrophysiology of the AV node, including slow conduction, dual 
pathway clectrophysiology and AV nodal reentry. 
11.2.1. Relation to previous studies 
Petrccca et at (1997) previously reported evidence of a lo%vcr level of cxpression of Na` 
channels in the mid-nodal cells of the rabbit. I lowcvcr, an antibody raised against a conserved 
region of the Nal subfamily was used and, therefore, Petrccca et al. (1997) could not 
discriminate between different Na* channel isoforms. There have been no previous studies using 
antibodies for specific Na* channel isoforms. in the present study, the labelling of I ICN4 in the 
posterior/inferior nodal extension, enclosed node and common bundle in the rat is similar to that 
in the rabbit reported by Dobrzymski et al. (2003). Ko et al (200.1) reported that Cx43 is 
expressed in the posterior nodal extension of the rabbit, whcrcas in this study and in the study of 
the rabbit AV node by Dobrzynski et al. (2003), the posterior nodal extension was Cx43- 
negative. however, this discrepancy is likely to be only the result of confused nomenclature - 
the "posterior nodal extension" in the study of Ko et al. (20W) probably corresponds to the tract 
of type 3, Cx40-cxprcssing (in the rat - Fig. 8.1) or Cx43-expressing (in the rabbit; unpublished 
observations) lower nodal cells. Above the "posterior nodal extension" In the study of Ko cl al. 
(2004), there is a tract of Cx43-ncgativc cells (termed "transitional cells" by Ko el al., 2004) 
and this corresponds to the posterior/inferior nodal extension in the present study (Fig. 11.1) and 
the study of Dobrzynski et al. (2003) 
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11.2.2. Understanding the clcctrophysiology of the AV }unction 
The AV node has dual inputs (slow and fast pathways) from the atrial myocardium and 
this is the substrate for AV node reentry (Moe et a!., 1956; Mendez & Moe, 1966). The slow 
pathway proceeds parallel to the tricuspid valve annulus from beneath the coronary sinus to the 
open node near the apex of the triangle of Koch, whereas the fast pathway enters the open node 
superiorly from the direction of the atrial septum. The results from the present study help to 
understand this dual pathway electrophysiology as well as other aspects of the 
electrophysiology of the AV junction. 
The upstroke velocity and amplitude of the action potential in the atrial (and 
ventricular) myocardium are high (dog atrial myocardium: 158 V/s and 108 mV, Patterson & 
Scherlag, 2002) and this is because the voltage-dependent Na` current, IN is responsible for it. 
In accordance with this, in the present study, labelling of both Narl. 5 and Na1.1 was observed 
in the atrial myocardium (chapters 6 and 7; Table 11.1). The fast conduction velocity (70 cm/s 
in rabbit, Meijler & Janse, 1988) in atrial myocardium can be explained by the high upstroke 
velocity (as a result of the expression of Na1.5 and N41.1). the abundant expression of the 
medium conductance gap junction protein, Cx43 (chapter 4; Table 11.1) and the expression of 
the high-conductance gap junction protein, Cx40 (chapter 8, Table 11.1), in the atrial 
myocardium, because the conduction velocity is dependent on both the upstroke velocity of the 
action potential and the coupling conductance between cells. 
Simultaneous optical mapping of action potentials and immunohistochemical 
delineation of the posterior/infcrior nodal extension in the rabbit has shown that the 
posterior/inferior nodal extension is the slow pathway (unpublished observations). The upstroke 
velocity and amplitude of the action potential in the slow pathway (dog: 41 V/s and 70 mV, 
Patterson & Schcrlag, 2002) are intermediate between those in the atrial myocardium and the 
enclosed node. Consistent with this, in the present study, labelling of both Na1.5 and Na1.1 
was observed in the postcrior/inferior nodal extension (Na. 1.5: 45 t2%; Fig. 7.12) but the 
labelling was less abundant than in the atrial myocardium (No, 1.5: 84 t 10 %; Fig. 7.12). In the 
rabbit, Nikolski et a!. (2003) measured the conduction velocity of the slow pathway to be 7.9 f 
3.4 cm/s (in the nearby atrial myocardium, it was 35.1 * 17.2 cm/s). The slow conduction in the 
posterior/inferior nodal extension could be the result of the lack of expression of the medium 
conductance gap junction protein. Cx43 (chapter 4, Table 11.1), and the high-conductance gap 
junction protein, Cx40 (chapter 8, Table 11.1), in the posterior/inferior nodal extension as well 
as the lower expression of Na' channels (chapter 7). In the posterior/infcrior nodal extension, It 
is known that the low conductance conncxin, Cx45, Is expressed (t)obrzynskl et cal., 2003). 
Figure ILIA, B shows three pathways into the opcn/cncloscd node: (I) the 
posterior/inferior nodal extension (Fig. 1 I. 18 shows that the posterior/inferior nodal extension 
and the open node are continuous), (ii) the zone of transitional cells (6 and 7 in rig. I LIA show 
connections between the zone of transitional cells and the open node) and (iii) atrial 
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myocardium (8 in Fig. 11. IA shows an apparent contact). The location of the zone of 
transitional cells means that it could be the fast pathway from the direction of the atrial septum 
to the open node. The upstroke velocity and amplitude of the action potential in the fast pathway 
(dog: 60 V/s and 71 mV, Patterson & Scherlag, 2002) is again intermediate between that in the 
atrial myocardium and the enclosed node. Consistent with this, in the present study, labelling of 
both Na1.5 and N41.1 was observed in the zone of transitional cells (Na1.5: 44 t 12 %; Fig. 
7.12), but the labelling was less abundant than in the atrial muscle (Na1.5: 84 f 10 %; Fig. 
7.12). The conduction velocity of the fast pathway could be faster than that of the slow pathway. 
If the zone of transitional cells does constitute the fast pathway, the possible difference in 
conduction velocity between the slow and fast pathways (i. e. between the posterior/inferior 
nodal extension and zone of transitional cells) is unlikely to be the result of IN. (because the Na` 
channel expression in the two regions was similar, Fig. 7.12; Table 11.1) or electrical coupling 
(because the expression of connexins was similar, Table 11.1). However, the terms fast and 
slow were originally introduced to describe differences in the observed time intervals not 
velocities during AV node reentrant tachycardia. In fact, it has never been demonstrated that the 
wavefronts deserve their adjectives (Mazgalev & Tchou, 2000a; Mazgalev & Tchou, 2000b). 
The faster conduction of the fast pathway is perhaps the result of the shortness (-1 mm) of the 
tract of Cx43-negative myocytes with reduced Na1.5 and Nal. 1 expression in the zone of 
transitional cells that the action potential has to propagate across in order to reach the open node 
(the length of the slow pathway, i. e. postcriorrnferior nodal extension, is much greater) (Fig. 
11.113). Across such a short distance, the electrotonic influence of the atrial muscle will be 
important. Alternatively, or in addition, the faster conduction of the fast pathway is perhaps the 
consequence of the "back door" connection between the atrial muscle and the open node (8 in 
Fig. 11.1 A). 
In contrast to the atrial muscle, the upstroke velocity and amplitude of the action 
potential in the enclosed node arc low (dog: 18 V/s and 54 mV, Patterson & Schcrlag, 2002) and 
this is because the [,. type Ca=' current, Ic., rather than IN, is responsible for it. In cells likely to 
be from the enclosed node, there is no 'Ni (Pctrecca et al., 1997). Consistent with this, in the 
present study, no or reduced labelling of either Na. I. S or Narl. 1 was observed in the enclosed 
node (Figs. 7.1 E, 7.11 C and 7.12). The absence or reduced level of Na, 1.5 or Nal. 1 expression 
continued from the open node, through the enclosed node and common bundle to the proximal 
left (and presumably right) bundle branch. Consistent with this, the upstroke velocity and 
amplitude of the action potential is still low in the Nil cells in this region (dog: 29 V/s and 61 
mV, Patterson & Scherlag, 2002). The slow conduction through the AV node (0.7 cm/s in chick 
embryo, Arguello et al., 1986) is responsible for the delay between the activation of the atria 
and ventricles in the cardiac cycle. The absence or reduced level of Nar1.5 and N41.1 
expression from the open node to the proximal lcft and right bundle branches will, at least, 
contribute to the slow conduction. The expression pattern of conncxins may also contribute: 
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from the open node to the proximal left and right bundle branches, the medium conductance gap 
junction protein, Cx43, is not expressed (or poorly expressed), although, from the enclosed node 
to the left and right bundle branches (and, presumably, onto the terminal Purkinje fibres), the 
high-conductance gap junction protein, Cx40, is expressed (chapter 8). In the open node and 
part of the enclosed node, Cx40 is not expressed and Cx43 is either not or poorly expressed and 
instead the low-conductance gap junction protein, Cx45, is expressed (Dobrzynski el al., 2003) 
and this pattern of expression, at least, is expected to contribute to the slow conduction of the 
AV node. 
In the dog, the upstroke velocity and amplitude of the action potential (dog: 140 V/s and 
III mV, Patterson & Scherlag, 2002) and conduction velocity (100-150 cm/s in dog, Ilofmann 
& Cranefield, 1960) in the common bundle are high. The high upstroke velocity and amplitude 
of the action potential in the common bundle in the dog are not consistent with the lack or 
reduced level of expression of Nal. 5 and N41.1 in the common bundle in the rat (Figs. 7.1 and 
7.11). It is possible that there is a difference between species and the upstroke velocity and 
action potential amplitude are low in the common bundle of the rat. The rapid conduction 
velocity in the common bundle in the dog may either not be true of the rat or it is the result of 
the abundant expression of Cx40 in the common bundle (Fig. 8.1). A reduction of Na' 
conductance can produce only a three-fold reduction in conduction velocity, whereas a decrease 
in coupling via connexin can cause a 100-fold reduction (Shaw & Rudy, 1997). In the common 
bundle, previous reports (Mazgalev et a!., 2001; Nikolski el a!., 2003) have described distinct 
electrophysiologies in the mid and lower nodal cells - does this correspond to the mid Cx40- 
negative and lower Cx40-positive nodal cells in the rat as shown in Fig. 8.1? 
N41.3 labelling (arguably an indication of innervation) was minimal in the atrial and 
ventricular muscle, present (but not abundant) in the specialised pathways into the AV node 
(posterior/inferior nodal extension and zone of the transitional cells) and abundant in the open 
and enclosed nodes. Therefore, innervation appears to be controlling AV conduction at the point 
at which conduction will be the most severely constrained by the absence of Na1.5, Naj. l, 
Cx40 (in part at least) and Cx43 (to a large degree at least). 
11.2.3. Why do mutations in or knockout of Na, 1.5 (SCN5A) result in AV 
conduction dcfccts? 
The role of Nar1.5 in AV conduction has recently been highlighted by the discovery of 
inherited AV conduction disturbances (AV conduction block or slowing of AV conduction) 
linked to mutations in SCN5A (Schott et al., 1999; Tan c! (il., 2001; Lupoglazoff cl al., 2001; 
Kyndt et al., 2001) and the discovery that SCNSA"* mice have impaired AV conduction (as 
well as other cardiac conduction defects) (Papadatos et al., 2002). Our findings provide the 
substrate for these conduction disturbances. There is no Na, 1. S expressed in a long tract from 
the open node to the proximal part of the left and presumably right bundle branches (Table 11.1 
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and Fig. 11.1). However, Na, 1.5 is expressed in the pathways into the open node 
(posterior/inferior nodal extension and transitional cells) (Fig. 11.1), but less abundantly than in 
the working myocardium, and these are the most likely regions that conduction defects will 
occur on impairing Na, 1.5 (because the safety factor for conduction is already likely to be low 
in these regions as a result of the lower expression of Na, 1.5). This raises the possibility that the 
AV conduction abnormalities could be corrected by local up-regulation of Na, 1.5 (perhaps by 
local transfection with further copies of SCN5A). Alternatively (or as well) the AV conduction 
abnormalities could be the result of impaired conduction in the bundle branches, because the 
bundle branches do express Na, 1.5 (Fig. 7.9) and indeed there is evidence of this (Papadatos et 
al., 2002). 
11.2.4. Mapping the AV conduction system 
Recently, a three-dimensional anatomical model of the human AV node has been 
generated based on histological information only (Mutharasan et al., 2004). Although an 
appreciation of the complex anatomy of the AV junction is undoubtedly important for the 
understanding of AV conduction, it is also important to understand the distribution of the 
proteins involved in the action potential and its conduction. Dobrzynski et al. (2003) mapped 
the distribution of HCN4 in the rabbit AV node, but HCN4 is involved in pacemaking. Ko et al. 
(2004) mapped the distribution of connexins in the rabbit AV node and this is important in 
understanding action potential conduction. In the present study, I not only largely confirmed the 
findings of Dobrzynski et al. (2003) and Ko et al. (2004) as regards HCN4 and connexins, I 
extended them to the whole of the AV junction. Although connexins play an important role in 
the conduction, Na' channels also play a major role and this is the first study to map in detail the 
distribution of Na' channels throughout the AV junction. The expression of the Na, channels 
was non-uniform at the AV junction and allowed the identification of various types of nodal 
myocytes. 
11.3. Limitations of this study 
The expression of protein is often qualitatively and quantitatively heterogeneous, both 
spatially within an organ or tissue and temporally in relation to development or disease. 
Cytochemistry is indispensable to the analysis of these heterogeneities in the pattern of 
expression. 
In this study, immunohistochemistry was the experimental technique most frequently 
used. Several intrinsic technical difficulties, including reliability and specificity of antibody 
probes and quality and interpretation of the image data, have been encountered during the 
investigation. In particular, the identification of genuine Na, 1.5 labelling was the most 
troublesome. In the present study, three independent Na, 1.5 antibodies were used (Table 6.1). 
These antibodies produced intracellular labelling in most cases. This labelling pattern was not 
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consistent with other investigators' observations. This difference could be due to a difference in 
antibody, a difference in species or the result of two pools of Na1.5 (with different antibody 
accessibility). The validity of Alomone Na, 1.5 antibody was confirmed with several control 
experiments including control immunolabelling, transfection experiments carried out by Dr. S. 
Xu and Western blot experiments carried out by Dr. S. Jones. 
There were some other difficulties and disadvantages in the methods and experimental 
conditions used. The number of levels studied was not enough to construct a precise 3D model 
of the AV node. As tissue deformation is inevitable in freezing and cryosectioning, jumps in the 
tissue architecture always happened from one level to the next. 
In the present study, morphological aspects of the AV node were investigated. It is 
possible that sections cut at a different angle would have made it possible to construct a more 
precise and information-rich 3D model. Although the importance of Na' channels has been 
reported in transgenic animal studies, elucidating the functional role of the Na" channels in the 
different cell types at the AV junction needs to be carried out. 
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